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In Sub-Saharan Africa, children' are"at4he greatest'risk"of morbidityand. mortality.. 
from malaria, which. is duemaiiily toPiasniodium faiciparum. Ne:wborn.children appeaL 
"to be relatively protected from infection and clinical illness when compared with.older, 
children. This, pTotection may be mediated by, bthinpae an4 imnwnplogiçai factors. As 
part of a longitudinal study into the hurnoral immune response to malaria in infants 52 
out of 156 children were found to be chronically infected with P.falciparum. In 15 of 
these children, the allelic diversity of these, infections was analysed by PCR typing of ,  
msp 1 and msp 2 alleles followed by sequencing the polymorphic region of rnsp 2.The 
study shows that infants become infected with a number of different allelic types of P. 
talciparum 1 hese infections were of very low density and were asymptomatic I he 
number of different genotypes varied over time in each child. Persistent infection in 
some children was clearly due to multiple new infections, whereas in other children 
singleparasite genolypes persisted for -very long periods of line, up to seven months in 
some children. 
In order to'ec'aivateseroiogicài responses to asexual stage.malari antigens, serum, 
obta1ncd at monthly Intcr%als ocr the frst year of 11fc -crc tested, by ELISA, against 
recombinant proteins.  representing varioiismerozoite antigens. To determine the specific 
response to MSP 2, novel polymorphic' Sequences of MSP 2 were expressed asGST 
fusion .proteins.: GST fusion, proteins representing the conserved and dimopi,ic 
sequences of !iISP 2 were also constructed. Responses to specific antigens varied 
between individuals. Different children produced antibodies to different antigens at 
different time points 'depending on the presence or absence of infection. There were 
occasions when adecline in a specific antibody titre was associated with infection or 
reinfection with parasites carrying the same specific polymorphic antigen, which may 'be 
indicative of "strain-specific immunity" operating at the level of MSP 2. 
interestingly; antibody responses "to' several different MSP 2 sequences .were.found to. 
         tifibe uoss-ieactv,indiatiiig th4tthe uinbeiofselologlcailyIdenable MSP 2 vanaits  
may,  be smaller than 'the number of sequence variants Intriguingly, vve also found that 
pairs of immunologically cross-Eeactive variants of MSP 2 were frequently, found1.
together in different children. This data provides, evidence in support of the Gupta-Day 
theory of strain-structuring of—malaria parasite populations and indicates that antibody 
responses to MSP 2 may he able to select for elimination or control of malaria parasites. 
If so, this would be strong supportive evidence for the effector role of anti-MSP 2 
antibodies and would suggest that MSP 2 might be an important component of a malaria 
vaccine. 
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2. 1. 1 introduction , to Plasmodium faiciparum 
Plasmodiumfalciparum is a vector-borne protist parasite, whose intermediate host is 
human; there are two stages in the intermediate host, know as the exoerythrocytic and 
erythrocytic cycles while the definitive host i the Anopheline mosquito. See Figure 1; As 
P. faiciparurn is a vector-borne disease the distribution of'thè vector accounts for the 
distribution of P.faiciparum. In areas where there has been successful malaria control,e.g. 
South Western USA. and. Italy, this .has been mainly. .dueto. vector control. 
in many areas of Africa. ,there. is seasonal -variation in the parasite rate and intensity of 
mfections,bc4h increasing during the .wetseason. This can be explained by the increase in 
sector numbers 1eadng to an increasing çntomoI9gca1 inoculation rate e.g.  in Senegal [1] 
This seasonal yariatiçn iS also seen in studies from other parts of Africa e.g.  Ghana [2] and 
The Gambia [3]. Gilles showed ,that there. wasagreat seasonal variation, of parasite .rates in 
infants from birth to 6 months of age in The Gambia [4]. 
2.1.1 'Allelic and genornic diversity 
Studies looking at isoenzymes, cytochrome C and surface antigens have shown-that 
there is a great deal of genetic variation in P. falciparum. This variation, may'bç expected 
as the parasite is in close contact with the host's immune system and so, as a population, 
the variation would be of great advantage in establishing a new infection in a previously 
exposed'host, if the variation was in critical antigens . There are mechanisms, which P' 
a1ciparurn possesses, which would enable this diversity to develop The karyotype shows a 
great deal of plasticity with frequent chromosomal transiocati'on [5] and recombination also 
occurs during, the. obligatory s,exuaI cycle in.the.mosquito46J.. The oniytirne That... 
Piasmodium can undecgonieiosis, and therefore.recombiiiatiou, is in the ookinete and early. 
oocyst as for all other stages of the life cycle PiasmQdium, is haploid. In the natural 
situation 3 there can only be recombination between paastes which are presnt.in the 
mosquitoat..the same time. So for recombinant progeny to be generated, an individual 
mosquito must pick- up two . ge.notypicaily.different parasites. These two genotypes may 
derive from a single human with a mixed infection in which both clones are producing 
gametocytes, or from different humans on which the mosquito has fed on within a short 
period of time. 
"-7 
Many antigens of P.-fálciparum are polymorphic; this diversity is seen in some 
erythrocyte stage antigens, for example merozoite surface protein 1 (MSP 1) [7],  merozoite 
surface protein-2 (.MSP.2)[8],.S antigens [.9], apical membrane protein 1 (AMA-1) [77] and 
GLURP,[10]. Two antigens .that,lutve been closely studied are merozoite surface protein i 
(MSP 1)andmerozoite,surface .prqtein 2,(MSP 2). 'rl'hese proteins re.expressedon the 
,... 1_ 	:... +i...- 	• + 	.t 	. 	c+i, o 	mrow 	 c, , in 	incradou 01 LUC 
eoçite and teerythrQcye [11]. MSP I ad MSP reglyeoproteins:.MSP 1..has a 
molecular mass of approximately 195 kDa and MSP 2 has a molecular..mass of 
approximately 45 kDa. Both proteins are attached to the merozoite. surface, by -a 
phosphatidylinositol anchor.'The size of the pmteins variesdepèndingon .the.aJlele that i. 
present in the parasite genome. 
2.1.2 "Merozoite surface protein '1 (MSP i) 
MSP 1 undergoes extensive proteolytic cleavage during the erythrocytic cycle. cleavage 
has been shown to be necessary for the invasion of erythrocyte by merozoites. Using 
monoclonal antibodies and immunofluorescence (WA), MSP.l. has been detected in 
maturing schizonts [12]. When schizont extract was run on a Western blot, MSP !.was 
detected - as a 195 kDã protein. 1-his protein is progressively cleaved during the maturation 
of-the nierozoit. This processing. occurs in two, stages, the initial stage. producing.. 
fraginentsof 83, 42, 38 and 30 kDa [12j. This occurs as the inerozoites maturein the 
schizont. These fragiients form a non-covalently bound complex. on the merozoite surface 
[ 13jj. The second processing step occurs on the free merozoite. In this step, the 42 kDa 
fragment isdegraded to produce a free 33 kDa fragment, which is. released from the 
merozoite [12], and a 19 kDa fragment, which is anchored to the merozoite surface by the 
phosphatidylinositol group. The 19 kDa polypeptide contains two epidermal growth factor 
like motifs [14]. These motifs are often found in proteins rnediatingcell/celi interactions 
which suggests that there may be interaction between this 19 kDa fragment and a surface 
molecule of the er throc te. Monoclonal antibodies that inhibit the invasion of erythrocytes 
by merozoites [.15] have been shown to bind conformation-dependent epitopes, which are 
only .found in the non-reduced 19.kDa recombinant fragment .[ 16]. Some inhibitory 
monoclonal antibodies appear to funcuon by biociung the final processing event [141 
MSP I was firt classified. iuto.two.sero.-groups by monocional anUb.ody reactivities [7]. 
Subsequent classification of these proteins was by analysis of their DNA sequences The 
ht 
'diversity of"MSP'l can be classified into discrete blocks of conserved dimorphic and 
polymorphic regions. The dimorphic regions are 'blocks 416 and the polymorphic region is 
block two. Regions one; three and 17 are classed as conserved.'In-biock 2 three types of 
poi.yniorphi.sm have .beeii described. Two of the alleic families consist of tandem rpea1sof 
diffèrene seqüéiice, based dn'SXLY trijptide sequence, and th third lacks trietide 
'cpcats ánd'is made up of a variabló non-Fópctiti'scqticncc [17-19]. Thc' 'cqucñccs for the 
.dimorphic families were first described from the MAD20 and Weilcome isolates and So- are-
know as MAD20-type and K 1-type alleles, while sequences for the polymorphic families 
were first described from the MAD20, Ki or R033 isolates, and are denoted according1y 
It has been suggested. that intragenic recombination in the insect diploid stages has 
generated many. of the variants [20]. The conserved regions  three and five seemed to he the 
main site for intragemc recombination. By analysing,a cross between two clones, 
recombination was found to' have occurred"between the end of region two and the 
beginning Of region six. [6]. This shows that recombination is a possible mechanism by 
which novel combinations of - different regions can be produced. 
It is not clear why there are only two major alleles, butit has been suggested to be 
b34us. there tire , two ligands or-a, single., dirnorphic ligandtawhich.MSP .1 binds 1.191. 
1_ 	_1.4'. 	 .1 	..0 
EYtUCik.e LU4L UIC I iva tegion is the ,only iiagment iett on tue uiia Oi tue iuvauiitg 
mérozoto [15] and that there are Ofli four amino acid differences bet%een the two forms 
[21] make this seem unlikely but the dimorphism. in the ligand may be quite subtle. Another 
possible explanation for the presence of two alleles is that the speciation of P. falciparuin 
occurred, in two geographically disparate regions and, then as P. falciparurn. ws spread 
the,igrat.iQn,ofman,.the.iso1stion,wasJot-Both allelic types of the allele are now found 
in the same regions (although in much of Africa the MAD20-type is much more common 
than the Ki-type) [22]. 
2.1.3 Merozoite Surface Protein 2'(MSP2) 
The sequence variation seen in msp2 is also found in discrete blocks with conserved, 
dimorphic and polymorphic regions.-There are N- and 'C- terminal conserved regions, and a 
central polymorphic region winch is flanked by dimorphic regions Unlike msp 1, the 
polymorphic region and dimorphic regions tend to be associated with each other, possibly 
due to the-lack of a conserved region between-the dimorphic and polymorphic regions to 
facilitate recotnbiiiation, although sonic hybrid alleles havebeed found. For exainpie,such 
alleles have been found in Senegal, usingPCR with mis-matched pairs of family—specific 
primers (23, '241 and in Papua New Guinea, recombinants have been found [25]. The type 
specific-dimorphic families were first described from FC27 (B) and ICI (A) isolates and 
are iid'di-iiiugly. Th'iihiii'of ihe [wo 'iiui1liCsvaries in both 
sequence arid size. The archetypal B-type poiyiñ'orphk region consists of two 32 amino 
A .4 ~. 	 4'.-,. 	 ,.-...-. 	 4-,. acid 	am 0 i cuAuw a.,I'..I 	 rcpca O a 
number of eight orToür amino' aid "repeats [26,27]. Polymorphisnis in the B type family 
tend to be in the number of repeats, wlere as A-type polymorphisv's 'end to involve 
changes in".sequenee of  - the -repeats as well as repeat number 
2.2. PCR-based genotyping studies 
msp / and msp 2 have been used 'as tarets'for PCR based detection of different alletic 
types 'n infected people and in mosquitoes 	The presence of conserved regions, which flank 
t 	 gins.allo 	neahe''ariable fe 	 C"ipir  of primers' 'to detect 'all parasites [2_3;; ,24; -29_ ~34 J. 
Polymorphisms are identified by size differences in the PCR products and by hybrization of 
oligo-nucleotide probes. The ability to type the parasites present in a host enables questions 
about the complexity of infection, the frequency of re-ithéction and the persistence of an 
infection in a field situation to be answered. - With this approach; there are a number of 
advantages and disadvantages. The use of PCR to detect the presence of  - parasites enables 
iowCrlevels- of infection. tobe. detected, than. would, bepossibie i. using blood : films [321. 
This method allows the parasites present to .beanalysed without the need to culture the 
samples, so theres no possibilit y of losing a parasite type h1ch does not grow well in 
culture while waiting for the antigen of interest to be expressed The main drawback, of 
using PCR.is that if no product is produced this could be due there being no parasites there 
r.th..parasite present may not have a sequence complementary to that to which the primers 
were desjgned [131 However, expenence suggests that mutations in the conserved regions 
are uncommon. 
PCR based. genotyping has been used to look at the effect of age/exposure and 
complexity of parasite ifectiôn in people with different cliniCal status. In a hôldendemic 
area of'Senega!, Ntoumi et at [2:31 found in a cross sectional 4udy that there was a change 
in the number of allelic types of MSP 2 carried with age. As age increased there was a 
decrease in the number of 'alleles detected. There was a significant difference between the 
nuinbr"of alleles fquud in people, aged. less than 15.years (3.9-4.8 alleles) and people aged 
_i'J. 
'175 years and 61'der'(1.923 al!les)This sugg,ests that the'devëlopment of immunity may 
be strain-specific. -In: this study, there was no association of a specific allelic type with any 
age group [23].7he  distribution of alleles in infected people in The Gambia was 
hwestigated using .monoelouai alfluibUdICS against MSP 1 and MSP 2 [34]. This -wurkfuund 
.tiat there was no difference inhe number .ofaileLes in different age groupsor -with' people 
of .diffctcnt,cUnicai ttus. The mean number .of allelic types round WaS 2:02. The 
difference i'n'thé findings of'this'stüdy cö 	red'With'stüdiesariied Out'iisiñg PCR based 
techniques may be due to the fact that  not all ,chaages in sqieIce lead. to achange in 
epitope and so nucle-otide changes may not be recognised by the monoclonal antibody 
panel; i.e. monoclonal antibodies recognise a small part of the sequence; but major changes 
may have occurred else where in the molecule. Studies from Papua New Guinea found that 
the B-type allele of msp 2 was most common in adults while the A- type allélé was more 
common in children E35').  In further work, this group has shown that the B-type allele is 
found more commonly in people with clinical illness, with fever and parasitaemia greater 
than 5000 parasites/yd; when compared to asymptomatic P.faiciparum infected controls 
• iiiatched f6jr, age and home. village.. E36]. .The.authors of the sepapeis.suggest.that this may. 
be due to the B- type allele being more able to e - ade an immune response due to the 
uiiicr 'Snrcy a 
In contrast' withthe work carried out ii Papua. New Guinea, a,sudy fron,SenegaI.[29] 
found no association of MSP 2 allelic type with clinical illness. In this study children were 
followed for a number of months, i;e. through periods of being asymptomatic and of being 
ill:The réstilts'from this study showed that when a child was ill; they were infected with an 
allelic type, which had not been previously detected. This suggests that clinical illness may 
be due to the rapid multiplication of parasites carrying novel alleles due to the lack of a 
specific immune response Daubersies eta! 1241 followed asymptomatic  individuals in an 
area of high transmission and looked at the allelic diversity of infections. Blood samples 
were taken approximately every 2 weeks. Over the two months of the study each individual 
sddeafof irhuti'on in thai1eIsof&)th mp i and np 2'ciiL An increase 
n parasitaenna correlated with an increase in the nuriiber of alielic types S'anipies taken 
,...' 	-1.. .1,-.. 	 1. blaing -4 uay iiw Cu tuii&ai iaflauiu uui. 1tuiiar aiiiS 	 ait ut..'i. 
detectedn a number of samples This could be eplaned by re-infection of the host after 
clearance or the parasite carrying that allele may have been sequestered such that peripheral 
blood samples did not contain these parasite types. In areas of low transmission,a.host 
,, 11 
appears to carry the same ãllëIe for a prolonged peritid of time showing that chronic single 
clone infections are possible without illness [24j. The authors suggest that this may 'be a 
good popuiation'to investigate anti-disease and anti-parasite immunity. 
In addition to antigenic diversity P.faiciparum undergoes antigenic variation. This 
phenoinenon is also seeiiu. Trypano.omabruceLantLGiat'diaiamblla. it isgeneraily 
believe' d that antigenic.,'variation has evolved to enable the parasite 19 ,establish a prolonged 
1nfcction, to ensure that transmission to thc next host occurs ifl contrast, antigenic dr cr&ty 
would enable a new host to be infected. Antigenic variation was çfirst seen in monkey 
malaria and murine malaria [37,38]. Antigenic variation is detected on the surface of the 
intederythocte;the. changeS in antigen type can be associated with a change in binding 
preference of the infected erythrocyte to human cell surface ligands e.g. CD36, ICAM 1. 
By selecting clones according, to their adherent phenotype and then looking at their binding 
of monoclonâl antibodies, it was found that antigeriic variation and host ligand binding are 
linked .[39];The variable antigen is. thought tobePfEMPI.'This protein is coded for by a 
large gene-family know as var with about 50 members found in any one parasite [40, 41']. 
There is a considerable sequence -variation between the members of the family. There are 
conserved domains, which are homologous to the cysteine rich domains found in the 
erythrocyte binding protein of P faiciparum and the Duffy antigen binding protein of P 
D 	 r,u ,iii ii.; 	 r'r' 	th 	 1, 	. • ,. 	 rao 	e cungs penop 
have been linked to a change in the expresion of a different.vargene [42]. The mechanism 
by which switching between different genes occurs is not known. 
2.3. Pathology and Age Distribution 
Thep$1o1ogy cf infection is sqçiad with the erythrQcytic cycle of the intermediate 
host stage of the iie-cycie. The  rupture of erythrocytes releasing merozoites into the blood 
streamis associated with 'the n lId pathology. Parasite 'derived toxins 'are thought to induce 
the fever and nausea which characterise the mild pathology of P.faiciparum. .These 
symptoms are generally found in children living in endemic areas or in naive adults who 
are infected.  
-, 1') 
- Xfl  
The two main severe pathologies, which are associated with P. fidlciparuminfection are 
cerebral malaria (CM) and severe malaria anaemia (SMA). These are most common in 
infants in endemic areas. The aetiology of these manifestations is not clear. The mean age 
for a cerebral attack in The Gambia is 45 months while in Coastal Kenya the mean age is 
40 months [433. In coastal Kenya there .isa -greater..malaria transmission than in The 
.Gambia. S.MA occurs most commonly .at 27 months in 3ambian children while in Coastal 
Kenya the meap age is 22 .qn,tb [43]. The jei.dcc.of,CM i not 4uc to tle patient not 
having prior exposure; when sera from severe malaria patients were compared toserafrom 
non-severe malaria patients, all severe malaria patients had pre-existing malaria antibodies 
and there was no difference in the number of parasite strains that the sera agglutinated [44]. 
When admissions to hospital for clinical malaria were compared in areas with different 
transmission rates, there was a greater proportion of children under one year of age 
admittedto hospital.' cerebral malaria was 4titiies less common and SMA was 3:-times more 
common, in the region with the highest transmission. if the under five of age group 
admissions were looked at, there was no difference in the rates between the two regions 
[45]. 
The effect of malaria infection, in, early life. has. been. studied by following a.group.of.64 
• 	 _. t. L 	11 	 1.J).r.. .. rA€1 ml. -- - ------ 11 tmant irom VU.UL Ufltu uy Weje. to IuvflLu Olu iu,lNlgeria .ui, i ure was asuiau 
difference in weight gain betveen infected and imnfected infants, but th1s was not 
significant. Detected.infections.were not cleared by chemotherapy rather being left to run 
their course. Asi-milar finding was noted-in -another study comparing infants who, had been 
given..regular anti-malaria chemotherapy compared with non treated infants [471.  It was 
sigeste4.that variation between individnals in their response to malaria infections may he 
due to differences in immune response/host physiology or due to micro-variation in the 
local transmission rate, which would lead to differential infection patterns in a village [48]. 
24; Infection in newborn 
Newborn infants have been suggested to have innate protection from malaria, which 
slows the onset of parasitaemia, morbidity .and mortality. A field study which supports this 
idea found that the duration Of infection in the first two months of life was much shorter 
than infections, which occurr6dbetween3 and 12 months of age [49].Factors that are 
thought-to contribute to this protection are-the presence of foetaihaemogiobin, para - 
aininobenzoic acid .(pABA)-deficient breast milk diets, intrauterine transfer of maternal IgG 
.L. i..? 
(as well as - intrauterine transfer there is alsoIgG transfer via the mothers' breast milk) and 
physical protection from vectors It has been shown that there is an inverse relationship 
between levels of foetal haemoglobin and parasite rates with increasing age [4].  Foetal 
haeinogiobin .(HUF) has been shown to reduce the in viiru growth rate of P. fuivipururn 
schizonts [50]. The effect of IibF on .erythrocyte paiasitism was also investigated by 
looking t blood smprs, wiicb w.crç ,takcn ftom a thrcç monti old child, 'and comparing the 
pisiiHbF and adult haemo o in (1 bA),cpig,cel. It was found that 
more paiasite were piesentin Hbcontaining cells [51]. These effects may be due to HbF 
inhibiting parasite growth once the erythrocyte has been invaded, possibly through. the 
higher oxygen affinity of foetal haemoglobin reducing oxygen levels in H hF erythrocytes. 
which inhibits the growth of the parasite. Alternatively the amino acid differences in the 
HbFmolëculë compared to adult haemoglobin may, prevent or slOw the digestion of 
haemogiObin by the parasite proteases[50, Si].  There may also be other differences in HbF: 
erythrocyte chemistry, which lead to inhibition of growth. 
• Experiments have shown that there was suppression of P. herghei parasitaemia in rats 
when they were,fed on a milk diet [52]. This led ,to the suggestion that breast-feeding 
infatits.wilcihave.agreater degree o protectio,41 	iion-breast-fed inf4nts. As the as 
majonty of mothers in Africa breast-feed their children, it can be 'very difficult to find a 
sufficiently large control groLp to test this The research into the role of pABA in malaria 
infection is therefore limited to observations from experirnent with rodent malaria.  It has 
been noted that a change to food with a hi gherpA'BA levels leads to, an increase in 
parasitaemias and mortality in a system usually showing low levels of both (Dr. J, McBride.. 
per s. comm.). This anecdotal evidence suggests that levels of pABA in the diet can have an 
effect on the severity of malaria infection. 
'25. immunity to P. falciparum 
In most of S411-Saharan Aft ca.. Phzvmodiumfql(.-in1MAm is endemic. Jnares were hr 
is endemic malaria transmission, there is a characteristic pattern  of infection: parasite 
prevalence increases from birth until about fl) 13 years of age [1, '43]  f011owed by a 
gradual decrease of prevalence into 'adulthood. As a population, adults are rareiy'free from 
infection but may be' free from illness."This pattern can be explained by repeated exposure 
leading to the development of protective immunity. The age at which' this immunity 
develops deueases with uu.reasiug trausuussiuu rate suggesting that a i..ertaiu tiuninial 
,,
I  '1 4__  
number of infections must occur in order to 'develop protection r78i Most studies have 
shown that the incidence of clinical illness decreases prior to the decrease in parasite 
prevalence. 'These findings have led to' the idea' that there are - two- types of immunity which 
develop in .respouse .I.o natur4 exposure: first, -ail anti-disease immunity develops relatively 
quickly being $fec,tive ,atabout 3 years of age, and then immunity 4eveiops against the 
parasite whichicãdsto the decrease in parasite density and prevalence sccn in adults [47]. 
2.5 Age vs Exposure 
It was thought - for a long, time.Lbat thedeveiopmentof,an effective immune ,response ,tQ, 
control patitc ñutnbcrs nd c!inial i'llficas required a prolonged peried of oxpourc, i.e. 
from birth to late adolesce'ce, as exposure to different variants of the parasite would be 
necessary. But work carried out by Baird et al [53-55] showed that the age of a population 
had.. greater influence on it's susceptibility to malaria infection than the. duration of 
Previous exposure to infection. Two study populations were followed for 16 weeks, one 
population being native to the study area (Irian Jaya where malaria is hyperendemic) and 
the second being migrants to Irian Jaya Irom Java where malaria is not endemic The 
migrants had been living in the endemic area for  years. When the prevalence Of malaria 
with age was compared in' - these groups, it was found that the same pattern was found in 
both groups but .the native group were more protected at all ages. Other measures of 
suseptibihty, su.,ii as mean peuud until fist j,alasitaenna, high ring stage counts and 
individual shde posltLve rates also showed th1s pattern When cumuiative exposure and 
acquird çrotectjo,l were plotted against age there was an increase in protection with age, 
independent of cumulative exposure. When an endemic population was looked at in the 
same way there was an increase in protection with increasing exposure. [55]. This work 
suggests than there are intrinsic differences between adults and children in.their.abiiity..to 
become resistant to malaria infection and clinical illness and that adults develop protective 
immune responses more quickly than children. 
Experiments using rodent malaria have shown that age can affect susceptibility to 
itifection; it has been shown that adoptive transfer can transfer adu!tlike immunity to 
young mice.' In humans, protection to schistosomiasis is associated with a change of isotype 
of antibodiesfromigM, lgG2 and igG4 to igE [56], which occurs with an increase in age 
and ,paraileis the decrease in prevalenee and intensity of  SCIMSUOS01111asis iii exposed 
population. in areas where environmental changes have led .to the introduction of 
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sthistosomiasis adults' have a greater level of protection than children from infection 
independent of their exposure [57]. This suggests that high parasite burdens in children may 
'be due - to-their immune system being unable - to mount an effective immune response. A 
siniiar .paUeni of antibody isot.y-pe .witehing and associated protection has been seen in P. 
fakiparum infected populations, .the switch from igG I to I9 G:3 antibodies against MSI? 2 
i...i. i..-. : 	 ....: 	-.-.:.- 	i: 	1 11 	ro icLU W ,tTh.'WcLSW 	 aaI,Lb,L ,Ciiflicai 1iuiS, t,. 
244 Development of immunity 
Immunity to 'P.falciparumis slow todeve!op; it. has been. suggested that, this is. because. 
there is a strictuai feature of the antigens hch dela, s the de clopmcnt of an cffcctl% c 
immune response. Many antigens contain repeat regions, for  example Pf155/RESA,1.
circumsporozoite.. (CS) protein, S antigens; MSP 1 and MSP 2; It was first suggested that 
these regions might be involved in cell-cell interactions Thefinding that these regions are 
immunodominant [59] and can induce cross-reactive antibodies lead to the hypothesis that 
these domains may be responsible for delaying an effective immune response [60]..Anders 
I.O I.  suggested that as these repeats cross-react they.. would prevent effective affinity 
maturation and so lead to-low affinity antibodies'being produced. Implicit in this theory is 
that the repeats themselves would be the target of a protective immune response, , but it is 
hard .to conceive how a region of a protein can have these two functions: an essential role 
for parasite suriva1 and oite of evading ,the iirimun.e response. Another explanation of how 
these repeats may lead to the .delayof an effective immune response ,s base4 on work in 
Which P/e  _sporqzo-tees was compared with the. 
same procedure carried out using Tetanus toxin. The NANP repeatis. found..in the. CS 
protien which is expressed by sporozoites This experiment showed that the addition of 
primed T-cells did not increase the production of anti NANP antibodies (measured using 
NANPpeptide) [6l].  The authors suggests that this phenomenon could be explained by 
the repetitive region cross-linking immunoglobulin on the B cell surface leading to T-cell-
independent antibody productiàn,  in a manner similar to Gram negative bacteria which 
express repetitive antigens on their surface (although the repetitive nature of the bacterial. 
antigens is generally due to repeating polysaccaride units) and induce a T-ceil-independent. 
antibody 	AIiLi'óOdieproduced without T 6tif Itlj iié inibie to ui"deijd ttfedti 
	
- -- -------l___ 	__.___.1_1I__ 	 .- 	-- diIlulty maturation or .class sw1tniug.anu would oc.poui ..eitecturs Ui an.Inin1uneiespuuse. 
However the presence of these antibodies could also prevent the development  bf an 
-. 
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"immune response to conserved regions Of 'the same molecule due to epitope suppression 
[t2J. 
A study carried out in Nigeria failed, to show any correlation between maternally-derived., 
antibodies and protection from infection in infants. The antigens used in this study 
contained repetitive epitopes. Peopieinfected. with, or.withproionged .exposure.to , P.. 
faiciparwn' havehypergammag1obulinaemi'a and the antody response increases with age, 
appearing torcflcct exposure. 
When' looking at the immune respous.e to ,malaria in.naturally. expoe4 popiIaions the 
type of'study, undertaken affects-the conclusions that can be drawn from the study. Cross-
sectional studies enable the. kinetics of immune factors, e.g. antibodies, to be seen with age.,1.
If individuals are followed longitudinally then the effect of a speciflc immune profile on the 
presence of parasites and the clinical status of the individual can also be analysed. 
In one study carried out in The Gambia in children aged between 1 and 11 years old, 
levels of"antibodies which were able to agglutinate infected erythrocytes were found to be 
correlated with protectiOn against clinical illness [3 -1. This suggests that the ability to 
aggulinate infected 'erythrocytes is important in protection against clinical illness. 
2.$.3 4iitjhi4y response to rnerozoite-sUrfaee pi"otein 1 
Most attention has been directed the CLtenninal fragment of MSP .1. due to the finding of 
two domains which share sequence similarities with epidermal growth factor which .was 
thought to be involved in cell 'to ccii interaction. In addition to this, a monoclonal antibody 
against the. EGF domains. of 19kDafragnient. prevent. in: vitro invasiou.of erythrocytes [21]. 
Even within the relatively conserved C-terrpinai 19kDa,fragment of MSE I thereare.point 
mutations which lead to4 amino acid chapgcs, one mutation bcingin the firsEGF domain. 
and the other three in the 2nd EGF domain. When recombinant antigens representing the 19 
kDa region with the different. amino acids were used it was found that human antibodies 
recognised the same epitopes on all the variants iç., the amino acid changes did not affect 
recognition by the antibodies [16]. Egan  et al found that antibodies in sera from The 
Gambia to MSP 119 kDa were mostly, IgGi and that the isotype of the immune response 
did not vary with age"l 161. Another study' looking at thé'humorl response to the 19 kDa 
region of MSP I in an endemic population from Kenya'found that antibodies recognising 
-the recombinant 19 kDa region were both igGi and lgG3; but onlyigG 1 correlated with 
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lower parasite densities. The major difference between the findings of these two studies is 
that in the Gambia no anti-19 ,k—Da IgG3 was 'found, while in Kenya the humorãl response 
was TgG1 or TgG3 or both .[63]. Tne authors suggest that this may be due' to genetic 
differences .iu the po.p.u1aliun or to differences in the transmissku'iates. Difftfrnees in 
concurrent exposure to other pathogens may also,affect ,aitibody isotypes. The-importance 
,of :sng ,conformtionally cQrrct zcc.ombinat antigçns was high1ightd by a ltigitudinal 
stdy oking at theijnnuie respQe to MSP 1 [64]. I this study no ,ignificant 
association between antibodies and clinical status were found.•urdike the two previous 
studies. This may be due to the recombinant antigens being produced in a bacterial 
expression system, which may not form correct disulphide bonds and therefore woulcinc* 
be antigenically correct. Whereas the recombinant fragments used in the Kenyan and 
Gambian studies were prodücedin either a yeast expression system or as UST -fusion 
proteins in E.coli. The importance of these disuiphide' bonds was highlighted when the 
reactivity of immune sera to 19 kDa MSP'1 was compared for reduced or oxidised (natural 
state) MSP. 1 9. It was found that the reactivity was lost when the molecule was reduced 
[65], showing that the. native. conformation, is .necessary for, Ijuinciral inuiiva ere cognition. 
2.5.4 -Antibody.response to. merozoite surface protein 2 
Hurnorai responses i recombinath,dimdrphic ,sequecesofMSP 2 .ha.e.been 
demonstrated in the vast majority. qf, cases to be predominantly, of .!gG3 isotype. This has 
been observed in sera from endemically, exposed individuals from The Gambia[66] (only 
adult sera-were analysed and about 80% of the study population had seroconverted) and 
...tleSolomon islands [67]. A study carried out in The Gambia found that lgG3 titre 
correlated with protection from..clinical.illness. The protective effect of antibodies to MSP 
.2,has been investigate4 in Papua New Gum a 168, 691. in these studies it was found that 
antibodies to a recombinant A-type protein and a recombinant A-type pr otein lacking the 
central repeat region correlated with protection against clinical illness. 
15.5 Antibody responses to malaria parasites and antigens 
The antibody isotypes in sera of exposed individuals has also been investigated using_ 
whole parasite extract rather than defined antigens [70] antibody isotypes were compared 
with the clinical status Of'thedonors.'The hypothesis beinginvestigated was that cytophilic 
(IgGi + .igG3) antibodies are protective against malaria while non-cytophilic (igG2 +'19G4 
+ 1gM) antibodies are not. It was found that there was a higher ratio of cytophilic to non- 
') 10 
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cytopiiilic antibodies in adult sera was than in those - from childrenThe change in ratio of 
isotypes occurred at the same time as the development of protective immunity, seen as 
reduction in parasite prevalence and density;- It would-therefore appear that cytophi-lic 
antibodies are associated -with protee1ion froiii maiar a.Siuce-t1is'tudy-iias-bezi carried 
t, a mcroplage receptor for I.gç2 las Jeen .diseQvered in abOut 50% of the population, 
icting that IgG2 cöuldalso bc inioiv'&in this icthôd of pärasitccotnrol [0. 
Mercreaa Puijaln, unpublished]. 
A- study carried out in Senegal investigated the changes in isotype of atintaiaria 
antibodies with age and at different times during the transmission season [71]. There was a 
steady  increase in titre of all IgG isotypes with age, and in people older than 7 years there 
was a boostingof !gGaiid  1gM levels duringthe transmission season. This suggests that the 
younger children are less able to boost their antibody levels when challenged than older 
people: When the protective nature of these antibodies was analysed, oriiy' increased lgG3 
titre correlated with decreased incidence of malaria attacks. 
The prevalence of antibodies to individual malarial antigens varies from population to 
population. Even in areas of very high transmission, the seropositive rate is often much less 
than 1007o. A study. whichinvesiigated,factors.that may explain. why noLali individuals-, 
seEoconvert when, exposed to .maiaria.antigens found that naive patients were .able.to - 
produce antibodies to MSP 1 and 2 after their f1rst malaria infection This demonstrated that 
these antigen Were inlinwidgehice [62]. Longitudinal SapleS, from chu1dén' and adultS in. 
The Gambia, were analysed and it was fOund that in samIes from children, aWtibody levels' 
peaked during the transmission seasor'; while samples from the adults' tended to be 
cpnsitently positive ornegative for antibodies to a speciflc antigen Noi-respbiisivness 
did not correlate to 1-ILA Class II type. The authors suggest that a possible explanation for 
the selective recognition of antigens may be a 'phenomenon called clonal imprinting [62].. 
- - -This phenomenon was first described in individuals who were given an influenza vaccine, 
which boosted antibody response to an influenza variant, which was not present in the 
vaccine. The first immunisation/infection is though to lead to the development of memory 
J3 cells .which xeaeLto shared epitopes.fouud on both -variants. When the second infection 
occurs these memory éelis are thought to outcompete naive B cells for the antigens, So only 
antibodics to shared ,çpitopcs arc produccd ad the immunç systçrn is blind to novel 
epitopes ;on the ntigen. with,.theshared epito-pe [621. 
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2.5.6 Immunity in infants 
Maternally derivedantibodies are thoughtto contribute to the protection of the newborn 
infant from malaria disease in endemic areas. A study-carried-out-in- Gabon- looked-at--the-
isotype. and fuuction of maternal, antibodies. The- authors coinpared the-antibodies present. in 
the mothers' sera taken at birth and sera from the ,umbilical cord [72] Specificity of 
anti-bodies to blood stage antIgens- were measured on Western blots. Sera-.were used in 
indirect;  mmur9fluoresce1cç aga inst vho1e pasts to measure antibody ley lsand.I " I
isotype Antibody levels were found to be lower in the cord sera than in the matçrliai sera 
but- the -pattern- of antigen recognition- was- the- same-The4ransfer across the placenta was - 
more efficient for IgGI and lgG4 isotypes because IgG2 and IgG3 were significantly lower 
in the cord sera when compared with the maternal sera. There was a higher IgGi titre in the 
maternal and cord sera in malaria-infected placentas when compared with uninfected 
placentas, --levels of.-IgG3 were alsohigher in cord sera from infected placentas. 1gM was 
also. found more frequently in infants born - to mothers with malaria-infected placentas. This 
suggests either .that foetuses are able to -mount an -immune -response in uleFo or that 
pthol.ogy leads to non-specific immuno.glQbuiin leage across the placenta from the 
mo.thr. in yitro .mhibttion assays wer .carri,ed out but they did not fled any correlation - 
etween IgGi leyels and inhibidon of erytuTqcyte inyaori. Other studies have shown that 
r IgGl to inhibit. parasite rytj the ait dy i, ut ,act together with monocy1c [73-]. As 
monoctyes were not included in the assays described above, this may explain the lack-of 
correlation between IgG 1 levels and inhibition of erythrocye-invsion 
ln,Papua New Guinea, two studies have followed the change in maternal antimalarial 
antibody levels over time. Sehgal et al found that 96 % of infants lost all their maternal IgG 
-. by  months of age (range 4 to  months) and the median was 21 weeks 1741.  In this study,. 
73 % of high parásitaemias occurred in individuals without lgG arid 67 % Of-infections in 
individuals with--igG were asymptomatic and had low parasitaemia [74]. These - findings are 
suggestive of a protective role for IgG in1he infant.:  Kramer et al- followed-the decrease in 
antibodies to ,MSP 1 .itiijifats an4 found tat the median age for loss of antibodies was 20 
- Weeks and the median age for malaria iMectión°wás 17 eeks [75]. This'stiggests-that a 
--  minimum ICVCI d'ántibody is necessary tO ovidc protcctiOn. Asthdy in Nigeria- [76] 
follo"ed a group of infants from birth" at two rionthiy Inter als until they were one year 
old and looked at the change in their antibody profile. Total IgG levels decreased from birth 
ntil 4 months and then increased, while the levels of both 1gM and IgA incr.ase u 	 d. from 
26-20. 
• birth. -When antibody'ievéts were compared with the infection status Of the infant, total IgG 
was significantly' higher in uninfected infants only at'2 months and at 8 months. There may 
•have - been a more significant difference' between infected and uninfected infants if anti-
malarial igG'had been vunrparod. All'iuiTant.s were positive 'for antibodies 'to blood stage 
antigens Throughout,their fir styar. 1gM as higher jn infected. infants' than 'uninlected 
Wants, ,thus 1gM appc4s to tfict LnfCtiQB. In summary t woul4 appear that high lçvcls 
of IgG in the ,first 24,ioith  of !ife aree irnpptant for pqeçtjo ,againt malaria. 
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2.6. Aims 
The aims of this project were, (I) to characterise genetic diversity of parasite infections 
by PCR. Two polymorphic genes were studied: MSP 1 and MSP 2; using specific primers  it 
is possible to obtain data regarding the dimorphic family and size of the polymorphic 
region, (u) to investigate the sequence variation in the polymorphic region of MSP 2 PCR 
primers were designed to amplify the polymorphic region. .These primers had 5' extension, 
which contained target sequence for restriction enzymes to enable the subsequent cloning 
ofthe CR ftagmeut.to pi:oduce reconibiiiant proteins, (iii) investigate the humoral 
response to iifferent regions of MSP 2. 
All novel repeat regions. 	subcloned.into pOX plasm ids to prod 	-ST fusjon 
proteins. Humoral responses tothisregion wre çompaed tqresponsestorecombinant 
MSP 2 molecules jacking the central repeat region. This approach had not been used before 
in malaria research ,and,mades it possible to tell whether the lack of response was due to a
1 1.
lack of antibodies rather than that the antigen used did not represent the parasite that 
individual was infected with. This was considered to be very, important for this study, 
where the investigation 'focuses on humoral responses to related but different antigens. 
-, 
3 Materia's and Methods 
Table of Coitent 
3.1. F 	 3-24 
3.1.1 Study Area................................................................................................. 324. 
312 	Study Design ............................................................................................. .3-24 
DNA extraction from field samples .............................................................. 3-25 
Standard PolyineTasp Cha Reactiou(PCR) ciiitions ....................  .. 325; 
3.4. 	Bacterial Culture Conditions, Bacterial Strains and Plasmids .................. 3-26 
3.4.1 Bacterial Culture Conditions .................................................................... 3-26. 
3.42. 	Preparation of Competent Escherichia COli ::zz::zz:zr::::::::.:z::rz::z:::: :3-26 
3. 1.3 Bacterial 	 3-26 
344 . 	Vectors .L .................................................................................................3-27 
3.5. 	
. 
Automated DNA Sequencing ........................................................................ 3-27 
3.5.1 Sequencing Reaction ................................................................................. -27 
36 SDS-poiyacylanude gel electrophoresis (SDS-PAGE) 	 3628 
.3.7. 	Bradford Assay ............................................................................................... 3-28 
•• Enzyme-linked immonoso itscay 	 3-29 
3-23. 
3. 1. 'Field Study 
11.1 Study Area 
The study site is situated in the coastal savannah region of Ghana, West Africa The 
village of Prampram (population 8000(1992, ,NMIMR census)) is about 50 km east of 
the capital. Accra. The main economy, is fishing and fish processing with some farming. 
There is a government-run health centrein the village and a district 'hospita'!'in'lema, 
about 20km to the west along a well-maintained tarmac road. 
3.L2. Study. Design. 
At the clinic, women in their last trimester of pregnancy attending the antenatal clinic 
were recruited into the study anda venous blood-sample was taken. The mother was 
given a study number that would be used to identify the child after the birth. At birth, a 
blood sample from the new-bon.i. aiidbasic.anthropometric.data.regarding..the.ehuid ;weie 
collected. The. inf ants  were. followe4 for up. to. two. years. Theinlants were.brpugbt. to the, 
clime at w ecks two, four and SIX after b1rth and then at 4 cckly intcri als A 
questionnaire regarding the iplant's health was administered verbally to the mother. The 
child was examined, basic anthropornetric data was recorded, the child's axillary 
temperature was measured and at the same time a blood sample was taken from the 
child. The blood samples were taken by heel prick until it was possible to use venous 
puncture at approximate 12 months of age. Two weeks alter each 4 weekly clinic visit, 
the study children were visited at home by local field workers. At these visits aheãlth 
questionnaire was verbally administered to the mother and the child's axillary 
temperature was measured. if the child was -febrile - 375C), athick'biood'fiim was 
made àiid -a-blood sample was taken onto filter paper. The blood smearsw'ere stained 
witirGiemsa stain and examined mioroscopi cal ly by-personnel from NMI PAR ( number 
of pààites per'3 00  leucocytes-were counted and then converted to parasites per l). The 
remainder of the bi 	àmple(000im1 to 1 rtil) was c011ected into a heparinized tube 
an'dtransported'back to NMTMR. At NMTMR, the bloodsaniples.were separated-by 
centrifugation to give a plasma and-a red blood cell fraction. These were. stored at 
—20 °C and then sent to ICAPB, University of Edinburgh on dry ice for further analysis. 
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11 'DNA extraction from fleidsamples 
As the main mammalian stage of Plasmodium lives in the erythrocytes of the host, 
this tissue provides an ideal 'source from which to isolate parasite DNA In this study, 
parasile DNA was. extractedirom paeked.red.bioodceiis.using.a:Na 2HPO4 extraction. 
method 1791.. 20,0 of freezethawed packed red blood cells were added,to 500 ,,&i of ice. 
cold 5 mM Na2HPO4 (Sigma) ortexed and thei centrifaged for 10 minutes,at 12 009 x g 
at 4 C The supernatant'. as removed and discarded, the pellet ..as then resuspended in 
450 p.lof ice cold 5 mM Na2HPO4. This was repeated three times' The pellet was' then 
resuspended in 50 41 of d.aH2O and placed in a boiling water bath for 10 minutes. Finally ,  
the samples were centrifuged for 10 minutes at 10000 x g and the supernatant. 
containing the DNA was removed and stored at - 20 °C until required. 
3.3. Standard Polymerase Chain Reaction 'PR) conditions 
PCR methods were used for both parasite detection and investigation of the allelic 
diversity of parasites. 
PCR reactions were set up containing, in addition to one j41 of sample DNA,, the 
following 100 nM of each primer, 75 jM of each deoxynucleotide tnphosphate 
(deoxyadenosine tnphosphate (dATP), deoxycytidine tnphosphate (dCTP), 
deoxyguanosine triphosphate (dGTP), deoxythymidiñe triphOsphate (dTTP) (Boehringer 
v .a nnnelm) ); lun .rv in s-r r i (pin  9ufl ), 50 mM rrue', l,011%   inton. .X-i00;.ujumts,of,, 
Ta4'DNA poiymera.se. (Promega). The.magnesium eh1oride.couçeutratiou used. was, 
3- mWIL for the parasite detection PçRs and .F5 niM for.tbe allele specific ,PCRs. The. 
reaction mix was oycriaid with mineral oil (Sigipa) to,.pr,c'vcncyaporation, PCR reaction 
volumes.varie.d from 20 to 100 d in size. The reaction mix was scaled, according to the 
final volume. 
To visualise the PCR products, four l of the reaction mix and two p! of DNA loading 
buffer (Appendix 8.1.3), were run on an agarose (Boehringer Mannheim) / 05 x TBE 
(Appendix 8.1 .2).gel,(The percentage (w/v) of agarose was varied depending on the 
expected size of the PCR product, 1-5% to 25%) with 500 ngml4 ethidium bromide 
(Sigma). Uhe products were visualised and photographed under UV illumination. 
100 base pair (bp) markers (Boehnnger Mannheim) were used to allow sizing of the 
PCR product. 
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3.4. Bacterial Culture Conditions; Bacterial Strains and Plasmids 
14.1 Bacterial Culture-Conditions 
LuEia-Bertatii agar ((LB) Appendix8.3.2) plates contained 12 jg nil 4 tetracycline 
(Sigma), 100 jig ml ampicillin (Sigma), 100 jig ml' 5.bromo-4-chloro-3-indôiyl-13-13 
gaiactopy.ranoside ((X-Gai) (Sigma) and 100 jig rnt' isopropyi--134hioga!actoside 
((1PFG) i.gma).(TAX1.p1ates). LB .agar.p!ates (Appendix 8.1.3) containing only 100 jig 
rut 1 ampiciliin were also usect(U3-AMP plates). in liqiid cultures, L13 media was used 
with anpicji.liu at 1(X) jig ml" a ,ttracyciinc at 12 jig ml" LB-\.MP-TEi') or with 
,o1y 	p,jcilliii it 199 jig ipt' (LB AMP). 
3.4,2 Preparation of Competent Echerichia coli 
.Competet R. eoii ye pre,pare4 in bulk .,4,w,ee tore,d for up .to 12 months at 
—70 °C (pers. corn. Dr. D.R. Cyanagh). A single colony was inoculated, into 5-ml of LB 
medium with appropriate antibiotic and was grown overnight at 37°C in. an orbital 
incubator. The overnight culture was added to 500 ml of LB.. me.dium with -appropriate.. 
antibiotic and returned to the shaking incubator at 37 °C until the OD was 04. This 
indicated that the bacteria were growing in the exponential phase. The culture was then 
transferred 'to ten 50 ml centrifuge tubes and' centrifuged at 3000-x g for 15minutes in a 
refrigerated centrifuge. The culture medium was removed and the pellets were 
resuspended in 100 'ml of transforming buffer 1 '(Appendix 8.1:5.1). The cells were 
centrifuged again as, above and then resuspended.. in' 20 ml oL transforming. buiTer1. 
(Appendix 8.1.5.2). The.. cells were, then. aliquoted into, sterile. 1-5rni microfugetubes, 
ci . a.i.i cr ozeu in r .qulu nitrogen , and .. ..i a - 
 
3.43 Bacterial Strains 
Two strains of E. cQii were used; XLI -Blu, (Stratagcnç),and. DH5a. XLI -Blucwcc, 
transformed with pBlucscript phagc,d and grown, on TAXI plates, or in, LB-AMP-TET 
media. XLI-Blue cells, contain an F" epispe that contain,genes,coding,fçr tetracycline 
resistance and AM 15 lac gene. In order for blue/white selection to be carried out IPTG 
must. he present in agar plates (Section 3.4.1) to induce AM15 lac and so inducing the 
expression of -galactosidase from the pBluescriptphagemid (Chapter 5.2.5). 
Tetracycline must be present in the agar plates used with XL1 E. coli in order to 
maintain selective pressure on the 1 episome. 
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DH5a E. coli were 'transformed with pGEX piasmid and grown on LB-AMP agar 
plates or in LB-AMP media. DH5a strain was used- for expression of recombinant 
proteins -because they lack aF episome and so are incapable of DNA transfer. This was 
necessary to obtain a low risk classification with -regard tothe Teguiatious covering 
genetically modified organisms. 
3.4.4 Vectors 
Two vecturswere used pBiues'cript phagemid (Stratagene) and pGEX-2T piasniid 
(Pharmacia). pB!uescript contains an ampki.11in rosistanco gone and -gaiactosidaso. 
gene containIng the multiple cloning site. This enables blue/white selection for the 
presence, of an insert to be, carried out as, insertional &rup.tion of the -galactosidase 
gene expression leads to, white colonies, while colonies, containing an undisrupted 
—galactosjclae gene are Iiç. nQFX-2Tcontnins an a.mpiciflin resistance gene and a 
multiple cloningsite at the 3' end of glutathione-S-transferase (GST). The presence of 
GST upstream of the multiple cloning site enables purification of fusion proteins 
expressed from cloned sequences using affinity tagged agarose beads in a batch 
purification method. The expression of OST is controlled by the tac promoter. 
To isolate sufficient amounts of vectors for the project, a Wizard Maxi prep kit 
(Promega) was used:to extract-between 0'.5 and .1mg of DNA from 500 ml overnight. 
cultures containing appropriate antibiotic of bacteria transiTormedwiLh. appropriate 
piasmid 
3.5. Automated DNA. SequencIng 
34.1 Sequencing R.eatIon 
Templates for sequencing were either PE2R products or piasmid DNA. The DNA 
concentration was estimated,  by running 2jd of the. sample ona 1-590 agaroseiTBE gel 
and comparing the. intensity.of the.band .withthat. of molecularweight. markers, 
(0'25ug il'), A ractioi, rn ture.contaii,ing.4 jl.DyeTeminatpr,  Recady.Mi (Perkin, 
Elmer Corp.), 1'6 .pmol'sequencing.primerand 2-5.4 of template containing 
approximately 75 ng of DNA was prepared, then made up to 10 jel with daH2O. The 
reaction  mix was overlaid with mineral oil (Sigma) to prevent evaporation. The 
following PCR programme was used for sequencing: denaturation at 95 °C for 30 
seconds, annealing at 50 °C for 30 seconds and extension at 65 °C for 4 minutes for 25 
':i ',i 
cycles. 'The reaction mix was removed 'from beneath the Oil and added to 50 lit of 100 % 
ethanol and 2 pl of 47M ice cold €H2COONa (pH 4.8) 'Sigma).'This was incubated at 
—'20 0€  for 10 minutes to precipitate 'the sequencing product then centrifuged at 40€  for 
30 minutes 'at '10000 x g. The 'supernataiit was discarded and the 'DNA pellet washed in 
200 1Aof 75% ethanol -and'cent rif uged"for 10 'minutes. The -supernatant was discarded 
and the pellet -was air -dried. Where necessary the -dried-pellets -were -stored at - 20°C. 
-Prior-to loadiiig,-the-p ell et was resuspended --in 3 -y 1  -loading-buff er-(5: 1 -ratio -of deionized 
forma-ride (Sigma)/25 mM EDTA /50 mg ml Dextran Blue (Sigma)), denatured at 
90 °C for 2 minutes and stored on ice- for up to 30 minutes until Ioade5j 18d of the-
denatured sample was Jaded in each well on aARI 373 sequencer aKlrjui at 40 W.fc&r 
65 hours. The sequence obtained was then compared with the trace generated by ABI 
373 using Sequencing Analysis (version 2.1.1,' Perkiri Elmer Corp.). This was because 
there were features of the reactiOn chemistry which lead to base G failing to produce a 
readable peak. Sequences were edited using Seqed (version 1.&.3, Applied Biosystems) 
and multiple sequence comparisons were generated' in Seqiab (GCG 9)' using the pileup 
prograiImIe. 
38. SDSpolyacrylamlde gel electrophoresle (SDSPAGE)- 
A 10 % resolving gel solution was prepared as decribed by Maniatis[137}.'Briefly, 
gel moulds were asembied according to instruction (Biorad) then the resolving gel 
solution was poured in -and -allow to polymerise. Then a five % stacking gel solution 
(Appendix 8.1.8.4) was prepared, poured on to the resolving gel with a comb in place, 
then allowed to polyrnerise. While the stacking gel was polymerising, samples were 
mixed with an equal volume of two .SD,S gel-loading buffer (Appendix 8.1.8.1) and 
then denatured at 100 °C for flyc minites and then loaded onto the gel. The gel was run 
Ic'r 15 	50 iM-- Tfr g w tjp1 wjtJ çcomasj brillant- Wuc (Appdix 
8.1.8.5) for 2 hours and then destained overnight. The gel were then dried and stored. 
3.7. Bradford Assay 
The Bradford- assay was use4 to ca1clate tc ctytjcn. nf recit pxoteiu.. 
This assay uses a dye which shows an increase in absorbancy at 595 nm with increasing 
protein concentration. A standard curve was generated by using bovine serum albumin 
(f3 SA') as a reference protein. To measure the concentration of recombinant protin, 10 
jd of protein was added to 90 jsl Of water and then one nil Of 'Bradford solution was 
added and the absorbency was measured at 595 nm. A standard curve was generated 
using BSA concentration ranging from 0 to 01 mg mi 1 . lithe absorbency of the sample 
was greater -than the standard curve then a more dilute solution of recombinant protein 
was 'used. 
38. Enzyrne.4lnked immunosorbent assay (EL ISA)- 
immulon TV plates 'Dynex'Technoiogy) were coated with 1 -00 jil of diluted antigen 
in carbonate coating buffer(Appendix 8. 1 ;9. 1). The optimal antigen concentration was 
determined by -titatiein -(chapter -6.2.7). The -plates were -covered with -an empty ELISA 
p1-ate, wrapped -in -foil -and -stored -at 4 °Covernight. These -plates were -then washed with 
3 -times with PBS!:f,ween 20 -(Appendix 8.1.9. 2). -A -blocking -step was -performed -using 
200 -il -per well. -of I % - 1,w/v) milk -powder -i-n PBS/Tween20 -(-blocking -buffer). Plate 
were incubated at -room -temperature. for 3-5-hours -and -then washed again -i-n 
PBSITw- e.n2.0, 100.Ld per well of diluted serum was added and the plates were incubated 
overnight at 4°C. Serum samples were ,prepared as a 1:10 dilution in PBS/Tween + 
002 % Azide (Sigma) and stored at 4 °C until required. They were then diluted 1:100 in 
blockin,g buffer to give a tThaf dilution of 1:1000. Plates were washed' -as described 
above and 100 Li of 1:1000 dilution in PBS/Tween of rabbit anti-human 1gG-
Horseradish Peroxidase (HRP) - (DA KO)- was added to each well. The plates were then 
incubated at room temperature for3 hours. Plates were washed - as described above and-
100 pzl of fresh o.pheny1enedi-ami-ne-- dihydroeMoride- (OP -I))- so-lut-ion(Appendi-x 8.1.9-3) 
was added to- each- well and incubated for 10-15 minutes. The- reaction was stopped with 
25- jl- of 2 M H2SO4, and plates were read at. 492 mn in a Titertek Muitiscan II plate 
reader. (Flow  I abs). The data was exported into. EXCEL. 5. (Microsoft). for analysis. 
As well as- using plates- coated-with- the-antigen- of interest, plates. coated- with- the 
 partner alone (GST). were. used. to. enablethe. reactivity (Q the fusion partner to he 
taken into account. These plates had the same sera added to them as the experimental 
plates. For analysis of the data, the optical density (OD) from GST plates was subtracted 
from the experimental plates giving, an OD Whichcorresponds to the reactivity to only 
the MSP2 region Ofthe fusion protein. 
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4.1. introduction 
4.1.1 Plasmodiumfakiparum diversity 
Pksnwdbimfaiciparwn has, been. fouud. to show extreme genotypic and. 
phenotypic diversity, for example with regard to isoenzymes,.karyotyping and 
antigen expression. It is rare,, except in areas of very low or epidemic malaria 
transmission, to find two parasite 'islates from different individuals, which are 
identical at multiple 'loci '[80,81]. These 'findings suggest that 'there is genetic 
recombination in the parasite population during 'the obligatory sexual stage in the 
mosquito vector f5j. 
The variability found in expression of different malaria aiitigens falls into two 
categories: anti-genie variation and anti genic- diversity (al'leiic' polymorphism' 
 variation is where 'a -single -parasite -clone is able 'to 'express 'antigenically 
dffcrent'forms of as 	cc  antigen 'throughout the course of an -infection, -enabling 
the parasite t avoid acquired immune -responses and survive longerin the host, so 
increasing the I.ikelihood.of-the parasite -being transmitted to the vector (definitive 
host).. Antigeni.c variation was first reported in P. knowiesi [38]; this phenomenon 
was later reported in rodent malaria [37. 82].  In these studies, recrudescing parasites 
were found not to react with sera collected before the recrudescence was seen, 
showing that the two parasite populations were antigenicalTy distInct. Antigenic 
variation was also seen in P'falciparum in vivo using immune serum from 
experimentally infected squirrel' monkeys [126]: More recently this has been seen 
with P. fidciparum' in vitro. Antigenic variation in P. faiciparum' has - been found to 
correlate' with changes' in the cytoad'h'erence' phenotype of the clone [84]' and' is' due to' 
the change' in expression' of a multi'gene-fami'lyof var genes' encoding P. faiciparum' 
erythrocyte membrane protein 1' (PjEMPI) [40]. 
Anti-genic -diversity '(allelic 'polymorphism) -is variation in antigens -between 
different parasite -clones -due -to the presence of-different alleles of -a single-copy 
antigen gene. This .diversity 'is seen in, some erythrocytic. stage antigens, for example 
mrcite surface protein .1 ,(MS.P 1) P11,, merozoite surface profein 2 (K_S R 2)[81 S 
antigens,[9], apical membrane protein I (AMA-l),,[77} and GLURP,[10]. Initially 
this anti genie diversity was investigated'using monoclónal antibodies (Mabs) raised 
against in vitro cultured isolates. The cloning of the genes coding for MSP r 1851' and 
MSP 2 [86] allowed investigation of this diversity at the level' of DNA sequence. 
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'These proteins are expressed on the surface of•the merozoite and are thought to be 
involved in the initial interaction between the merozoite and the erythrocyte. There is 
evidence from in vitro studies '[87]  and immunoepideniioiogicai surveys [68,69,88] 
tat the 'antibody response to these antigens may be protective against high 
-parasi'taemia -and clinical -malaria. Much 'attention has 'been If 	on M S P -1 'and 
MS-P 2 as markers of parasite 'dvcrsity, which -may also be under immune selection. 
MSP All and MSP 2 arc g-iyeoprotcins and- arc attached- to- the mcrozoi-te surface by 
a phosphati-dylinos-itol- linkage. M-SP 1 has a molecular mass of 190-210-kDa- and-
MSP 2- has. a molecular mass. of 35-53. kD-a. The. size of the. protein, varies depending 
on the allele that. is. expressed- The genes. are present. in. the genome as. a. single allele, 
as the blood stage of the parasite is haploid. 
4.1.2 Merozoite Surface Protein I 
The gene coding for msp 1 is located. on chromosome 9 [89 1 .. MSP 1 was. first 
classified into two groups by monoclonal antibody reactivities [7]. Subsequent 
classification of these proteins was by analysis of their DNA sequences. The 
diversity of msp 1 can -be classified 'into discreteblocks of conserved, dimorphic and 
polymorphic sequence (See figure 1). The dimorphic 'bioks are blocks 6-16 and 
form the -basis of the classification of the alleles into two families. Archetypal alleles 
are -found in the 'MAD20 and -K-i isolates -[191 and the only truly polymorphic 'block 
is -block 2. Blocks 1,3 -and 17 -are classed 'as -conserved but 'a 'few 'd-i-nnorphi'e point 
mutations are -present. -in. -block 2,-three-types of -polymorphism ha-ye been -described; 
two -of -the allelic families -contain -tandenn repeats -of different -seq-uence.s, -based -on a 
-t.ripeptide sequence -consisting of sei-ne follow-ed by 2 other -a- u-no acids. The 
polymorphism. 'in block 2 was -first thouglit -to -be solely -to variation in the -number 
am1 seqll.ence of tripeptide- repeats .1191 but.analysis of im isolate from s patient. 
showed that a third form of block 2 existed which lacked tripeptide repeats but 
contained a linear sequence[18, 201. This non-repetitive sequence is classified as 
1(033-like. The dimorphic families are defined as MAD20-like and K i-like and the 
polymorphic block 2 families are classified' as MAi)20. K  or R033-iike. It has been 
suggested that intragenic recombination in the insect diploid stages may be one 
iriechanism by which diversity' in irr I is generated ['6,20] The userved blucks - 3 
and 5 seemed- to- be- the- most likely sites' for i'ntrageriie reco'i-i'bination'. By analysing a 
cross between two CIOflOS, a recombinant insp'I allele- has been- found' [6].  The-
recombi-na-tion was found- to- have occurred- in block 1 This- demonstrated- that 
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recombination was a possible mechanism by which novel combinations of different 
blocks could be produced. 
rnsp 1 genes comprising, for example, MAD20 polymorphic sequence and KI 
dimorphic sequence are commonly found in patient isolates; the lab established 
Wellcome line is an example of such a hybrid allele 
in the relatively conserved C terminal 19 icDa fragment of MSP 1, there are only 
four amino acid differences between the two forms 1121].  The amino acid changes 
from Wellcome to MAD20 alleles are in EGFdomain I residue number 14 Q to E 
and in .EGF.domain 2 residue number iSKto T,residue.number27Nto.S and 
residue number 28 G to .R (numbering is from the start of each EGF domain). In 
West Afnica, a very low pro portion of the parasite population canies the dimorphic 
K I type of MSP ] .[901. There has been no clear explanation of this finding but it has 
been suggested that certain African populations may be refractory to infection with 
parasites carrying the dimorphic KI type of msp I or that msp I may be in linkage 
disequilibrium with another gene which affects erythrocyte invasion or parasite 
multiplication (E.M.Riiey pers. comm.) 
4.13 Merozoite Surface Protein 2 
The gene encoding rnsp 2 has been mapped to chromosome 2 [89]. The sequence 
variation seen in msp 2 is also found in discrete regions. As with msp 1, the gene 
sequence can be divided into conserved, dimorphic and polymorphic regions. There 
are N'- and C-terminal conserved regions, and a central polymorphic region flanked
by dimorphic Mocks (figure 1). The dimorphic families are classified as A (IC 1) type 
and B (FC27> type. The polymorphic blocks of these two famiiies vary both in 
sequence. and length. The. archetypal. A repeat block consists, of a number of 8. or 4 
amino acid repeats,. while the B polymorphic. block consists. of one. to. four 32 amina 
acid repeats and a. tmnihet of 1.2 amino acid, repeats, [26,. 271...  hi A-type genes there is 
variation in the sequence and number of the repeats,, while in the B-type alleles there 
is a small degree of sequence variation and most of the polymorphism is due to 
different numbers of repeats. Unlike msp 1, the polymorphic and dimorphic regions 
of msp2 are associated with each other, possibly due to the lack of a conserved 
region between the polymorphic and dimorphic regions which could facilitate 
-recornbi-nation. 'Nevertheiess'sequenckng studies have -revealed hybrid alleles -in field 
samples. One example of a hybrid allele had the 5' A type sequence and 3" B type 





Figure 1 MSP I and MSP 2 showing primary amino acid domains 
MSP 1 (Block schematic from Tanabe et al [211) 





MSP 2 (Block schematic from Symthe et al [271) 
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sequence homólogyin the repetitive region, which is shared between the two 
dimorphic types; has been found [91]. Hybrid alleles have been identiiiedfrom'field 
samples fromSenegal [23,24] using mis-matched pairs of family specific primers in 
PCR. 
4.1.4 Use-of PCR• in-field-situations- 
- it - has - been possibleto use these antigen genes astargets'for-PCR-based detection 
of different allelic -types of parasites in infected people and in mosquitoes [23,24,28-
311. The-presence of conserved sequences- flanking- the variable-sequences allows-the 
use of PCR primers, which should amplify all alleles of-a specific gene. The ability 
to type the parasites present in a host enables questions -about-the-complexit-y of 
infection, the freqieuey of re-infection and the persistence pf m infection in a-field 
situation  be addressed. With this AprTqaph there are , pmberof.ad-vantages.and 
disadvantages. The use of PCR to d etect the presence ofpraies enables. lower 
levels of infection to be detected than would be possible using blood films [37] and 
allows detection of all alleles present rather than.just those to which specific 
serotyping reagents have been prepared PCR methods for detecting the presence of 
parasites have been found to be between a 100 [32] and a 1000 [92] times more 
sensitive than blood films. PCRbasedmethods allow the parasites present-to be 
analysed withoul-the- need' to-culture- the- sarnpies The- need. U culture- parasites-for-
serological. typing may. lead, to. the- loss of some- parasite-types due-to. in vitro. 
selton. The main drawback of using.PCR is that, if, no-product s produced, this 
could be due there being no parastes present or the parasite genorne present may.. ot 
have .a sequence complei 	 tp whjpb the p 	rs.er designd331. 
Using this 	of PCR,, it isot possible to obtain data regarding the co-location of 
aU.?ie from different Penes to a single parasite i.e..inamti!tiple infection where two 
different alleles of two genes are detected it is not possible tell which alleles from the 
two genes are found together i.e.identification of gcnotypes is not possible. 
-However, such-information can 'be obtained 'by either using immunofi uorescence 
-typing ..[34, -93] or in situ PC  on -blood -films -[941. 
The more sensitive detection level -of PCR when compared with blood-film has 
shown that there is a much higher rate of parasitism in natural -populations than 
previously appreciated. A study cairied-,out- i-n- a- iioloendeinic- area, of SenegalfWad. 
that 66. % of the-individuals whosethick bloodfilms w ere, negative-w ere .foundto.be, 
posit4vc for paiasitcs when. PCR was cairid.out on. blood,.s.amplcs. taiccn.ai. the same 
time [95]. The frequency of blood flu negativeiPCP positive snp1çs, did it 
ëhange with age implying there was the same distribution Of low density 
parasitaemia throughout the age range of the study. 
4;L5 in-vestigation into- the -number-ofparasite.types .found,in. human- hosts 
from endemic areas 
An. early study. into the number of- different."types' of.parasites.carried by-an. 
individual.in., an-endemic area, using isoenzy.n.po1ymorphisms as . rar.k.rs.fpr 
diffrent,clones, found that there were approximately 2 clones per isolate 196] .A 
similar study. using Mabs to investigate the number of parasite types found in 
individual malaria patients found that the mean number of parasite types per isolate 
was 	 were no differences in the number Of parasite types cartiedin 
patients with mild or severe malaria or any change with the age of the patient; These 
-two studies were -both carried out in The Gambia where malaria - transmission is 
seasonally endemic and of moderate intensity (1 -to 5 infectious bites per year). 
Daubersiesel - al [24] -Irave investigated the aiieiic- diversity- aud.d-ynamics.of. 
parasite populations. in. asymptomatic hosts in.two. regions of Senegal- one.with..high.. 
peronnial..maiaria, transmission, and, a.sccond, wherc.,tbcr,c.was no apparcnt, malaria, 
transmission at the time of the study.. S amp lçs. were taken. either every. tw.weelcs.or. 
at. two t • thre day iciya1s.  The diversity of .'isp.1, a44 iisp,2 was analysed using 
PCR and Southern blotting followed by hybridization with allele specific probes. In 
the hi Ph transmission area, different parasite types were present in each sample taken 
at fortnightly. intervals. These changes could be due to new infections emerging from 
the -liver or minor parasite types may have proliferated to a -level detectable by PCR. 
Samples taken at-2 to 3 day intervals showed that a parasite type could persist for up 
to 50 days-but that it may not 'have been detectable consistently over that time. 	- 
-Specific parasite-types fluctuated around -the PCR detectabielevel, being seen in one 
-sanple and -then -seen -again 4 days later but -ut detected -in the 44itethn sample. As 
variations in -detected .alleJes may ,be .explained by new inocula from mosquitoes, the 
authors investigated the dynamics of ,parasitc infection in an area where there was no 
tranarusiou at ,he ,t,ime ,o,f,he study. in ,t.his area, there ya& aconsistent-allel.ic 
pattern present for up to 5 weeks. The data from the two study ,aras iggsted that1 : .1
some of the new allelic types detected in the high transmission area wçre dte,to new 
infections emerging from the liver as well as toparasite..populations fluctuating about 
the detection threshold within an individual. 
A study carried out in Tanzania examined blood samples taken every day from 
children aged between 2 and it) years 111 and investigated állelic diversity using.  
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PCR. Most of the children showed daily variation'in their blood film parasitaeniias 
and carried a single clone infection as defined by three unlinked markers -(msp 1, msp 
2 and giurp).Other children showed daily alternation in the alleles present i.e. allele 
A - was seeii on day 0, 2, 4 and allele 'B - was seen 'on -day I aiid 3. This - is probably -due 
-to- the- presence -of-two asynchronous' populations -of-parasites, -one-being detected-in 
-thc-periphcrai- blood and the-second- beang-sequoster-ed-in-the -rnicrovasculature at a 
particular- time. 
Another study. investigated the effect- of age/exposure and -complexity- of- parasite 
infection- in- people. with-different- clinical . status. The study. was -carried out-in -a-
h.oloend.emic.area..of Senegal .and.used.PC1 followed by Southern blotting and 
hybridization with allele specific probes [231.  This cross sectional study,. - 
demonstrated a change in the number of allelic types of msp 2 earned with age. As 
age increased there was a decrease in the number Of állëles detected.There was a 
significant 'differencebetween the number of ailelesfound in people agedless than 
15 years - (3.9-4-.8 alleles) and people aged more - than 45 years ('L923 alleles). - The 
authors suggest'thatwith increasing -age, individuals - have - been exposed -to more 
strains-audare -consequentiy'abie'to'controi'more -of'theinfections'i;e. the 
development of immunity may be ,strain-specific. There -was-no association-of a 
specific allelic type with any age group in the Senegal. However a study-carried-out 
in Papua New ,Guinea found that in chiJ4,en  <.lO.years.old, 375 %-of-the-msp 2 
1,e1e were B type where as inalults,-65 %of.alleles .wereB. type. [35],-this 
difference being satisticaily sigifit. Thisiiggsts...that- imrnunity..toB.type. msp2 
alleles may develop more slowly than immunity to A type MSP 2 alleles. This is 
surprising, given the greater degree of polymorphism in the A type alleles. A study 
that has investigated "'the development of 	immunity to MSPZ with age found' 
that there was an increase in titres of 1gW tO both MSP dimorphic types but there 
was no increase in titres of the other IgGisotypes [58]. In addition to this, high levels 
o.FlgG3 Lu the- A typt MSP2 were associated- with-proteclion -'againstdinical 
infection 1381  The -differences 'in-the - prevalence .of, different, alleles fromthese-two-
studies maybe-du&to-differences in. the study. areas or dietothedifferent.rnethod, 
used for detecting die.-:en alleles. 
4.16 Allele distribution in relation to clinical malaria 
A study carried out in-.Papua-Now Guinca suggcstcd that ccrtain..msp 2. ailcics 
were associated with morbidity. [36]. The prevaince of ,nsp,2 alleles, was. compaxed 
in, clinical cases, defined as individuals with parasitaemias> 5000 parasites per 
44' 
and a'history Of fever, and'in controls, defined as asymptomatic'indiViduisinfected 
with P. fa'iciparum, matched 'for age and village. The msp 2 'typing was carried out by 
PCRfollowed -by restriction fragmentiength polymorphism (RFLP) analysis. Using 
condthonaiTegressron analysis, symptomalicindividuais were twice -as 'likely - to 
-carry B 'type- alleles -rather-than -A' type- alleles. The-authors -suggest-that -this -may -be 
because-B type alleles arc'hghiy -immunogenic,- possibly -due -to the -presence of a 
-strong -B-cell -epitope. -within-the -repetiti-veregion -which -may -direct-the -immune 
-response lo. the.repetith'e -block. Therefore. the -immune -response.may.not-be 
protective.  This would. allow parasites-to multiply rapidly andso reach a-pyrogenic 
,theshp!.d jisj 	iljjcl ttsk.,Jnwevex.jmmJ*pnepiclemjnlQg!caJ studies 1ave 
not shown any differences in the immuno-recognition of the two allele types. 
In two studies where the prevalence of antibodies to the different dimorphic types 
was measured,ithas'been'found thatinThe Gambia S1 % of the sera samples were 
positive' to A' type while'86% were positive toE type[66] While inPapua'New 
Guinea90'% of- the sera samples were positive - to A'type while 9i -% were positive to 
' - B type' [68]. The antigens' used intheGambian 'studies and the --Papua - New -Guinea 
study'could-not discriminate-between 'the 'diniorpkic'and 'polymorphic -region. These 
two-studies-do-not-suggest-that' there is- differential immune 'recognition-Of t - thetwo 
dimorphic types although there may be dfferencesn -antibody titre-s, affinitesor 
subtypes. 
Another study carried out in, Papua. New Guinea, [98], monitored clinic4l cases by. 
active. case- detection. (field-workers visited members of the study. at homea 
eollected.dinieatdata) rather than passive ease detection (cases of malaria are 
recorded when members of the study, visited the clinic), as was used in a previous 
study [36] In this prospective study, the allelic diversity of msp 1 and msp 2 found in 
'individuals was compared with clinical outcome - in the'fo!lowing weeks:It was 
found that the presence of msp 1 R033 or msp'2 A alleles was associated with a 
decreased risk of clinical malaria, which supports - the data-from-the previous 
study[36]. in addition it was found that children who carried multiple -alleles -had -a 
lower risk of clinical malaria-when compared-with' aparasitaemie children or -with -a 
child carrying a single clonc. Children who-were aparasitacmic -were at lower risk-of 
clinical illness than children carrying one clone. The authors suggest that this -may-be 
jcaiise children who y  are ,ap 	itaernjc riy live in rea with 1°w  transmission 
pressure. 
A study, carried outin Senegal, also looked at the àllë!ic types Of parasites found 
in clinical cases[29].Duringthe  transmission season, samples were taken from 
individuals with clinical malaria and at any subsequent clinical episodes. The alielic 
-diversity 'of the -parasites 'found in samplestaken aL consecutive 'clinical 'episudes was 
compared. Clinical -attacks-were-associated -with-the-presence 'of-a -single -allelic -type 
-(putati-v-e-clonal -infection) -but-thcrc -was -no association -with a-specific all-die -type-of . 
-msp -1, -n&cp 2 -or -glurp. When-children-had -a -second -or -third-clinical -attack, -the 
-parasites were-different-to-previous -infections -b y -at-least-one -marker. This -suggests 
that children.becarne ill when .infected withparasites which carry a .novel allele. 
How every a potential. problem. with. all.PCR-based studies. isthat..they may 
underestimate the number of clones in a sample: minor clones may not he detected 
because of a large difference in the ratio of template DNA of the two parasite types. 
The result 01 this would be thathigh parasite densities (i.e. clinical cases) appear to 
be due to a single clone infection andlow parasite densities (i.e. asymptomatic cases) 
appear - to -be due - to mixed infections. Another -factor with any sampling -technique is 
-that by taking samples at asingietimepointthe results are liable -to - under estimate 
-the -cioiie-nuiuber -due -to sequestration-of-parasites-away-from-the-peripheral -blood 
-system- [97]. -Despte-this,--it -seems -probable - that -clinical -attacks may-be -due-to 
-tnocul-ation -with -a-parasIte-type -which-the-host's -immune -system -h-as -not -seen -before 
-and-to -which-it-  has -no .preexi sting. irnmunity, -leading-to-- uncontrolled -proliferation -of 
-theparasiteleadingtofebrilesymptoms. This problem of template -ratio leading to-a 
reduetion.in 4eteeted.alleles has to .,be-hornein mind when.Iooking at all PCR-based 
estimations of allele numbers. This.problem could be circumvented to some extent 
by designing dimorphic region-specific primers which do not share target sequences 
so there is no competition for primers between parasites belonging to different 
dimorphic families. 
4.L7 Different PCR techniques-used- for- investigating allele distribution 
-DNA sequence datahas'been used to design PCR primers which enable rapid 
processing of large numbers of samples generated during longitudinal studies. -One 
strategy is -to use PCR primers which anneal - to - the conserved - blocks flanking the 
-pokyniorphic - blocks and then use 'family specifieprobes to type -the PCR -product by 
Southern- blotting. and.hybridisation. This -method -gives-information -regardingthe 
-size and-polymorphic-type-of the alleles- present and-has-be-en-used by --Contamin -et -a-i 
-[33] -and-Babike.-et-al- [28]. The dimorphism--and- polymorphism -of-msp 2-have also 
- been.analysed- by .producing.a.PCR. product, -as- for- the- Southern blotting. technique, 
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and then performing RFLV(restrictibn fngrnent length polymorphism) analysis with 
5' . endonuclease restriction enzymes [35]: In addition, a PR-based approach has 
been developed- to discriminate between different allelic families of nsp 1 and- msp 2' 
[99]; 5' primers were designed to anneal-to .hrnorpntsequencesau&a - 3' pruner was -
designed to anneal-to- a conserved- block. The-resulting- PCR products 'froim different-
allelic families ace- of different sizcs allowing- the-dimorphism-to-bc-typed -simply by 
scoring- which- sized- PCR product is present. 
-In studies so far, -information -regarding-the -poLymorphism-of -mrp i-has -only -been 
-obtained-from-region .2-using-PCRlSouthern-blotting -methods. -Another -technique 
.(PCRbase.d)ha-sbeen developed .wh ch typ sthedimorphisrn..fQund in block 16-17 
of msp 1. The dimorphism of block 16/17 may he important as antibodies to blocks 
16 and 17 have been shown to be,,protective against high ,parasitaemias and fever 
J'iOi although human antibodies dO tend to recognise epitopes in block FTwhich are 
conserved'between the two allelic sequences [16]; There may also be antibodies 
produced' to the CterminaiMSPi 33 fragment- but- due problems in the production of a 
representative antigen this'hasn'otbeenr fully - investigated - [101]; 
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4.1.8 Aims of the work 
The work described in this chapter was carried out on blood samples taken during 
a study in Ghana, West Africa to investigate the role of maternal antibodies in 
protection of *the new-born child against maiãriä ihfëctiOn and illness. Initial 
investigation of parasite prevalence in the samples by PCR found thata proportion of 
the infants (521156) - were either repeatedly or persistently infected with R. falciparum 
(G. Wagner and M-. Waterfall, unpublished' )-. In- this - study presented-here, 13 - such 
infants (with- a-4 PCR positive-samples in. the-first-70-weeksof life-)- have- been.  
select-cd for detailed study. 
The aims of this section- of the project- were (1)- to type the MSP I and-MSP 2 
alleles, of the parasites. causing these persistent/recurrent. infections-,(H). to-use these 
data to. investigate, whether the. same. parasite. was. persisting over several. months.or 
whether the infant was.. repeatedly infected. with different parasite types (iii). to. 
determine whether clinical malaria was associated with particular parasite genotypes 
or the presence of novel genotypes,. (iv) to enable future comparison of the antigenic 
type Of the parasites presentin a child with the specificity Of the thud's antibody 
response, to address'the question of strain specific immunity to malaria. 
Existing PCR-based techniques were used to analyse the genetic diversity in this 
study. Two genes were used as markers, msp I and msp 2:. The PCRs generated - two 
pieces of data about each- gene; the po'lymorphie size of m.p 1' block- 2 - and'tlre ahiehie 
type- of block 16,-the-size of the- ploymorphic- region of msp-2' and-the- allelic'type-of-
block 4 Thus each infection- can- be- designated -with- a-,'nsp-i- and msp-2- family and-
the size of two respective polymorphic regions-; 
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42 Materials anaMethods 
4.2.1 Sample Collection 
SampleS. were collected, as. described. (Chapter 312).. Briefly r blood was,takexifrom. 
the study infants by heel prick or venous puncture and collected in heparin-treated 
tubes. The blood was separated into packed red cells and serum by centrifugation and 
was then stored at -20°C.'The packed red cells were then used for DNA extraction as 
described in chapter32. 
4.2.2 RB typing 
A sample of each blOod sample was tested for the isofOrms ofhaemo,globin present. 
This was carried out: by cellulose acetate electrophoresis [102]; using gels produced by 
Helena Labs Ltd. 
4.2.3 DNA Extraction 
Extraction of sample DNA was carried out using the Na 2FIP04 method as described 
before (Ch apter3.2).. Control DNA was obtained'frurrr iii vitro cuitures of the HBS and 
3D7 clones of P. fakiparurn The-3D7- clone-was derived-by micro-manipulation-from-a-
case-  of airport malaria- [5]- and-  HB-3- was cloned-from- a- Honduran-isolate- by- limiting-
dilution- [1-0]-. HB3 carries-the KI- dimorphic MSP I allele [-1.04 and-the B-like MSP 2 
allele, whi-le-3t.7 carries.MAD2O-di.morphic MSP 1 allele.[-1-04] -and-A--like.MSP 2 
allele-.. The cultures. were. grown. to. a.parasitaemia.of 64 %. and the.infectederythrocyte.s. 
were harvested by centrifugation at 400 x g for 10 minutes. DNA was extracted from 
packed erythrocytes by the same method as was used for the field samples. 
4.2'.4 PCR detection of Fl4srnodiunafakiparum 
Th inijial, det tisif malaria. 	 ccthnrt ws earned .nut.usinga.. PCR 
based test 1921. The primers used were based on a repetitive sequence found in the 
telometic regions of the chromosomes of P. kilciparum.There are a number of copies 
of the target sequence present'in each genome therefore PCRs carried out using these 
primers showed a greater degree of sensitivity then a nested 'PCR using primers -to a 
single copy gene. This detection method -bad -been used -to screen -the whole study group 
-from -PramPram - to - select the -cohort-described - in -this -work. 
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Figure 2 PCR parameters used for Genotyping PCRs 




Extension No. of 
I Z.- 
Step 
i 	step ep Cycles i 	\tension• 
I step  C i Sec C I Sec I 'C I Sec I U I Sec 
MSP I  
Polymorphic lu I. (iLi 1 94 1 25 1 50 1 35 68 1 	1501 30 I 	)8 1600 1 
MSP1 I I 
Poiyniotphic 1 N1,N2 94 25 50 35 68 150 30 ,8 600 
Inner[361  
MSP1 --t--------- 
 Dimorphic I(!Fi 1 95 60 50 45 .72 60 401- - 
Outer( @) I 
MSP1 I I I I 




Outer(*) 1.0,H 94 60 56 45 72i60 40 2 600 
MSP2 — 1 T 
Polymorphic SI, 54 	I 94 1 25 1 50 60 1 70 1 1201 35 1- - 
InnerI361  
MSP2 I - 
Dimorphic 2D, 2E, 21 94 60 55 60 72 60 40 - 
Inner[51] 
(@) Wagner, G. Unpublished 
(*) McBride, J.S. Unpublished 
For primer sequences see appendix 8.2.2 
4.2.5 -PCR -ana1yis -of allelic diveisity of iifec1ing parasites 
As many of the infections- were of low parasitaerrthr, Le. iuw copy - number-of the target genes 
a technique- was- used to- increase - the- sensitivity- of the- P-CR- for single- copy genes: ifl this 
technique nested- PCR, i-.e two-rounds of PCR, was carried- out. The second-PCR was performed-
with- primers- which- were internal- to. thefirst- set. The template for the first- PCR was. I- '- of 
sample- DNA; for the- second round. I. p1- of the-first PCR product was. used.. Some-times-it proved. 
necessary.to- dilute- the- first PCR product to- obtain- a- product from. the-secondPCR- This-was-
probably due to a high. copy number of the target. sequence geiierated.hy the outer PCR s-a that 
the primers hybridized to the target sequence in the first round of annealing, and so were 
unaváiláble for priming new DNA synthesis. The dilution factor was determined empirically, 
raningfrom '1 ro to 1:10000, and was carried out using distilled autoclaved water (daH20). 20 
PCR mixtures were used as described inChapter3.3 withthe combination Of primers 
described -below. The PCR products were visualised -by running 4 pl of the PCR product and'2 jil 
-of-loading -buffer-on -a -.1-5-% -agarose-(Boeliringer-Mannheim-/05 -x T-BE-gei -containing 500 -rig
mt' -ethidium-brornide-(Sigma). The -gels -were -viewed-under -UV -illumination. -100-base -pai-r 
-markers -were-used-to allow -si-zing- ff. - the -PCR-product. The-base -pair-markers were used -to -draw 
-a standard-curve-of-distance-migrated-plotted -against.-logiO- -molecular -weight-to -estimate -the -base 
-pair. size-of-the -P-CR-product. -For samples, which-failed to -give -a-positive -P-CR-  result -for -one -or 
-more-of-the .genotype.markers, DNA was xe-extractedfrom.the red.. blood cell stock where 
possihIW.this was tpcsihLe.ti.ieu the flNA sampJe .w---treated with CbeJex J 00tcremoye 
contaminants, which may inhibit a PCR reaction. If these treatments were not sufficient to 
produce a PCR product then 2,141 of DNA and2jdof the outer PUR reaction were used Ifalithe 
above failed to produce a P-CR product, then no data was obtainedTOr that genotype marker on 
that sample. 
The sequences of the primers are given in Appendix 8:2: The positions of the primers are 
shown schematically - in Figure 3- md - the PCR parameters -in Figure- 2: Th- predictedband sizes 
for the di-morphie PCR products- were;- msp - I MAD20-type-475- bp; msp -1- K/-type- 204-bp;-msp-2 
A- type- 269- bp- and -msp-2- H type-306-bp- 
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Figure 3 Schematic diagram showing position of PCR genotyping 	primers used 
MSP I block scheme from Tanabe [211 and MSP 2 block scheme from Thomas 271 






02 	 1A -4' #- IC 









21)(FC27) 	0 *-_ 21: 
Conserved regions 
Dirnorphic regions 	 2E(ICI) 	0- *--2F 
Polymorphic regions 





PCR positive 53 (24) 30(14) 
PCRnegalive 2(1) 136(62) 
Total 55 (25) 166 (76) 
(Percentage in brackets) 
Sensitivity 	531(53+2) 	100 
Speeiflcity 1361(30i-136) x 100 
PCR and microscopy 
Total 
83 (J8,  
13S63) 
221 (100) I 
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4.1 Results 
4.3.1 Results from the cohort 
Two hundred. and. twenty one blood, samples. froni 13 infants. were screeneici for the, 
presence of P.falciparum by microscopy and by PCR. The minimum detectable 
blood film parasitaemia was approximately 43 parasites per yl E551, (which is equal to 
1 parasite per 3tXYleuocytes) assuming '13,(Xxileucocytes per ,il óf'b!ood in infants. 
'The minimum parasitaemia detectable 'by 'the'7H8/6 PCR was 1-5 parasite peril of 
whole 'blood'[55], which represented a 30 fold increase in sensitivity over 
microstopy. 
Parasites were detected by PCR iii 38' % (83/221)' of sampies. Ninety sbu percent 
of blood flinT positive samples were also PCR positive-(Figure-4'   ; The two' samples' 
which failed t& give a PCR positive result both had high' parasitac ias. The probable' 
explanation for the failure of the PCR wa& poor sample storage, high concentration 
of target DNA or the microscopically detected. parasitaemias. were not. P. faiciparum. 
Thus,. using microscopy as the gold standard,. PCR. diagnosis. has. a. sensitivity, of 
96 % ansi. a, specificity of 82, W. The apparently tow specif1ci.ty is because PCR 
positive blood film negative samples are classified as "false positives". Using,PCR 
as the gold standard., microscopy 'has a sensitivity of 64 % and a specificity of 99 %. 
fn 25% (55122 1) of samples, parasites were detected by microscopy; the 
parasitaemias ranged from 43 . .parasites per j€i to 172 (XX) parasites per /41: Eighty four 
per cent (46/55)' of parasitaemias were less than 5000'parasites per jL A frequency 
distribution graph shows that- the data is over - dispersed - (Figure 5) The biood'fiirn 
slides we're not read at the' time' of sample' collection unless the' infant presented- with' 
clinical' symtoms, i.e. fever or vomiting; Children' did 'not receive anti-malarial-
chemotherapy. 
Only 7 blood samples were taken frominfants. who had fever at the time. A fever 
was defined. as a body temperature. 375°C.' In. 4. cases no. parasites. were .detected. 
by either PCR or microscopy. in. the other 3. cases, the. samples were. PCR positive. 
and. blood, film, positive hut in, all. cases thei parasite densities, were, less than. 1,Ofl 
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Figure 8 Prevalence of MSP 2 dimorphic alleles 










More 9 Prevalence of polymorphic al* 
• MSP I prevalence 
• MSP 2 prcvalcncc 
Forty seven per cent (39/83) of the infections consisted of one detectable parasite 
genotype and 35% (29/83) consisted of 2 or 3 parasite genotypes and 18% (15183) 
of samples did not have complete data (Figure 5). When incomplete samples are 
ignored, 57 % (39/68) of infections were of a single genotype and 43 % (29/68) were 
mixed genotype infections (Figure 6) 
The minimum -number of genotypes present was estimated -using whichever of the 
two markers (MSP 1 or MSP 2) showed most diversity in the sample. For example, 
in child 5, at week 34, single alleles are detected for all four markers, while at week 
38 there are single alleles for all markers except for the MSP 2 polymorphic PCR 
where two alleles giving PCR products of different sizes were detected; therefore 
week38 was classified .as a mixed infection consisting of two genotypes, but week 
34 was classified as a single genotype infection. All estimates of clone number are 
minimal estimates: if more loci had been characterised the number of genotypes 
detected may well have increased. 
In the following section, each sample was treated as an independent sample i.e. no 
account was made for consecutive sampling within a child. Using only samples with 
complete data, the distribution of msp] allelic family was as follows; 86 % (64174) 
were MAD20-type, 8% (6/74) were Kl4ypeaudin5 % ( 4174) of samples both 
-allelic types were detected. MAD20-type alleles were significantly more common 
than KI-type alleles (x2  =4.1 x 10-12, p-< 0.0001) (Figure 7). msp 2 alleles were 
distributed as follows, 72 % (57/79) were A- type, 9 % (7/79) were B- type and in 19 
% (15/79) of samples both allele types were detected. A-type al leles were 
significantly more.comnron than .13-type allehs (x2 = 4.1 x 10-12, p c  0.0001) 
(Figure 8). 
The sizes of the polymorphic region (block 2) of msp I ranged from 380 to 660 
bps with the mode being 540 bps (figure 9). The range of msp 2 polymorphic region 
sizes varied from 420 to 780 bps with the mode being 580 bps (figure 9). 
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Agarose gels showing PC-Rs carried out on [)NA samples from Child 
Key 
- ye - negative control 
FIB3 - H133 cultured strain (positive control) 





MSP] block 2 I'CR 
4.3.2 Individual infection patterns by child 
The criteria for inclusion in the study were that the infants were infected on at 
least 4 occasions over the first 70 weeks of life.These infections were detected by 
PCR. Using the most conservative estimates, a maximum of 8 different parasite 
genotypes were detected in one child while child 15, 47 and 62 were infected with at 
least 7 genotypes. 
Figure 10 shows the results from PCR reactions carried out on all DNA samples 
taken from child 15. The child was found to be infected at birth and at week 10 and 
these parasites carried different insp I and iiisp 2 alleles. msp I and msp 2 dimorphic 
types are the same at week 0 and week 10 but the polymorphic alleles are different. 
The infection at birth was probably contracted in utero or during the process of 
placental separation at parturition; but these parasites did not persist The child was 
then found to be persistently infected from week 34. to. week 66 with, the exception 
of week 56. The same alleles were present from week 34 to week 42. The alleles 
seen on weeks 50 and 66 were different from each other and differed from the early 
infections, indicating that novel parasite types were present. Low level parasitaemias 
were detected by microscopy at weeks 34 to 42, 66 and 70 (PCR data not shown). 
These data are summarised in figure 13. 
EM 
4.55 
MSP I di 	MP] dimcrphic family 
MSP 1 poly MSP 1 polymorphic Size (bp) 
MSP 2 di 	 MSP 2 dimorphic family 
MSP 2 poly MSP 2 polymorphic size (bp) 
No product 
M 	 Maternal sample 
(vernous sample that when the mothet was enmied in the study prior to the birth of the chiftd) 
Blood film parastaeinia iirlit; -• parasites per .i4 
Gen. code - Genotype code is an arbitrary code assigning a, number to each infection, which is different within a child 
igrL Child 5 
Female, haemoglobin gehotype - AA 
Week No. M 2 4 6 10 14 18 26 30 34 38 
Date of Sample 24/094 817/94 22/7/94 18/8/94 1619/94 - 13/12194 6/1195 3/2/95 7/3,95 
PCR Positive - - - + - + - + + 
Slide Positive  
Fever - - - - - - - + - 
MSP I di K MA D20 MAD2O MAD20 
MSP I poly NP 540 540 540 
MSP2di B B B B 
MSI' 2 pply 440 485 690 690 
42.0 
Gen. code 1 2 3 3,4 
4.3.2.1 Child 5 
Child 5 (Figure 1 1) was found to be briefly infected on weeks 14 and 26 with 
parasites which carried ditThrent MP I and MSP 2 allClés. Then, on weeks 34 and 
38, the same MSPI and MSP 2 alleles were detected in both samples. This indicates 
that the same parasite had persistedfor atleast4 weeks. On week 38; an additional 
MSP 2 allele was detected indicating that the infection at week 38 comprised at least 
2 ckjnes. None of tire PCR positive - samples- were- blood- film- positive. Fever- was-
reported at week 34, as was a cough, but this- w-asunlikely to- be- due-to the- presence-
of parasites as the parasaacmia was too- lOW to be detected by blood-film- at this time. 
From the detected infection& it- seems- that in- her first- 38-weeks of life, the infant- was-
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Gpnccde 1 23 2,37 23 - - 
Child .15 
.FP1ale., haemoglobin genotype - AS 
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4.3.2:2 	Child 12 
Child 12 (Figure 12) was free from detectable malaria infection from birth until 
week 42 when he was found to be iiifectedby a single détectablé parasite genotype. 
The infant was fOund to be persistently infected - in 4-consecutive samples with the 
same MSPI alleles being detected: However a single P2 allele was detected -at 
week 42 and 2- different alleles were detected at weeks 46, 50 - and-54.- This indicates 
that this- child had been- infected with- one - parasite- clone on- week 42 and-that - two-
different- cloneswere-detected-in the-blood-from-weeks 46-to-54; Low blood-film-
detectable parasitaemias were seen at weeks 42,46 ; and-50 but-the blood-film taken 
at week 54 was- negative. This-infant had been- asymptomatically- infected-with. 3 
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4.3.2.3 	Child 17 
The sample taken from the mother of child 17 was parasite positive (Figure 14). 
The child was then found to be infected on weeks 2 and 18 with parasites possessing 
different MSPI and fY15? 7 alleles. The child continued to be parasitiedirom week 
26 through to week 46 with a single genotype carrying apparently the same MSP I 
and MSP 2 alleles. It is possible that this is the same parasite genotype that was 
found' in the motIrei but further molecular - markers- or- sequencing information are 
needed to shed further light on this. Low parasitaerni-as- were detected- by' microscopy 
at weeks 34 and- 42. The infant was infected-with- at least- 2 different- parasite 
genotypes., one genotype appearing to- persist for at- least- 20-weeks 
4.3.2.4 	Child 29 
Child-29-(Figure 15)- wa-s found- to- be persistently infected- wit-h- a- single parasite 
genotype from- week 18-to30- and. then- 2 brief novel-infections- were-detected- in- week 
34 and 38.. Fie. was-then. found. to- be-infected. with. a. newparasite. type. at week- 46, 
which persisted. until. week. 58 althiuugh. the sample at week 54. was. negative... Very 
low parasitaemias were detected by microscopy at weeks 34 and 50. A fever and 
diarrhoea were reported at week 34, which may be associated with a novel infection. 
The parasite detected at week 46 and 58 could represent a mixture Of the genotypes 
detected earlier, thus the conservative estimate of the number of genotypes present in 
-this child would -be three. -Some genotypes appeared -to persist for at -least -12 weeks. 
4.., 
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43.2.5 Child 45 
Child 45 (Figure- 16)- appeared to be-infected with 4 different- parasite types in 
consecutive months, weeks 44, 46, 50 j 54. Although all parasites carried the MAD20-
type rnsp 1 di. morph.ic sequence and. the A-type MSP 2 dimorphic sequence, parasites-
carried various- sized msp. 2. polymorphic. regions Very hi.gh..parasitaemias. were. detected. 
by microscopy at week 50 and. 54;. but were, not associated.fe.ver or other symptoms The-
parasites detected at week 54 could be a combination of genotypes present at week 46 
and 50. This child appears to have had multiple short-lived infections. 
4.1.2.6 Child 47 
The first detected infection in child 47 was at week 26,, when two MSP 2 alleles were 
detected (Figure 17). In both weeks 30 and 34, the same three M1' 2 alleles were seen 
in each sample. The most conservative interpretation of the data is that three parasite 
genotypes were present at both week 30 and 34 but only two MSP1 - alleles could be 
detected. Alternatively there may a shared - MSP I allele in two of genotypes. A novel -
allelic type was seen at week 42 and the same- alielic type- was- seen- again at week 50 
The same- parasite clone- was almost certainly present at week 46-but was-not detectable; 
Parasites detected at week 66- earned different- alleles to- all- previous infections but the 
parasites present at week 70. possessed- similar alleles- to- parasites- seen- at week 30 Low 
to ..moderate. blood, film. parasitaemias. were. recorded. at weeks. 30, 34,42,50. and- 70. and. a. 
transient  .episode of fever was- recorded. at. week. 38 The most conservative. estimate. 
would he that this child was infected by at least 5 different clones from 26 to 70 weeks 
of age,, with one of these genotypes persisting.for 40 weeks while others were transient. 
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4.327 Child 52 
Child 52 (Figure 18) experienced the least number of parasite positive weeks of 
this cohort. The cliffd was congenitally infected with malaria but the sample could 
not be typed - possibly due the high parasite density. A second brief apparently 
single clone, infection was detected at week 10 At weeks 38 and 42 -, two parasite 
genotypes were detected, the same alleles being present in both samples, indicating 
that the same two clones of parasite had persisted for at least 4 weeks; Very low 
parasitaemias were recorded in weeks 10 ; 30; 42 and high- blood- film- parasitaerni-as 
were recorded in weeks C- and 38- but ac-fevers were detected. The sample at week 30 
was- blood- film positive but was- not PCR positive, possibly due to DNA degradation. 
4.3.2.8 	Child 62 
In child 62 (Figure 101)-a- brief infection was detected at- week 2. Then, from- week 
10. to 22, two- MSP 1 alleles- andto. MSP 2 alleles- were- detected suggesting-that. at 
least two. parasite. types. were. persisting for 12. weeks.. The.- same. MSP 2 alleles. were. 
also apparently detected. at week-26 hut. a novel. M5P I allele was- a!s-a. detected. in 
this sample. A transient polyclonal infection, with at least two novel MSP 2 alleles,. 
was detected at week 42. A completely new parasite clone was present from week 46 
to 62. Week 54 was *blood film positive but was PCR negative, probably due to 
degradation of sample. - The child was repeatedly parasitaemic but parasite densities 
were always low and fever was only documented on one occasion (week 26) 
triggered -by infection -with aiiuvel clone. A conservative estimate indicates 
-that -this child -was -infected -with -at -least 7-parasite -genotypes over the -first 70 weeks 
-of-life -with-some-clones per for at -least -14 -weeks. 
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4.329 Cizild65 
Child 65 (Figure 20) was found to be briefly infected at week 18 with a parasite 
which could only be typed for the MYP 2 dimorphic allele. At weeks 38 and 42. two 
different parasite genotypes were detected At week 54, two MSP 1' and two MSP2 
alleles were detected The child continued to be parasite positive until week 70 The 
allele typing data suggests that the child - was infected with a novel parasite type in each 
sample' except that one genotype was--detected-at week 62'and - week 66. Parasiaenii'a 
was detected' micrscopi call y at weeks38, 42, 54"to'70; but the- child remained' 
asymptomatic despite parasitc densities reaching up to 1O ;000parasites. per ph Aticast- 8 
genotypes, were detected-;. - t.hischild, all infections-were transient. except .for one which. 
persisted. for at least 4 weeks. 
4.3.2.10 Child 71 
Child. 71. (Figure .2 1.). was.found.to . be infected.from. weeks.30.to.42; different. MS! 1 
and MSP 2. alleles. were detected. in. each. sample... On, weeks. 34. and.38,. two different. 
MST 2 alleles- were. detected iii each. samp1e. Two brief, infections.. wer.e. d.etected..at...w.eeks.. 
54 and 62. Genotyping. data could not be completed for weeks 42 and 54. Low 
parasitaemia was detected microscopically at weeks 34 and 38, parasite densities at 
week 30 and 62 were quitehigh'but the child remained asymptomatic. This child was 
transiently infected with at'ieast '6 different genotypes. 
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4.32.11 Child 81 
Child 81 (Figure 2.) was found to be persistently infected from weeks 38 to 54. 
The MSP I allele present at week 38 was different from those present at subsequent 
weeks. The same parasite clone was detectedfrom week 42 to 50, with an additiOnal 
clone transiently detected at: week 46. No allele typing data could - be obtained for the 
infection at week 54. All PCR positive samples were associated with blood -film 
detectable parasitaemias. A fever-was- recorded - at week' 54- but - the--associated-
parasitaemia- was. very-low. This-child-was -infected-with- at- least- 3-different-
genotypes with one persisting for at least- 8-weeks. 
43.212 Child 120 
Child- 120-(Figure-23)-is unusual-- in that she-experieneed-a complex infection-
pattern- within- the first-6-months-of- birth-and-then-was-free of detectable parasites, 
from. week 30- to- 70. Tw-o-MSP I and.-two-MSP 2 alleles- were- detected. at, week 1.0; 
one-. of these. parasite .types .may still, have-been, present at weeks. 14,18 and. 26.. Two 
aQVeI. MSP 1, alleles. were present. at..week IR anil.anoyel.MSP 1 allele. was. seen.at . 
week 26. Moderate blood film parasitaemias were detected by microscopy, at weeks 
10,, 14,22 and 26 and a very high blood film parasitaemia was detected *by 
microscopy at week 18. A'fever was recorded at weëk'34 with no associated 
parasitaemia; There were 'Stransientiy detected MSP 1 alleles in - this child with -two 
alleles apparently persisting over -the entire period of infection. - More detailed 
analysis 'ofLhe - infections'in'i.his -child-is-required-Lo -detennin-e -wheLherparaiie 
- persistence -Was 'occurring. 
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Duration of infection wasdefined-as follows 
<4 weeks 	Clones were detected in one sample 
4 weeks Clones were detected in two consecutive samples 
8. weeks. 	 Clones.w.ere detected in-three consecutive samples. 
12 weeks -Clones were detected in-four consecutive samples 
20 weeks 	Clones were detected in six consecutive samples 
Any number of clones is the total number of infections with a specific duration 
(The-number-of-clones -present--was-estimated using -whichever-of-the-two -markers 
s1iowedmost d-i-versri-t-y- (note:- this is- the minimum number-of- clones))- 
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Based onPCR genotyping data, the number of infected samples detected in the 
cohort ranged from 3 to 8 with a median of 4. The number of the new genotypes seen 
by the cohort ranged from 2 to 8 with a median of 4 (Table 25). The maximum 
duration of a single clone ranged from <4 weeks to at least 36 weeks with a mode of 
4 weeks. 
Figure 26 shows the number of clones detected and how long they persisted Sixty 
six percent (35/53) of infections were transient, i.e present in only one sample. Two 
clone infections persisted for amaxirnum of 8 weeks. interestingly as the duration of 
infection increased there is  decrease in complexity , of the infection or low 
complexity infection last longer (Figure 27). The data shown here. 
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This is graphic representation of some of the data from table 6 
Kea 
Duration of infection was defined as follows 
<4 weeks 	Clones were detected in one sample 
4 weeks Clones were detected in two consecutive samples 
8 weeks 	 Clones were detected in three consecutive samples 
12 weeks Clones were detected in four consecutive samples 
20 weeks 	 Clones were detected in six consecutive samples 
(The nimher of clones present was estimated using whichever of the two markers 
showed most diversity (note: this is the minimum number of clones)) 
ENIN 
4.4. Discussion 
The work described here was undertaken in order to investigate whether multiple 
infections found in a group of infants from coastal Ghana. West Africa were due to 
persisting infection or due to repeated 'infection with novel parasite genotypes. This 
type Of study hasbecome possible due'to the development of parasite typing 
'techniques, which require small quantities of blood from infected 'hosts i.e. PCR-
'basedtechniques. 
The cohort presented - here were s'electedfrom' a larger -study in which the presence 
of P. faiciparum was' detected-by' PCR (G. Waguer-'and'M;Waterfaii; unpublished) 
All of the- children- studied were-infected- with- at least- 3- different parasite- genotypes 
during this time. P-eviously published work [102] from this- study area- on- a- larger 
cohort. (n=71.). had found-that there -was- a low rate of infection. (9.7 %) -in- the .first-.26-
weeks. of life. while. in. the cohort presented. here.9113. were. infecte.d.within. this .time.. 
In the. thrger study the risk.of thfe.ctioii was-found to he -3. times higher. in the. wet.. 
season when compared with the dry season. This seasonal effect was not found in the 
cohort presented here possibly due to the small cohort size so the effect of season 
coUld not'be seen or'it maybe due tointrist differencebetween this cohort and the 
larger study group. 
There are limits in the PCR-based techniques used in this study. One drawback of 
the protocol used' here is that there is an inevitable bias towards detecting the major 
cione because the outer'primers - used'ai'e - to' common sequences - found- in both allelic 
types so- there is-no- specific- amplification of the-minority' clone; Using' the-dimorphic-
primer sets it was found- that- it was possible to-detect- minor parasite genotypes in a 
ratio- of 1:1.0.. of mixed-infected- erythrocytes-(G.. Wagner, unpublished, results). This-
may not have an. effect on- the results but should. be.borne in, mind. Another study. 
using different- PCR primers.to. anaiayse.msp. 1 and..rnsp. 2 polymorphisms found..tiat 
it was only possible to detect minor alleles at a ratio of 1:10 [33]. In this study DNA 
from different isolates were mixed rather than infected erythrocytes. 
As mentioned in the introduction, the non-detection of a.parasite type may be due 
to the failure of the detection rather than that the parasite type i not -Present. FOr 
example, in child 29, clone 4has the same MSP -i' allele as clone 1' andihe same MSP 
.2 - allele as clone 2. Clone 4may therefore be amixedinfection of clones Fand'2 -
where only - one allele from each' clone was detuctd. Situatiousiike this - can be seen 
throughout the- data; 
ME 
'Using size as the criterion for distingüihing pOlymori$hisms 'limits the 
information obtained. As well as size pbiymorphism, 'there is sequence 
polymorphism, which would enable each polymorphic region to -be assigned a size 
and a -type,i.hus iuereasing' the 'amountinfonnation regardiu'g 'the - parasite - type. POR 
-alone therefore underestimates 'diversity -as-products 'of-equal 'size -but with -different 
-sequences -would-be-classed as-identical. 
The use of further polymorphic genes for parasite typing would increase the 
robust-nes& of the data. Other antigen- coding- genes which-are known- to-exhibit 
polymorphism, which. could-be, usedincluding. giurp. or S. antigen. Microsatellite. 
markers. have been deve.lopeifor P Jaiciparum [105]; the. use. of thesc markers. has. a.. 
number of advantages. They, are not thought to he expressed as a protein and so 
would be unlikely to be subjected to any selection by the host's immune system and 
a large number (8 -10) of different microsatellite markers can be typed uing 
genotyping gels on an automated sequencer;However, we can not yet -be completely 
certain 'that all microsatellites identified come -from non-coding regions of -the 
genome. 
It is not possible to link- different' mjx I and - msp2'aiieies tugetlieri:e.. onw cannot 
define genotypes. ill. mixed-infections-(e;g'. in child- 62- week' 14, 18, 22); it is not-
possible- to- tell which-msp-1- allele-is linked- with- which- insp-2- allele-, but-this does not 
hinder the interpretation- of the data for this- study. 
In -this. cohort,--of -all.the.typed samples, 72 % of -rnsp .2 alleles were A. type, 9 % 
were .Btype and .19 %-of -infections were -mixed allele infections. In -a-high 
.transmiss ion. are. aof.EastAfrica, of. all L the, t.ype.d. samples, .17 % .ofinsp .2 alleles were 
.A-ty.pe, i.9 .% wreB- type and 65 .%were mixed (JIe,,infecticuis .wbiJein a Jcw 
transmission area of East Africa, 63 % of msp 2 alleles were A-type, 31 % were B-
type and 18 % were mixed' allele infection . .UO6J  Fiequenciès found'in this study 
show that A-type alleles were more common that B - type allè!ës. Thus the data from 
this study are comparable with another low transmission zone. 
The'Iinding'that'the predominate msp I dimorphic allele isMAD20, is not 
surprising as -there is a geographical - bias 'in'frequency 'of -this allele. in West Africa it 
-has -been 'consistently found -that 	-is 'the 'dominant MSP I dimorphic 'allele 
[90]. 
I n order to- gain further information regarding- the-parasite-types present-, 
sequencing of the polymorphic region- of MSP 2 was carried- out (-see chapter 517  This-
region- was chosen- because it- is- know-n- to- be highly polymorphic and- because a. 
further part 01 this. study was- to. investigatethe. humoral. immune .response to.both. the 
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polymorphic and dimorphic regions ofMSP2 for this anal'sis sequence data were 
required (chapters 6 and 7). 
The rate of sampling would not detect all - parasite infections as some infections 
may be cleared prior to the next sample being taken. In this study, there may be bias 
towards- detecting - parasite types - which- are able to establish a blood- stage infection 
for at least 3 weeks; No- short interval- studies have- been- carried- out in- Prampram, i;e; 
taking blood- samples every 2 days, so-it-is not possible to-know- how- parasite 
populations fluctuate in- infants, within- this- time scale. Studie& usin.g frequent-
sampling, e.g. 2-days, have- been. carried, out with. older.children. These. studies. have - 
found- that. the parasite. types. d.etected.ia theperipheral. blood..vary every few days,. 
possibly due to asynchronous parasite populations .24,9711, The interval of sampling. 
used in this study really only,gives a snap shot of the parasite types present rather 
than a comjilete infection history Of the study infants. It -is prObable that short term 
fluctuation in parasite populations depends on the transmission intensity; in the 
published studies the transmission intensity was much higher than 'that'found in 
Prampram. 
The variation in parasite type with time in air individua!'suggests that tnnismission 
is occurring, as it is- probable- that new inocula-front mosquitoes would-be-of- different-
allelic types to those of existing infections. The-differences between- infection 
patterns within- the cohort compared- with-the whole study-group-may, be due to-local-  
differences- in- malaria- transmission-in- the town. Other factors-e.g. environmental. or
socio-economic. f actors. may. explain, the. differencein- infection, patterns.. Infants . who . 
are repeatedly infected with. new parasite- types. may live, cluset to a.wdlLw.aterhoie, 
which may act as a mosquito breeding. site. Alternative., there may be an older person 
in the -home whois chronically infected and therefore acts as a reservoir of infection. 
There may älso'be'locai variation'in the mosqüitobiting ratein the Village. 
When an infecticn is detected by the protocols used here, the parasites are 
presumed to be in the blood stream having undergone exoerythrocytic schizogony 
and a number of rounds of erythrocytic schizogony, in order to reach a detectable 
level. Therefore the mosquito bite which- resuited-irr the detected-infection would-
have occurred- at least 10-days 'prior' to the detection of the-infection; 
The -persistent-infections -became -more-common -at -10-to -1-8 -weeks -alter birth, e.g. 
-child _51, child -17,-child 29,-child-62 -and-child -120. After -this -period, -mediators -of 
.passive -immunity such -as-maternal .l.gG,..fetal .haemoglobin and -PABA -deficiency 
may bedecreasing. [41. However the -fact -that .most.infections are -controlled -to very 
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low levels and without clinical illness, Indicates that some kind of protection is still 
operating. 
The duration of detected infections varied from less than 4 weeks i.e. only 
detected in a single sample (77 % of detected infections) to up to 20 weeks in one 
ease (possibly even 40 - weeks- in another case) (Figure 25); 68 % of the infections -
detected- in only one- sample- consisted- of only one- clone; I-n- endemic-areas, the-fact 
that re-infection may take place means that the duration of any one infection- can only 
be inferred- by molecular characterisation. In cases- of experimental- infections-,it was-
found that infections. with-malaria, would- resolve. after 207 to-237 days. [107]. 
Molecular studies. in. naturally infected individuals, have shown. that.parasite. types. 
can persist for at least 50 days [24]. Long term studies into parasite persistence 
carried out in Sudan found that an individual can remain infected with same parasite 
genotype for up to 6 months 1108i In the study present here the maximum duration 
of infection was seven months. 
The infection profiles of the 13' children studied here can be classified into 3 
groups; 
Children (n=1') who are infected with a single parasite genotype which persists 
e.g. child 17. This- is indicative of persistent infe'eti'oir. 
-Children '(n=2) -who re-persistently -infected -but -the-parasite type 'changes 'over 
time -and -only -one -parasite type-is -found -in-each -sample 'e;g. -child 29. These -are cases 
-of-reinfection -rather-than -persistent -infection. 
Children (n=10)- who- are repeatedly infected wit-h a- number of different- parasite 
types- detected- in- each- sample. Some of these super-infections- exist- over a- number of 
samples. i.e.. persistent superinfection, e.g., child. 62.. In. these. children, persistent 
infection of some. genotypes. is. superimposed. aa a patteru of frequetre-infection, 
i.e. a combination of persistence and re-infection. 
There were only 7 recorded fevers and just 3 of them occurred when blood film 
parasi'taemi'as were detected, albeit at the lower limit of detection. In this cohort there 
were .probaby no clinical episodes of 'malaria. This was important as the infèctibns 
were not treated with cifioroquine, so it has been possible to follow the pattern of 
persistence without the confounding effect of drug clearance. It seems that the 
infants are effectively controlling tiieirparasita'eirrius below a py ro'genic threshold; 
This ability persists beyond-the age at which- innate protective-factors, which-are-
thought to- mediate- passive protection, have waned; therefore-, there-must- be-some-
other mechanism by which the level- of infection- is- eontrolled Setting-aside the role 
- 
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of antibodies in protection (Which will be discussed in chapter 7), a type of non-
antibody-dependent immunity maybe involved. 'T cells are thought to be involved in 
protection against exoerythrocytic stages, either by being directly cytotoxic or by the 
release 'of cytokines, 'e.g. TNF, 1-FN', IL-i, 11.6 and NO ['109]. Protection 'against 
'erythroeytie 'stages -may also 'be -mediated by -similar -mechanisms. 
In' summary, repeated' parasite- positive samples in. infants in- Pram pram appear to-
be due to- a combination of parasite persistence over, many weeks and- reinfection or 
superinfection-. What is notable about these infections is- that they tend- to-be 
maintained- at relatively low density and- are- rarely accompanied- by fever or other 
clinical syniptom& 
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5. 1. Introduction 
The aim of this study was to chacterise, at the DNA level (and inferred amino acid 
sequence), variation in the MSP 2 antigens carried by parasites infecting individual 
children followed longitudinally for up to 70 weeks. Prior to this study, sequence 
analysis of variant antigens of P.falciparum, such as MSP 1 [18-20,22], MSP 2 [25-
27,110-112] and S-antigen [9], was restricted to a number of cloned field-derived 
isolates. No previous studies have been carried out where a cohort was studied 
longitudinally and where variation of an antigen at the nucleotide sequence level was 
investigated. The only comparable study took samples at 29 month intervals from a 
random sample (N=17) of the whole population [113]. Due to the long time period 
between the two samples, this study was more like two consecutive cross sectional 
studies rather than a longitudinal study. This study found that individuals were infected 
with different MSP 2 alleles at the two time points. The authors suggest that this is 
evidence for the development of strain-specific immunity [113] although the data are 
hardly convincing. 
In the present study, MSP 2 was the antigen chosen for investigation because it is 
highly variable and is a target of immune responses in exposed individuals [58,66,67]. 
The humoral immune response to MSP 2 has been shown to discriminate between the 
two dimorphic forms of the protein [58] so MSP 2 may be a target of strain-specific 
immune responses. DNA sequence data [25-27,110-112] indicate that the greatest 
variation within the antigen is found in the central repetitive region. This region was 
therefore selected for sequencing to provide a good marker to distinguish new infections 
from recurrent or chronic infections. 
Sequencing was carried out in order to clarify some points from the PCR results; to 
confirm whether same-sized PCR products in consecutive samples are in fact identical 
alleles and to investigate the potential that a single-sized product from a single sample 
may comprise more than one sequence. In order to investigate the potential 
immunological cross-reactivity between different MSP 2 alleles it is necessary to know 
what repeat structures are present. It is possible that different-sized alleles may consist 
of either different number of the same repeats or different repeat sequences. Sequencing 
enables these points to be cleared up. There is a difference in antibody recognition of 
antigens which vary in the number of repeat units even when these repeat units are of 
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identical sequence [114]. Thus the number of repeats may affect epitope specificity 
and/or antibody avidity. 
In addition to using the sequence of the MSP 2 polymorphic region as a marker of 
new or recurrent infection, the products obtained were used to produce recombinant 
antigens. In order to investigate the immunogical characteristics of these regions, the 
sequences that code for these regions need to be cloned into an expression vector and the 
cloned products need to be expressed as recombinant proteins. These antigens would 
represent the polymorphic regions which had been detected in blood samples from the 
infants. ELISA assays were then used to investigate the development of humoral 
responses to dimorphic and polymorphic regions of MSP 2 (Chapter 7). 
The molecular cloning of the polymorphic regions was initially carried out to ensure 
that the template for sequencing would be monomorphic. There was a possibility that 
where a single sized PCR product was seen, the sample could contain multiple PCR 
products of different sequences. In fact, it was found that there were very few infections, 
which contained a single-sized PCR product, which contained multiple sequences, so 
direct PCR product sequencing was then carried out. The PCR product was generated by 
primers 2A/2B and 2C 
In summary, it was decided to clone and sequence all the MSP 2 alleles found in all 
the children in order to, (i) gain a better estimate of the levels of antigenic diversity 
within a child and within the population, (ii). look for clustering of similar or different 
sequences, which may indicate whether strain-specific immunity may be operating, (iii). 
provide antigens for serological studies. 
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Materials and Methods 
The initial strategy to clone the polymorphic regions of 
MSP 2 genes was to clone 
31-S4 PCR products into TA vector (Invitrogefl) these PCR products were generated 
using the inner polymorphic MSP 2 
primers. This vector was chosen because it would 
allow the cloning of existing PCR products and the presence of a cloned insert would 
disrupt the galactosidase gene allowing blue/white selection. Bacterial colonies, which 
contain a vector and ligated insert, grow on ampicillin agar plates and appear white, 
while colonies c
ontaining self-ligated vector appear blue, due to presence of X-gal on 
the plates. The TA vector is supplied linearized, with a deoxythYmidine triphosphate 
overhang at the cut ends. Most Taq polymerases add a 
5' deoxyadeflOsifle triphosphate 
to the PCR product making it possible to ligate the PCR product with the TA vector. 
However in this study we found that the Sl-S4 product would not ligate stably into the 
vector, possibly due to secondary structure of the insert. 
As an alternative strategy, PCR primers were designed to amplify the polymorphic 
region of MSP 2. 
Three primers were used - one conserved 5' primer and two allele 
specific 3 primers (chapter 4, figure 3). These primers had 5' 
extensions, which 
contained endonuclease restriction enzyme sites to assist in the cloning of the fragment. 
The conserved primer (2C) is the same as primer Si but has been modified to include a 
5' EcoRI 
site (Appendix 8.2.3). A primer from the conserved 5' sequence of 
MSP 2 was 
used due to the extensive polymorphism found in the 5' 
dimorphic region. Two family-
specific primers 2A and 2B, each contained a stop codon and 
Ba?nHi site (Appendix 
8.2.3). These PCR products were then cloned into pBluescript vector, following 
linearization of the phagemid by endonuclease restriction enzymes. Again blue/white 
colour selection could be used with this vector. The use of different restriction enzyme 
sites in the 5' 
and 3' primers ensured that the insert could only be cloned into the correct 
orientation in the vector-and that the insert was in-frame with the fusion protein. 
possibly due to the small size of the insert, the blue/white selection did not show good 
discrimination between self-ligated colonies and colonies containing a cloned insert, so 
this method was abandoned. 
Finally, as the inserts had to be sub-cloned into a pGEX vector for protein expression 
the decision was made to clone the PCR products directly into pGEX so removing the 
need for sub-cloning inserts from pBluesCriPt into pGEX. 
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5.2.1 Production of polymorphic region PCR products for cloning 
100 itl amplification reactions were set up as described in Chapter 2.3 with either 
2AC or 2BC primer combinations, depending on the alleles previously found to be 
present in the sample (Chapter 43.2). The templates used were one J41 of the msp 2 outer 
PCR reaction or the msp 2 inner PCR reaction diluted 1:1000. The PCR programme for 
2AC was 94°C for 30 sec, then 50°C for 1 mm, then 70 °C for 2 min for 30 cycles. The 
same programme was used for 213C except that the annealing temperature was raised to 
55 °C. 
Four microlitres of the PCR reaction mixture were run on a 15 % agarose/05 x TBE 
gel to check the reaction. If more than one band was present indicating that there was 
more than a single allele present in the sample. The whole of the remainder of the PCR 
reaction mixture was run on a 1-5 % agarose/05 x TBE gel and individual bands were 
excised for extraction from the agarose using a Prep-A-Gene kit (BioRad). If a single 
band was present the PCR product was purified and eluted from a High Pure PCR 
Product Purification kit ((HPPPK) Boehringer Mannheim) in 30 ILI of daH20. HPPPK is 
a glass wool spin column, which binds DNA in the presence of high salt solutions and 
allows the removal of unincorporated nucleotides and incompatible buffers. 
The purified PCR products were used as templates for direct sequencing 
(Chapter 5.2.7.1) 
5.2.2 Digestion of PCR products 
Purified PCR products were then double-digested to allow ligation of the insert into 
the double-digested vector. A digest contained 20 units each of EcoRI and BamHI 
(Boehringer Mannheim), 4  y of 10 x Buffer B (Boehringer Mannheim), 30 id PCR 
product; the volume was made to 40141 with daH 20. The digest was incubated for two 
hours at 37 °C or overnight at 37 °C. The digested fragments were then purified and 
eluted from HPPPK in 30 itI of daH 20. Two microlitres of the eluate were run on a 
15 % agarose/0-5 x TBE gel to estimate the DNA concentration as described for the 
sequencing templates (Chapter 3.5. 1) 
RM 
5.2.3 Producing double-digested pBluescript II phagemid for ligation with double 
digested PCR products 
As the efficiency of BamHI is greater than that of EcoRE when cutting away from the 
end of a DNA molecule (NEBL catalogue), and because the EcoRI site is very close to 
the BamHI site, the phagemid was cut using the following protocol. The plasmid was 
first digested by BamHI and then EcoRI. The digestion mixture contained 5 1g of 
plasmid DNA, 75 units of BamI-H and 15 tLI of 10 x Buffer B, made up to 150 gl with 
daH2O and incubated at 37 °C. After two hours, 75 units of EcoRI were added and the 
incubation was continued for a further two hours. The linearized plasmid was purified 
and eluted from HPPPK in 15 1d of daH 2O. 
5.2.4 Producing recombinant phagemids 
600 ng of linearized phagemid DNA was ligated with 150 ng of digested PCR 
product (this gives a 1:3 ratio vector: insert molar ends). The ligation mix contained two 
units of T4 ligase (Boehringer Mannheim), one pl of 10 x ligation buffer (Boehringer 
Mannheim), 2-3 yl (600 ng) of double-digested plasmid, 2-5 il (150 ng) of fragment and 
the final volume was made up to 10 pl with daH20. This was incubated for two hours at 
22 °C or overnight at 16°C. 
5.2.5 Transformation of competent XL1-Blue E. coil with recombinant phagemids 
The ligation mix was used to transform competent XL1-Blue E. coil. 100 1d aliquots 
of competent XL1-Blue were rapidly thawed and placed on ice. 5141 of the ligation mix 
was added, then incubated on ice for 10 minutes. The cells were heat shocked at 37 °C 
for 15 minutes then placed back on ice. 500 pl of LB broth was then added and the cells 
were incubated at 37 °C for 15 hours in an orbital incubator. 200 jd of transformed cells 
were spread onto TAXI plates (Chapter 3.4. 1) and incubated overnight at 37 °C. 
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5.2.6 Screening for recombinant phagemids 
Single colonies taken from TAXI plates were inoculated into three ml of LB-AMP-
TET (Chapter 3.4.1). The use of blue/white selection was severely limited as it was 
found that colonies with an insert may retain a blue phenotype. This is probably due to 
the small size of the insert resulting in minimal disruption of the LacZ gene. Primers 2A 
and 2B had stop codons prior to the EcoRl site, but there may be read-through of this 
stop codon as insert containing colonies were found to be blue, blue-white or white. As 
colour selection was not reliable, colonies were screened for the presence of an insert by 
PCR. Between 5 to 10 colonies were picked, inoculated into 3 ml of LB-AMP-Tiff and 
incubated for 12 to 18 hr in a 37 °C orbital incubator. A 50 pl aliquot of the culture was 
removed and centrifuged in a microcentrifuge at 12 000 x g for two minutes. The 
supernatant was discarded and the pellet resuspended in 40 J4l of daH20, transferred to a 
boiling water bath for 10 minutes and then centrifuged at 12 000 x g in a microcentrifuge 
for two minutes. One microlitre of the supernatant was then used as a template for PCR. 
An insert-specific primer and a plasmid-specific primer were used to ensure that only 
colonies with an insert ligated into the plasmid in the correct orientation gave a PCR 
product. The primers used were M13F and 2C. 20 d PCRs were set up as described 
before (Chapter 3.3). Positive colonies gave a product, which was approximately 109 bp 
larger than the PCR-generated insert (Chapter 5.21) 
5.2.7 DNA extraction from insert-containing colonies 
Plasmid DNA was extracted from insert-containing colonies using the alkaline lysis 
miniprep method modified from Maniatis (1989). Briefly, 15 ml of culture (5.2.5) was 
centrifuged at 12 000 x g for one minute in a microcentrifuge. 100 PI of solution one 
(Appendix 8.1.7.1) was added to the pellet, which was resuspended by vortexing. 200/41 
of solution two (Appendix 8.1.7.2) was then added and the tubes were inverted four 
times to mix the solutions. 150 pl of solution three (Appendix 8.1.7.3) was added and the 
tubes were inverted four times to mix the solution. The supernatant was harvested 
following centrifugation, as described above, and added to 900 yl of ice cold 100 % 
ethanol, then centrifuged again. The supernatant was removed, the pellet washed with 
1 ml 75 % ethanol then centrifuged. The pellet was dried in a 65 °C heating block for 
10 mm, and finally resuspended in 50141 of daH20 containing 20 jg m1' RNase 11 1A 
(Sigma, prepared as described in Maniatis). 
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5.2.8 Sequencing 
Direct sequencing of the recombinant phagemid proved impossible, possibly due to 
secondary structure of the inserted DNA. Linearization of the phagemid using restriction 
enzyme digestion and alkaline denaturation to relax the phagemid failed to surmount this 
problem. The following method was used to produce a sequencing template to enable 
successful sequencing. A 1:100 dilution of phagemid DNA was prepared in daH 20 and 
used as template for PCR with M13 primers. The PCR product was 209 bp larger than 
the insert and contained T3 and T7 primer sites. 50 pl PCR reactions were used. The 
PCR products were purified with HPPPK and eluted in 40 td of daH 20. Two microlitres 
of the eluate were run on a 15 % agarose/05 x TBE gel to estimate DNA concentration. 
Inserts cloned into pGEX were prepared using the same method but different primers 
were used for generating the sequencing template and in the sequencing reaction 
(Chapter 6.2.3). 
The sequencing reactions were set up as described before (Chapter 3.5). Briefly, a 
sequencing reaction contained three to five microlitres PCR product, four microlitres 
Dye Terminator Ready Mix and 1-6 pmol T3 primer made up to 10141 with daH 20. The 
reaction mixture was overlaid with mineral oil and run on the sequencing programme. 
The product was purified by ethanol precipitation and run on an ABI 373 automated 
sequencer as previously described (Chapter 3.5). 
5.2.9 Direct PCR product sequencing 
Direct sequencing of AC or BC PCR products was carried out as described above, 
except that 2 pmol of primer (A, B, C) were used. Three to five pI of purified PCR 









5.3.1 Ensuring the specificity of the allele specific primers 
The AC primer pair amplifies only A-type msp 2 alleles, e.g. from parasite clone 3D7 
and sample 47-66, but does not amplify B-type msp 2 alleles, represented in this 
experiment by HB3 (shown in lanes 1 to 4). The BC primer pair amplifies only B-type 
msp 2 alleles including HB3, 5-34 and 62-14, but not the A-type msp 2 alleles 
represented in this experiment by 3D7 (shown in lanes 5 to 9). The size of the PCR 
product varies according to the length of the polymorphic region of the template allele. 
Figure 1 PCR products generated using AC and BC primer pairs 
S . - 
ii'- .1. 
PCRs carried out 	PCRs carried out 
using AC primers using BC primers 
Key: 
Lane 
M - 100 bp markers 
- -ye control 	 5 - -ye control 
2-3D7 	 6-HB3 
3-47-66 7-5-34 
4-HB3 	 8-62-14 
9-3D7 
5-86 
5.3.2 PCR screening for recombinant pBiuescript phagemids 
Due to the difficulty in using the blue/white selection, colonies were picked and 
subjected to PCR to determine the insert size. In figure 2, Lane 2 shows that pBluescript 
only does not produce a PCR product. Only one colony picked from 5-26 contained an 
insert (lane 5). Two colonies picked from 5-34 contained inserts (lanes 8 and 9). Three 
colonies picked from 5-38 contained inserts (lanes 11, 12, 13). Four of the five colonies 
picked from 62-62 contained inserts; the colony run in lane 14 was sequenced and it was 
found not to be an MSP 2 sequence, while colonies run in lanes 15, 16, 17 were 
sequenced and contained MSP 2 sequences. 
Figure 2 Agarose gel showing the PCR products from a screening PCR to detect 
reconibi nant 




M 100 bp markers 
1 -ye control 
2 uncut pBluescript phagemid 
3 - 6 Template source -:- 4 colonies generated by cloning with the 
fragment generated from sample 5-26 
7 - 10 Template source -:- 4 colonies generated by cloning with the 
fragment generated from sample 5-34 
11 -13 Template source -:- 3 colonies generated by cloning with the 
fragment generated from sample 5-38 
14 - 17 Template source -:- 4 colonies generated by cloning with the 
fragment generated from sample 62-62 
5.3.3 Production of sequencing templates 
As all attempts to sequence the vectors containing a polymorphic sequence had 
failed, a sequence template was produced by PCR using a vector containing an insert as 
a template. Sequence templates were generated by PCR using M13 F + R primers. The 
templates used were minipreps diluted 1:100 in daH 20. All samples produced a product 
except in lane 7; in this case a new dilution of the miniprep was prepared, the PCR was 
repeated with this new template and a product was generated. 





M- 100 bp markers 
I - ye control 
2 - 5 Template source -:- diluted miniprep from 4 recombinant 
colonies containing the A-type fragment generated from sample 
47-66 
6 Template source -:- diluted miniprep from recombinant colonies 
containing the B-type fragment generated from sample 15-38 
7 - 8  Template source -:- diluted miniprep from 2 recombinant 
colonies containing the A-type fragment generated from sample 
15-501 
9 - 11 Template source -:- diluted miniprep from three recombinant 
colonies containing the B-type fragment generated from sample 
120-10 
Figure 4 Purified sequencing templates 
The above products were then purified by HPPPK and two microlitres of product 
were run on this gel, in order to ensure the purity of the product and to check the 
concentration of DNA present. Three rnicrolitres of the eluate were used in the 
sequencing reactions except lane 8 when four microlitres were used. 
Key: 
Lane 
M - 100 bp markers 
1 - 15-501 A-type template 
2-5 47-66 A-type template 
6- 15-38 B-type template 
7-9 120-10 B-type template 
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5.3.4 Sequences obtained 
The sequences obtained from the automated base-calling software were checked 
against the chromatogram generated during the sequencing run. The primer sequences 
were deleted and the cleaned sequences entered into the pileup programme (GCG 9) for 
companson. 
As discussed in the introduction, with direct sequencing of PCR products sequences 
could potentially be confounded by the presence of multiple templates, but in practice 
this was only seen in four samples, 15-42,47-30, 6242 and 62-62. At this stage in the 
project, all inserts were being cloned prior to sequencing. This practice was discontinued 
when it was discovered that very few samples contained mixed alleles of the same size. 
When sequencing was carried out from cloned PCR products at least 5 clones were 
picked and used as sequencing templates. 
The numbering of the samples follows the same format as used in the chapter 4, e.g. 
17-34 is the sequence obtained from the blood sample of child 17 on week 34. Where 
this is supplemented by a number, it indicates that there was more than one sequence 
found in that sample e.g. 47-301,47-302,47-303. These represent three different 
sequences from child 47011 week 30. 
In total, seventy three fragments were sequenced of which 57 were A-type, 15 were 
B-type and one was a hybrid containing sequences from both dimorphic types (71-38). 
The sequences are classified by the dimorphic type and then by the repeat units. There 
were 37 unique sequences: 24 were of the A-type while 13 were B-type. Representative 
antigens from each group were expressed (Chapter 6). 
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Figure Group 17-34 
17-34 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
17-26 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
17-31 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
15-10 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
17-38 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
17-46 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
17-18 AESKTPT GSGAGASGSA GSGAGASGNA GSG 
47-66 AESKTPT GSGAGASGSA GSGVGASGSA GSG 
15-34 AESKTPT GSGAGASGSA GSGAGASGSA GSG 
17-34 DGAVASARNGANPGAEGSSST 
PAT TTTT K TTT TTT T T N 
17-26 DGAVASNGANPGDGSSST 
PAT TTTT K TTT TTT T T N 
17-31 DGAVASARNGANPGADAEGSSST 
PAT TTTT K TTT TTT T T N 
15-10 DGAVASARGANPGADGSSST 
PAT TTTT K TTT TTT T T N 
17-38 DGAVASARNGANPGADGSSST 
PAT TTTT K TTT TTT T T N 
17-46 DGAVASARNGANPGADGSSST 
PAT TTTT K TTT TTT T T N 
17-18 DGAVASANGPGGSSST 
PAT TTTT K TTT TTT T T N 
47-66 DGAVASARNGANPGADGSSST 
PAT TTTT K TTT TTT T T N 
15-34 DGAVASARNGANPSADAGSSST 
PAT TTTT K TTT TTT T T N 
The amino acid differences within this group were due to the 
following nucelotide changes 
17-18 difference AAT (N) rather than AGT (S) 
47-66 difference GGT (V) rather than GCT (A) 
15-34 difference AGT (S) rather than GGT (G) 
Figure 6 Group 29-18 
29-18 AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
17-rn AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
15-18 AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
29-34 AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
62-2 AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
62-262 AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
29-58 AKSKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
15-42 AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
29-18 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
17-rn DGNGAD?EGSSST PAT TTTT K TTT TTT T T N 
15-18 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
29-38 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
62-2 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
62-262 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
29-58 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
15-42 DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
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5.3.4.1 	A-type sequences 
3.4.1.1 Group 17-34 
The sequence of the group typified by 17-34 was found in 9 isolates (Figure 5). This 
group consists of two repeats of the amino acid unit, GSGAGASGAS followed by a 
GSG motif. A central region of 23 amino acids is then followed by a single PAT 
tripeptide, four T residues, a K residue, and then eight T residues. Six of the nine 
examples of this sequence were identical. Three isolates contained a single nucleotide 
difference leading to a single amino acid difference. Six of the nine isolates including 
one of the non-identical sequences, were from the same child (17), two were from child 
15 and one was from child 47. One of the two sequences from child 15 was identical to 
five sequences from child 17. 
5.3.4.1.2 Group 29-18 
The sequence of the group typified by 29-18 (Figure 6) consists of seven identical 
sequences from four different children and one sequence that contained a single 
mutation. GA residues are followed by six copies of a four amino acid unit, GGSA. The 
GSG motif is followed by a 13 amino acid central region. A single PAT tripeptide is 
followed by four T residues, a K residue and then eight T residues. 
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PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT 
PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT --- --- --- --- --- ---  
PAT PAT PAT PAT PAT PAT PAT 
PAT PAT PAT PAT PAT PAT PAT 





























29-22 PAT PAT 
15-502 PAT PAT 
29-30 PAT PAT 
29-34 PAT PAT 
29-46 PAT PAT 
47-70 PAT PAT 
71-62 PAT PAT 
62-621 PAT PAT 
29-50 PAT PAT 
62-18 PAT PAT 
62-22 PAT PAT 
62-421 PAT PAT 





















































29-22 --- TTTTTT --- TN 
15-502 --- TTTTTT --- TN 
29-30 --- TTTTTT ----- TN 
29-34 --- TTT TTT T N 
29-46 --- TTT TTT --- T N 
47-70 - 	 TTT TTT --- T N 
71-62 --- -TTTTTT --- -TN 
62-621 --- TTT TTT - 	 T N 
29-50 --- TTT TTT - 	 T N 
62-18 --- TTT TTT --- T N 
62-22 TTT TTT TTT --- T N 
62-421 TTT TTT TTT --- T N 
62-14 --- TTT TTT TTT T D 
The amino acid differences within this group were due to 
the following nucelotide changes 
62-18, 22 and 421 - AAA (K) rather than GAA (E) 
62-14, 18, 22 and 421 - GAG (E) rather than AAG(K) 
- GGT (G) rather than AGT (S) 
62-621 - ACT (T)rather than GCT (A) 
62-14 - GAT (D)rather than AAT (N) 
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5.3.4.1.3 Group 29-22 
The next group, 29-22 type (Figure 8) can be subdivided into two subgroups. The 29-
22 type sequence which was seen in nine isolates (eight of them identical), from five 
different children, consists of the N terminal dimorphic heptapeptide followed by a non 
repetitive 19 amino acid sequence of G, A, S. V and N residues (with a single point 
mutation leading to an amino acid substitution (A=T)), a non repetitive 13 amino acid 
sequence, four repeats of PAT and seven T residues. 
The other subgroup comprises two identical isolates from child 62 and differs from 
29-22 in that there is an E=K substitution at the N terminus, a K=E substitution in the 
central 13 amino acid region, an insertion of six additional PAT repeats and three extra 
T residues. 
Isolate 62-18 has the N terminal sequence of subgroup two and the C terminal 
sequence of subgroup one, suggesting that there may have been recombination between 
the subgroups. 
Finally in this group, isolate 62-14 has the N terminus of subgroup one and the C 
terminal of subgroup two, except that two PAT repeats have been lost and there is a C 
terminal N to D substitution. The N=D mutation was probably a PCR artefact as it has 
not been recorded before in the sequence database. 
MUM 
Group 15-66 
15-66 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
15-501 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
52-38 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
52-42 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
15-66 GAGGSGSA GSG DGAVASANGAPGGSSST 
15-501 GAGGSGSA GSG DGAVASARNGAPG1GSSST 
52-38 GAGGSGSA GSG DGAVASARNGAPG.GSSST 
52-42 GAGGSGSA GSG DGAVASARNGAPGJ&IDGSSST 
15-66 PAT TTTT K TTT TTT T T N 
15-501 PAT TTTT K TTT TTT T T N 
52-38 PAT TTTT K TTT TTT T T N 
52-42 PAT TTTT K TTT TTT T T N 
ge9 Group 71-30 
71-30 AVSNPST GAGGSGSA GGSGSA GAGGSGSA GSG 
71-34 AVSNPST GAGGSGSA GGSGSA GAGGSGSA GSG 
71-30 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
71-34 DGAVASARNGAPGADAEGSSST PAT TTTT K TTT TTT T T N 
Figure 10 Group 47-26 
47-26 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-303 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-34 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-302 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-301 EESNLPT GAGAVA -------- -------- ------ ------ 
47-26 GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
47-303 GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
47-34 GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
47-302 GSGAVA ------ ------ ------ ------ ------ 
47-301 ------------ ------ ------ ------ ------ 
47-26 GSGAGA GNGA GNG ANPGADAKRSpST PAT TTT TTT T N 
47-303 GSGAGA GNGA GNG ANPGADAKRSpST PAT TTT TTT T N 
47-34 GSGAGA GNGA GNG ANPGADAKRSPST PAT TTT TTT T N 
47-302 GSGAGA GNGA GNG ANPGADAKTSpST PAT TTT TTT T N 
47-301 GSGAGA GNGA GNG ANPGADAKRSpST PAT TTT TTT T N 
The amino acid differences within this group were due to the 
following nucelotide changes 
47-302 - ACA (T) rather than AGA (R) 
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5.3.4.1.4 Group 15-66 
The group typified by 15-66 consists of four identical sequences from two different 
children (Figure 8). There are five copies of an eight amino acid unit, GAGGSGSA. A 
GSG motif is followed by a 23 amino acid central region. A single PAT tripeptide is 
followed by four I residues, a K residue and finally eight T residues. 
5.3.4.1.5 Group 71-30 
The next group consists of two identical sequences from child 71 (Figure 9). 
GAGGSGSA is followed by GGSGSA then a repeat of the initial eight amino acid unit. 
A GSG motif is followed by a 23 amino acid central region. A single PAT tripeptide is 
followed by four T residues, a K residue and finally eight T residues. 
5.3.4.1.6 Group 47-26 
The 47-26 group consists of three identical and two variant isolates from child 47 
(Figure 10). In all isolates, a conserved N terminal heptapeptide is followed by 
GAGAVA. In four isolates this is followed by two degenerate repeats G(S)SGAGAVA. 
In three isolates this is followed by eight repeats of GSGAVA and in the fourth isolate 
there are three such repeats. All five isolates share the same C terminal sequence. At 
week 30, three variant sequences of the type sequence were found in the same isolate. 
S.. 
gure H Group 120-1 ) 
120-10 TESKPPT GD GAGSGA GAVASA GNG ANTGADAKKSPST 
120-14 TESKPPT GD GAGSGA GAVASA GNG ANTGADAKKSPST 
120-18 TESKPPT GD GAGSGA GAVASA GNG ANTGADAKKSPST 
120-10 PAT TTT TTT T N 
120-14 PAT TTT TTT T N 
120-18 PAT TTT TTT T N 
g2 Group 65-38 
65-38 AESKTPT GS GAGASGSA GSG DGAVASARNGANPGADAEGSSST 
65-42 AESKTPT GS GAGASGSA GSG DGAVASARNGANPGADAEGSSST 
65-38 PAT TTTT K TTT TTT T T N 
65-42 PAT TTTT K TTT TTT T T N 
Figure 13 Group 62-46 
62-46 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA 
62-422 AESKPST ----------------------------------
6 2-50 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA 
62-622 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA 
62-623 TESNPPT GTGT GAGASG RAGAGA ------ ------ GASGRA 
62-46 GASGRA GASGRA GAGAGS GDGAVA SA GSG DGAVVSAGN 
62-422 ------ ------ GASAGS GDGAVA SA GSG DGAVASAGN 
62-50 GASGRA GASGRA GASAGS GDGAVA SA GSG DGAVASAGN 
62-622 GASCRA GASGRA GASAGS GDGAVA SA GSG DGAVASAGN 
62-623 GASGRA GASGRA GASAGS GDGAVA SA GSG DGAVASAGN 
62-46 GANPGADAEGSSST PAT PAT TTT TTT TTT T N 
62-422 GANPGADAEGSSST PAT PAT TTT TTT TTT T N 
62-50 GANPGANAEGSSST PAT PAT TTT TTT TTT T N 
62-622 GANPGADAEGSSST PAT PAT TTT TTT TTT T N 
62-623 GANPGADAEGSSST PAT PAT TTT TTT TTT T N 
62-422 has different 5' dimorphic 
but has the same repeat structure 
The amino acid differences within this group were due to the 
following nucelotide changes 
62-46 - GGT (G) rather than AGT (S) 
62-46 - GTT (V) rather than GCT (A) 
62-50 - AAT (N) rather than GAT (D) 
(predicted to be a PCR induced mutation) 
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5.3.4.1.7 Group 120-10 
The group typified by 120-10 consists of three identical sequences from the same 
child (Figure 11). GD residues are followed by two different six amino acid units, 
GAGSGA and GAVASA. A GNG motif is followed by a 13 amino acid central region. 
A single PAT tripeptide is followed by seven T residues. 
5.3.4.1.8 Group 65-38 
The group typified by 65-38 consists of two identical sequences from the same child 
(Figure 12). GS residues are followed by a six amino acid unit, GAGASGSA. A GSG 
motif is followed by a 23 amino acid central region. A single PAT tripeptide is followed 
by four T residues, a K residue and finally eight T residues. 
5.3.4.1.9 Group 62-46 
The group typified by 62-46 consists of five sequences from the same child (Figure 
13). Three of the sequences are essentially identical. While the other two have short 
deletions in the repetitive region. GTGT residues are followed by an eight amino acid 
unit, GAGASGRA, then GAGA residues, followed by a six amino acid unit, GASGRA. 
A six amino acid unit, GAGAGA, is followed by three copies of the amino acid unit, 
GASGRA. Then GASA residues are followed by a GSG motif then by a 33 amino acid 
central non repetitive region. 62-46 differs from 62-50 and 62-622 by two point 
mutations and 62-50 differs from 62-622 by a single point mutation. Two PAT 
tnpeptides are followed by ten T residues. 62-623 lacks residues 17 to 24 (GASGRA 
GAGAGA) and contains only three copies of the amino acid unit, GASGRA. 
Wfl 
5.3-4. 1.10 A-type with single sequence 
Finally, seven isolates contained sequences that were seen only once and were not 
closely related to each other or to any of the previous groups (Figure 14). All sequences 
had classic features of A-type alleles - an N terminal heptapeptide (in one case a 
hexapeptide) followed by G, S, A rich region and C terminal PAT and poly  sequences. 
Figure 14 Single Sequences 
15-70 TESKPPT GDGA GASGRAGA GASGRAGS GAGA SGSA GSG 
15-70 DGAVASARNGANPGADAEGSTST PAT TTTT K TTT TTT T T N 
45-50 AESNPST GA GGSA GGSA GGSA GGSA GGSA GGSA GGNA 
45-50 GGSA GGSA GGSA GGSA GGSA GGSA GGSA GGSA GGSA GGSA 
45-50 GGSA GGSA GSG DGNGANPGANAKKSPST PAT TTT TTT T N 
47-50 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
47-50 GAGGSGSA GAGGSGSA GAGA SGSGSAGAS GSGSAGAGA 
47-50 GAGASGSA GSG ADAKRSPST PAT TTT TTT TTT T N 
52-10 AESNLPT GAGARS GDGARS GDGARS GDGARS GDGAVA SA GSG 
52-10 ADAEGSSST PAT PAT TTT TTT TTT TTT T N 
65-58 TESNPP AGAGAS GNPPAG AGAS GSAGAS GNPPAG AGAS 
65-58 GSAGAS GSAGAS GSA GAEGSSST PAT TTT TTT T N 
71-38 EESNPPT VAGA GSGAGA VAGSGAGA VAGSGAGA VAGAGAGA 
71-38 GSG ANPGADAKKSPST PAT TTT TTT T N 
S. 
gure 15 Group 5-34 
5-34 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 
62-18 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 
62-14 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 
62-22 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 
47-30 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 













5-34 ADTPTAT ESNSPSPPITTT ESSSSGNAPNKT 
62-18 ADTPTAT ESNSPSPPITTT ESSSSGNAPNKT 
62-14 ADTPTAT ESNSPSPPITTT ESSSSGNAPNKT 
62-22 ADTPTAT EGNSPSPPITTT ESSSSGNAPNKT 
47-30 ADTPTAT ------------ ESSSSGNAPNKT 
47-34 ADTPTAT ------------ ESSSSGNAPNKT 
The amino acid diffe: 
following nucelotide 
62-14 difference AGA 
62-22 difference GGT 
47-30 difference GGT 

















IFAgure  Group 65-62 
65-62 ANKGSNTNSVGANAPN ADT IASGSQRSTNSASTSTTNNGESQTTTPTA 
65-66 ANKGSNTNSVGANAPN ADT IASGSQRSTNSASTSTTNNGESQTTTPTA 




65-62 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
65-66 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
65-58 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
65-62 KSNSPSPPITTT ESSSSGNAPNKT 
65-66 KSNSPSPPITTT ESSSSGNAPNKT 
65-58 KSNSTSPPITTT ESSSSGNAPNKT 
The äthi± Acid differences within this group were due to the 
following nucelotide changes 
65-58 difference ACT (T) rather than CCT (P) 
3tIIC 
5.3.4.2 	B-type sequences 
5.3.4.2.1 Group 5-34 
The group typified by 5-34 consists of six isolates, three from child 62, two from 
child 47 and one from child 5 (Figure 15). Each sequence has a 16 amino acid dimorphic 
sequence followed by a 32 amino acid unit and a degenerate 32 amino acid unit. A 
seven amino acid region is then followed by a single 12-mer repeat unit. Four of the 
sequences (those from child 62 and 5) followed this pattern except for two point 
mutations in one isolate and a single point mutation in another isolate. The sequences 
found in child 47 were very similar to the rest of the group except that the second 32 
amino acid sequence is repeated and the 12 amino acid C terminal is deleted. The two 
sequences from child 47 differ by a single (S to G) substitution in the third 32 amino 
acid block. 
5.3.4.2.2 Group 65-62 
The group typified by 65-62 consists of three sequences from the same child (Figure 
16). A 16 amino acid dimorphic region followed by three perfect 32 amino acid repeats. 
A central region of seven amino acids is followed by a single 12-mer repeat unit. There 
is a single point mutation (P to T) in the 12-mer repeat unit of one of the sequences. 
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this group were due to the 
than GGT (G) 
than AGT (S) 
than GGT (D) 
than ATT (I) 
than AGT (T) 
than AAT (N) 
than GAA (E) 
than AAT (N) 
than ACT (T) 
Figure 17 Group 15-34 
15-34 ANEGSNTNSVGAN ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
15-38 ANEGSNTNSVGAN ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
15-34 ADT IASGSQRSTNSASTSTTNNGESQTTTPTA 
15-38 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
15-34 ADTIASGSQRSTNSASTSTTNNGESQTTTpTA ADTPTATESS 
15-38 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTATESS 
15-34 SSGNAPNKT 
15-38 SSGNAPNKT 
ire 10 Group 5-26 
5-26 ANESSNTNRVVANAPK ADTVASGSQSSTNSASTSTTNNGESQTTNPTA 
65-54 ANEGSSTNSVGANAPK ADTIASGSQSSTNSASTSTNNNGESQTTTPTA 
5-38 ANEGSNTKSVGANAPK ADTIASGSQSSTNSASTSTTNNGESQNTTPTA 
120-10 ANEGSNTNRVDANAPK AYTIASGSQSSTNSASTSTTNNGESQTTTPTA 
5-26 ADTPTAT ESNSPSPPITTT KSNSPSPPITTT KSNSPSPPITTT 
65-54 ADTPTAT KSNSPSPPITTT ESNSPSPPITTT KSNSPSPPITTT 
5-38 ADTPTAT ESNSPSPPITTT ESNSPSPPITTT KSNSPSPPITTT 
120-10 ADTPTAT ESNSRSPPITTT ESNSRSPPITTT 
5-26 KSNSPSPPITTT --------------- ESSSSGNAPNKT 
65-54 KSNSPSPPITTT ------------ ESSSSGNAPNKT 
5-38 ------------ESNSRSPPITTT ESSSSGNAPNKT 
120-10 ESNSRSPPITTT ESNSRSPPITTT ESSSSGNAPNKT 
The amino acid differences within 
following nucelotide changes 
5-26 difference AGT (S) rather 
5-26 difference AGG (R) rather 
5-26 difference GTT (V) rather 
5-26 difference GTT (V) rather 
5-26 difference GGT (N) rather 
65-54 difference AGT (S) rather 
65-54 difference AAA (K) rather 
5-38 difference AAG (K) rather 
5-38 difference AAT (N) rather 
120-10 difference TAT (Y) rather than GAT (D) 
Figure 1971-38 (A/B hybrid sequence) 
71-38 TESRTPT GAVASAGS GAGS GAVASAGS GAVASAGS GAVA 
71-38 SGSQSSTNSASTSTTNNGESQTTTPTA ADTPTAT KSNSPSPPITTT 
71-38 ESNSPSPPITTT ESSSSGNAPNKT 
A type sequence 
B type sequence 
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5.3.4.2.3 Group 15-34 
The group typified by 15-34 consists of two identical sequences from the same child 
(Figure 17). A 13 amino acid dimorphic region is followed by three perfect 32 amino 
acid repeats, which are identical to the repeats in group 65-62. There is a seven amino 
acid central region followed by the dimorphic C terminal sequence. No 12 amino acids 
repeats are present. 
5.3.4.2.4 Group 5-26 
The 5-26 group consists of four related, but distinct, sequences from three different 
children (Figure 18). The sequences have only a single 32 amino acid unit followed by a 
number of degenerate 12 amino acid units. There are two substitutions in the 32 amino 
acid unit, D to Y and V to I. 
Finally, the 71-38 sequence was seen only once and is a hybrid of the two dimorphic 
forms (Figure 19). The N terminal A type dimorphic sequence is followed by a classic 
G, S, A, V rich sequence including three complete repeats of GAVASAGS followed by 
a partial B type repeats. The seven amino acid central region is followed by two variants 
of the 12 amino acid repeat sequence and a C terminal dimorphic B sequence. 
Figure 20 Examples of the same msp 2 sequence being found in different children 







All other sequences were only found in a single child 
No evidence of time clustering was found. This analysis was carried out by 
performing a pileup of all sequences and labeling them with the date of collection rather 
than the sample number. 
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5.3.5 Modification of the obtained sequences 
Table 21 and 22 summarises the mutations detected. Any mutation in a sequence, 
which leads to a substitution to an atypical amino acid, was assumed to be a sequencing 
error. For multiple sequence comparison these amino acids were "corrected" to the 
perceived "normal" residues. 19 changes were made in 17 sequences. One sequence (5-
26) had five residues changed while two other sequences had two residues changed. In 
the remaining 14 sequences there was one change per sequence. 
Figure 21 Mutations in A-type sequences 
Region Position Amino 
Sequence of Nucleotide of mut. acid Note 
mutation change in codon change 
62-18 5D G > A 1 E > K 
—22 
-421  








62-14 Final A > G 1 N > D 
residue  
62-621 P G > A 1 A > T  
29-18 P T > A 3 - § 
17-18 P T > C 3 
17-18 P G > A 2 S > N 
47-66 p C > T 2 A > V g 
15-34 3D G > A 1 G > S  
47-302 3D G > C 2 R > T * 
62-46 P A > G 1 S > G * 
62-46 3D C > T 2 A > V * 
62-50 3D G > A 1 D > N * 
Key: 
5D 5' Dimorphic region 
P 	Polymorphic region 
3D 3' Dimorphic region 
§ - This mutation was seen in the first two repeat units of the polymorphic region but not 
in the subsequent four repeat units and not seen any other members of that group. 
49 - This mutation was decided to be a sequencing error. 
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G > S 
Note 
5-26 5D T > G 3 S > R 
5-26 SD G > T 2 G > V 
65-54 5D A > G 2 N > S 
5-38 5D T > G 3 N > K 
5-26 P32 A > G 1 I>V 
5-38 P32 C > A 2 - 
120-10 P32 G > T 1 D > Y 
62-14 P32 G. > A 1 G > R  
62-18 P32 T > C 3 - 
62-22 P32 A > G 2 D > G  
47-30 P32 A > G 1 S > G  
62-22 P12 A > G 1 S > G 
65-58 P12 A > C 3 - 
65-58 P12 C > A 1 P > T  
120-10 P12 C > G 2 P > R § 
Key: 
5D 5' Dimorphic region 
P32 32 mer repeats 
P12 l2mer 
§ - This mutation was found in all 12 mer repeats from this sequence and was there fore 
assumed not to be an error. 
49 - This mutation was decided to be a sequencing error. 
The following refers to figure. 21 and 22 
Residues coloured blue in the following pileups indicate that the mutation was 
decided to be a sequencing error and so the associated residue was changed 
Residues coloured red in the following pileups indicate that the mutation was decided 
not to be a sequencing error and so the associated residue was not changed 
The following figures are the pileups shown above (Figure S to Figure 18) with the 
residues modified as described in Figures 21 and Figure 22 
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GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
GSGA GASGSA GSG 
17-34 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
17-26 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
17-31 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
15-10 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
17-38 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
17-46 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
17-18 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
47-66 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
15-34 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
The amino acid differences within this group were due to the 
following nucelotide changes 
17-18 difference AAT (N) rather than AGT (S) 
47-66 difference GGT (V) rather than GCT (A) 
15-34 difference AGT (S) rather than GGT (G) 
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Figure 24 Group 29-22 (modified) 
29-22 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
15-502 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
29-30 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAXRSPST 
29-34 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
29-46 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
47-70 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
71-62 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
62-621 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
29-50 EESKPPT GASGSA GSGS GAVASA GNG ANPSADAKRSPST 
62-18 KESKPPT GASGSA GSGS GAVASA GNG ANPGADAERSPST 
62-22 KESKPPT GASGSA GSGS GAVASA GNG ANPGADAERSPST 
62-421 KESKPPT GASGSA GSGS GAVASA GNG ANPGADAERSPST 
62-14 EESKPPT GASGSA GSGS GAVASA GNG ANPGADAERSPST 
29-22 PAT PAT PAT PAT ------------------
15-5 02 PAT PAT PAT PAT ------------------
29-30 PAT PAT PAT PAT ------------------
29-34 PAT PAT PAT PAT 
29-46 PAT PAT PAT PAT ------------------
47-70 PAT PAT PAT PAT ------------------
71-62 PAT PAT PAT PAT ------------------
62-62 1 PAT PAT PAT PAT 
29-50 PAT PAT PAT PAT ------------------
62-18 PAT PAT PAT PAT ------------------
62-2 2 PAT PAT PAT PAT PAT PAT PAT PAT PAT PAT 
62-421 PAT PAT PAT PAT PAT PAT PAT PAT PAT PAT 
62-14 PAT PAT PAT PAT PAT PAT PAT PAT 
29-22 --- TTT TTT --- T N 
15-502 --- TTT TTT --- T N 
29-30 --- TTT TTT --- T N 
29-34 --- TTT TTT --- T N 
29-46 - TTT TTT --- T N 
47-70 --- TTTTTT ----TN 
71-62 - TTT TTT--- T N 
62-621 --- TTT TTT --- T N 
29-50 --- TTT TTT --- T N 
62-18 --- TTT TTT --- T N 
62-22 TTT TTT TTT --- T N 
62-421 TTT TTT TTT --- T N 
62-14 - TTT TTT TTT T N 
The amino acid differences within this group were due to the 
following nucelotide changes 
62-18, 22 and 421 - AAA (K) rather than GAA (E) 
62-14, 18, 22 and 421 - GAG (E) rather than AAG (K) 
- GGT (G) rather than AGT (S) 
62-621 - ACT (T) rather than GCT (A) 
62-14 - GAT (D) rather than AAT (N) 
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Figure 25 Group 47-26 (modified) 
47-26 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-303 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-34 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
47-302 EE SNLPT GAGAVA GSGAGAVA S SGAGAVA GSGAVA GSGAVA 
47-301 EESNLPT GAGAVA ---------------------------- 
47-2 6 GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
47-303 GS GAVA GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
47-34 GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
47-302GSGAVA ------------------------------
47-301 ------------------------------------ 
4 7-26 GSGAGA GNGA GNG ANPGADAKRSPST PAT TTT TTT T N 
47-303 GSGAGA GNGA GNG ANPGADAKRSPST PAT TTT TTT T N 
47-34 GSGAGA GNGA GNG ANPGADAKRSPST PAT TTT TTT T N 
47-302 GSGAGA GNGA GNG ANPGADAKRSPST PAT TTT TTT T N 
47-301 GSGAGA GNGA GNG ANPGADAKRSPST PAT TTT TTT T N 
The amino acid differences within this group were due to the 
following nucelotide changes 
47-302 - ACA (T) rather than AGA (R) 
Figure 26 Group 62-46 (modified) 
62-46 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA 
62-422 AESKPST ----------------------------------
62-5 0 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA 
62-622 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA 
62-623 TESNPPT GTGT GAGASG RAGAGA ------ ------ GASGRA 
62-46 GASGRA GASGRA GASAGS GDGAVA SA GSG DGAVASAGN 
62-422 ------ ------ GASAGS GDGAVA SA GSG DGAVASAGN 
62-50 GASGRA GASGRA GASAGS GDGAVA SA GSG DGAVASAGN 
62-622 GASGRA GASGRA GASAGS GDGAVA SA GSG DGAVASAGN 






62-422 has different 5' 
but has the same repeat 
PAT PAT TTT 
PAT PAT TTT 
PAT PAT TTT 
PAT PAT TTT 
PAT PAT TTT 
dimorphic 
structure 
TTT TTT T N 
TTT TTT T N 
TTT TTT T N 
TTT TTT T N 
TTT TTT T N 
The amino acid differences within this group were due to the 
following nucelotide changes 
62-46 - GGT (G) rather than AGT (S) 
62-46 - GTT (V) rather than GCT (A) 
62-50 - AAT (N) rather than GAT (D) 
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Figure 27 Group 5-34 (modified) 
5-34 ANEGSTTNSVDANAPK ADTV.ARVSQSSTNSASTSTTNNGESQTTTPTA 
62-18 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGEsQTTTPTA 
62-14 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGEsQT'r'rpTA 
62-22 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTpTA 
47-30 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTP'rA 
























------ ~ ----- ESSSSGNAPNKT 
The amino acid differences within this group were due to the 
following nucelotide changes 
62-14 difference AGA R rather than GGA IGI  
62-22 difference GGT G rather than GAT D 
47-30 difference GGT G rather than AGT S 
62-22 difference GGT IGI rather than AGT S 
Figure 28 Group 65-62 (modified) 
65-62 ANKGSNTNSVGANAPN ADTIASGSQRSTNSASTSTTNNGESQTTTpTA 
65-66 ANKGSNTNSVGANAPN ADTIASGSQRSTNSASTSTTNNGESQTTTpTA 




65-62 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
65-66 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
65-58 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
65-62 KSNSPSPPITTT ESSSSGNAPNKT 
65-66 KSNSPSPPITTT ESSSSGNAPNKT 
65-58 KSNSPSPPITTT ESSSSGNAPNKT 
The amino acid differences within this group were due to the 
following nucelotide changes 
65-58 difference ACT (T) rather than CCT (P) 
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Figure 29 Group 5-26 (modified) 
5-26 ANESSNTNRVDANAPK ADTIASGSQSSTNSASTSTTNNGESQTTNPTA 
65-54 ANEGSNTNSVGANAPK ADTIASGSQSSTNSASTSTNNNGESQTTTPTA 
5-38 ANEGSNTNSVGANAPK ADTIASGSQSSTNSASTSTTNNGEsQNTTP'rA 
120-10 ANEGSNTNRVDANAPK ADTIASGSQSSTNSASTSTTNNGEsQTTTPTA 
5-26 ADTPTAT ESNSPSPPITTT KSNSPSPPITTT KSNSPSPPITTT 
65-54 ADTPTAT KSNSPSPPITTT ESNSPSPPITTT KSNSPSPPITTT 
5-38 ADTPTAT ESNSPSPPITTT ESNSPSPPITTT KSNSPSPPITTT 
120-10 ADTPTAT ESNSRSPPITTT ESNSRSPPITTT 
5-26 KSNSPSPPITTT ----------- ESSSSGNAPNKT 
65-54 KSNSPSPPITTT ------------ ESSSSGNAPNKT 
5-38 ------------ESNSRSPPITTT ESSSSGNAPNKT 
120-10 ESNSRSPPITTT ESNSRSPPITTT ESSSSGNAPNKT 
The amino acid differences 
following nucelotide chang 
5-26 difference AGT (S) 
5-26 difference AGG (R) 
5-26 difference GTT (V) 
5-26 difference GTT (V) 
5-26 difference GGT (N) 
65-54 difference AGT (S) 
65-54 difference AAA (K) 
5-38 difference AAG (K) 
5-38 difference AAT (N) 





































B1 5-26 ANEGSNTNSVVANAPK ADTVASGSQSSTNSASTSTTNNGESQTT1PTA 
B2 5-34 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 
B3 5-38 ANEGSNTKSVGANAPK ADTXASGSQSSTNSASTSTTNNGESQTTPTA 
Bi 5-26 --------------------------------ADTPTAT 
32 5-34 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
B3 5-38 ------------------ --- ------- ---- ADTPTAT 
BI 5-26 ESNSPSPPITTT ------------ KSNSPSPPITTT 
32 5-34 ESNSPSPPITTT ________________________ 
B3 5-38 ESNSPSPPITTT ESNSPSPPITTT KSNSPSPPITTT 
Bi 5-26 KSNSPSPPITTT KSNSPSPPITTT ESSSSGNAPNKT 
B2 5-34 ------------ ------------ ESSSSGNAPNKT 
B3 5-38 ------------ ------------ ESSSSGNAPNKT 
Figure 31 Child 15 
Bi 15-34 ANEGSNTNSVGAN ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
Bi 15-38 ANEGSNTNSVGAN ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
Al 15-10 AESKTPT GSGAGASGSA GSGAGASGSA-----------------
Al 15-34 AESKTPT GSGAGASGSA GSGAGASGSA----------------- 
A2 15-38 AESKPST GAGGSA GGSA GGSA GGSA GGSA GGSA -------- 
A2 15-42 AESKPST GAGGSA GGSA GGSA GGSA GGSA GGSA------- 
A3 15-501 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA --- 
i L5--02 EESKPPT GAS GSA 	---•GSGS•- GPVASA- 
A3 15-66 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA --- 
A5 15-70 TESKPPT GDGA----GASG RAGA GASG RAGS GAGA SGSA-- 
Bi 15-34 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA -------------- 
B1 15-38 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA --------------
Al 15-10 ----------------GSG DGAVASARNGANPGADAEGSSST PAT 
Al 15-34 ----------------GSG DGAVASARNGANPSADAEGSSST PAT 
A2 15-38 	 GSG ----------DGNGADAEGSSST PAT 
A2 15-42 -----------------GSG ------------DGNGADAEGSSST PAT 
A3 15-501 GAGGSGSA--------GSG DGAVASARNGANPGADAEGSSST PAT 
A4 15-502 --'----GNG -- 	-ANPSADAKRSPST PAT 
A3 15-66 GAGGSGSA--------GSG DGAVASARNGANPGADAEGSSST PAT 
A5 15-70 ----------- - ---- GSG DGAVASARNGANPGADAEGSTST PAT 
B1 15-34 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
Bl 15-38 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
Al 15-10 --- --- --- TTTT K TTT TTT T T N 
Al 15-34 --- --- --- TTTTKTTTTTTTTN 
A2 15-38 --- --- --- TTTT K TTT TTT T T N 
A2 15-42 --- --- --- TTTT K TTT TTT T T N 
A3 15-501 --- --- --- TTTT K TTT TTT T T N 
A4 15-502 PAT PAT PAT ---- TTT TTT - T N 
A3 15-66 --- --- --- TTTT K TTT TTT T T N 
A5 15-70 ---------TTTT K TTT TTT T T N 
Bl 15-34 ADTPTATESSSSGNAPNKT 
Bi 15-38 ADTPTAT ESSSSGNAPNKT 
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5.3.6 Sequences found in each child 
B! refers to the first B-type sequence found in a specific child, while B2 refers to the 
second B-type sequence found in that child. Al refers to the first A-type sequence found 
in specific child, while A2 refers to the second A-type sequence found in that child. 
Sequence Al in one child is not the same as sequence Al in another child. Residues in 
bold represent mutations in sequences from a single child. These figures use the 
modified sequences from section 5.3.5 
	
5.3.6.1 	Child 5 
The three fragments sequenced from this infant were all of the B-type (Figure 30). 
There are multiple single residue differences in the N terminal region and three residue 
differences in the first 32 amino acid repeat unit. One isolate contains a 32 amino acid 
repeat commencing ADTV, one contains a 32 amino acid repeat unit commencing ADTI 
and the third contains two 32 amino acid repeat units - one of each sequence. All isolates 
contain the central seven amino acid unit, a conserved 12 amino acid unit and then zero, 
two or three additional 12 amino acid sequence. Although isolated from the child within 
a 12 week period, the alleles are clearly different but show sufficient homology that they 
may be immunologically cross-reactive. 
5.3.6.2 	Child 15 
Eight A-type and two B-type sequences were isolated from child 15 (Figure 31). A-
type fragments from weeks 10 and 34 were identical at the DNA sequence level. The 
fragments sequenced from weeks 38 and 42 were also identical to each other while 
being distinct from the sequences in the earlier samples. Two A-type sequences were 
sequenced from week 50, one sequence (15-502) was only seen in this sample while 501 
was seen again in week 66. The fragment from week 70 was distinct from other 
sequences from this child. Two B-type fragments were sequenced from weeks 34 and 
38, these were identical to each other. These data suggest that the infant was infected by 
6 different parasite clones, one B-type and five A-types, over the period of sample 
collection. Given that the parasites present at week zero could not be sequenced, these 
data correlate very well with the PCR data (Chapter 4.3.2.3). It is likely that the A-types 
may show some immunological cross-reactivity. 
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IFAguire 	Child 17 
Al 17-rn AESKPST GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
A2 17-18 AESKTPT GSGA GASGSA GSGA GASGNA ----------- GSG 
A2 17-26 AESKTPT GSGA GASGSA GSGA GASGSA-----------GSG 
A2 17-31 AESKTPT GSGA GASGSA GSGA GASGSA-----------GSG 
A2 17-34 AESKTPT GSGA GASGSA GSGA GASGSA-----------GSG 
A2 17-38 AESKTPT GSGA GASGSA GSGA GASGSA-----------GSG 
A2 17-46 AESKTPT GSGA GASGSA GSGA GASGSA-----------GSG 
Al 17-rn ----------DGNGADAEGSSST PAT TTTT K TTT TTT T T N 
A2 17-18 DGAVASARNGANPGA.DAEGSSST PAT TTTT K TTT TTT T T N 
A2 17-26 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
A2 17-31 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
A2 17-34 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
A2 17-38 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
A2 17-46 DGAVASARNGANPGADAEGSSST PAT TTTT K TTT TTT T T N 
Figure 33 Child 29 
Al 29-18 AESKPST 
A2 29-22 EESKPPT 
A2 29-30 EESKPPT 
A2 29-34 EESKPPT 
Al 29-38 AESKPST 
A2 29-46 EESKPPT 
A2 29-50 EESKPPT 
Al 29-58 AKSKPST 
GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
GASGSA GSGS GAVASA---------------GNG 
GASGSA GSGS GAVASA --------------- GNG 
GASGSA GSGS GAVASA---------------GNG 
GA GGSA GGSA GGSA GGSA GGSA GGSA GSG 
GASGSA GSGS GAVASA---------------GNG 
GASGSA GSGS GAVASA---------------GNG 









Al 29-18 DGNGADAEGSSST 
A2 29-22 ANPSADAKRSPST 
A2 29-30 ANPSADAKRSPST 
A2 29-34 ANPSADAKRSPST 
Al 29-38 DGNGADAEGSSST 
A2 29-46 ANPSADAKRSPST 
A2 29-50 ANPSADAKRSPST 
Al 29-58 DGNGADAEGSSST 
TTTT K TTT 
PAT PAT PAT -----TTT 
PAT PAT PAT ---- - TTT 
PAT PAT PAT -----TTT 
TTTTKTTT 
PAT PAT PAT -----TTT 
PAT PAT PAT -----TTT 
TTTT K TTT 
TTTTTN 
TTT - T N 
TTT - T N 
TTT - T N 
TTT T T N 
TTT - TN 
TTT - T N 
TTT T T N 
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5.3.6.3 	Child 17 
Six A-type fragments were sequenced from this child, and an additional A-type 
sequence was isolated from the maternal sample (Figure 32). Sequences from weeks 18 
to 46 were identical. These data suggest that the infant was chronically infected by the 
one parasite clone from weeks 18 to 46. The sequence from the maternal sample was 
distinct from those isolated from the child. These data agree with the PCR data (Chapter 
4.3.2.3) except that on week 18 there is a different MSP 1 dimorphic allele from the 
MSP 1 allele detected from week 26 to 46, but the MSP 2 markers are the same. 
5.3.6.4 	Child 29 
Eight A-type fragments were sequenced and two distinct sequences were obtained 
(Figure 33). One sequence was found at weeks 18, 38, 58 and the other sequence was 
found at weeks 22,30,34,46 and 50. These data suggest that there were two parasite 
populations, fluctuating about the detection threshold, which persisted from 18/22 weeks 
of age until 50/58 weeks. The PCR data (Chapter 4.3.2.5) also suggest that individual 
MSP 2 alleles persisted but there was only a poor correlation, date for date, between 
PCR and sequence data. However, if both parasite clones were at very low density, the 
differences might be explained by stochastic events leading to either clone being 
detected at any time point. One product of a polymorphic PCR with a size of 640 bp 
could not been sequenced. 
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IFAgure 	Child 47 
Bi 47-30 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTT1NGESQTTTPTA 
Bi 47-34 ANEGSTTNSVDANAPK ADTVARVSQSSTNSASTSTTNNGESQTTTPTA 
Al 47-26 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
Al 47-303 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
A2 47-302 EESNLPT GAGAVA 
A3 47-301 EESNLPT GAGAVA GSGAGAVA SSGAGAVA ------ -------  
Al 47-34 EESNLPT GAGAVA GSGAGAVA SSGAGAVA GSGAVA GSGAVA 
A4 47-50 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA-- - 
A5 47-66 AESKTPT GSGAGASGSA GSGVGASGSA- ------------ ---- 
A6 47-70 EESKPPT ----GASGSA GSGS GAVASA ---------------- 
Bl 47-30 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
B1 47-34 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
Al 47-26 GSGAVA ------GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
Al 47-303 GSGAVA ------ GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
A2 47-302 ------------------- ------ GSGAVA GSGAVA GSGAVA 
A347-301 -----------------------------------------------
Al 47-34 GSGAVA ------GSGAVA GSGAVA GSGAVA GSGAVA GSGAVA 
A'! 47-50 (!AGGSGSA GAGGSGSA GAGA SGSGSA GASGSGSA GàGA-- 
A5 47-66 
A6 47-70 
Bl 47-30 ADTIASGSQRGTNSASTSTTNNGESQTTTPTAADTPTAT 
BI 47-34 ADTIASGSQRSTNSASTSTTNNGESQTTTPTAADTPTAT 
Al 47-26 GSGAGA GNGA GNG -----------ANPGADAKRSPST 
Al 47-303 GSGAGA GNGA GNG ----------ANPGADAKRSPST 
A2 47-302 GSGAGA GNGA GNG ----------ANPGADAKRSPST 
A3 47-301 GSGAGA GNGA GNG ------------ANPGADAKRSPST 
Al 47-34 GSGAGA GNGA GNG ----------ANPGADAKRSPST 
A4 1 /--5(; 	A(AS1S?--1 	 - - 
A5 47-66 ------------GSG DGAVASARNGANPGADAEGSSST 
A6 47-70 ---------- --GNG ----------ANPSADAKRSPST 
BI 47-30 ESSSSGNAPNKT 
Bl 47-34 ESSSSGNAPNKT 
Al 47-26 PAT --------------TTT TTT --- - T N 
Al 47-303 PAT --- --- --- ---- - TTT TTT --- - T N 
A2 47-302 PAT --- 	 TTT TTT --- - T N 
A3 47-301 PAT --- --- --- ---- - TTT TTT --- - T N 
Al 47-34 PAT --------------TTT TTT --- - T N 
All 47-50 PAT -------------- TTT TTT TTT - P N 
A5 47-66 PAT --- --- --- TTTT K TTT TTT --- T T N 
A6 47-70 PAT PAT PAT PAT ---- - TTT TTT --- - P N 
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5.3.6.5 	Child 47 
Eight A-type fragments and two B-type fragments were sequenced (Figure 34). The 
A-type fragments from weeks 26,30 and 34 were identical. Two other fragments were 
detected at week 30; these were identical to the persisting sequence at the 3' end and at 
the 5' dimorphic region but have differences in the 5 repeat structure. Fragments from 
weeks 50, 66 and 70 were different to those described above and to each other. The two 
B-type fragments, from weeks 30 and 34, were identical at the DNA sequence level. 
These data suggest that the infant was infected with the same A-type parasite from 
weeks 26 to 34 with two different A-type parasites detected on week 30 and the same B-
type parasite on weeks 30 and 34. Subsequent infections were with different A-type 
parasites. The sequencing data correlates extremely well with the PCR data (Chapter 
4.4.2.7). 
5.3.6.6 	Child 52 
Three A-type fragments were sequenced from weeks 10, 38 and 42 (Figure 35). 
Sequences from week 38 and 42 were identical at the DNA sequence level, while the 
sequence from week 10 was different in both length and repeat structure. The infant 
seems to have been infected with 2 parasite clones, one briefly on week 10 and another 
that persisted for atleast four weeks. 
Figure 35 Child 52 
Al 52-10 AESNLPT GAGARS GDGARS GOGARS GDGARS GDGAVA-
A2 52-38 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
A2 52-42 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
Al 52-10 SA ------- GSG --------------ADAEGSSST PAT PAT 
A2 52-38 GAGGSGSA GSG DGAVASARNGANPGADAEGSSST PAT --- TTTT 
A2 52-42 GAGGSGSA GSG DGAVASARNGANPGADAEGSSST PAT --- TTTT 
Al 52-10 - TTT TTP TTT TTT - T N 
A2 52-38 K TTT TTT --- --- TTN 
A2 52-42 K TTT TTT --- --- TTN 
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IRguire 36 Child 62 
51 62-14 ANEGSTTNSVDANAPK ADTVARVSQSSTN8A8TBTT8Q'r?rprA 
81 62-18 AGSPNSVDAP1( ADTVRVSQSSTNSABTSTTNNGESQTp'rpTA 
B1 62-22 ANEGSTTNSVDMThPX ADTVARVSQSSTNSASTSTTNNGBSQT'ZI2PTA 
Al 62-2 AESKPST GAGGSA GGSA c-GSA GGSA GGSA GGSA---------- 
A2 62-14 EESKPPT GASGSA GSGS GAVASA----------------------- 
A3 62-18 KSKPPT GASGSA GSGS GAVASA----------------------- 
A4 62-22 KESKPPT GASGSA GSGS GAVASA-----------------------
Al 62-262 AESKPST GAGGSA GGSA c-GSA c-GSA GGSA GGSA----------
A4 62-421 KESKPPT GASGSA GSGS GAVASA ----------------------- 
AS 62-422 A2SKPST -----------------------------------------
A6 62-46 TESNPPT GTGT GAGASG RAGAGA GASGRA GPLGAGA GASGP.A--
A6 62-50 TESNPPT GTGT GAGASG RAGAGA GASGRA GAGAGA GASGRA-- 
A3 62-621 BESKPPT GASGSA GSGS GAVASA 
A6 62-622 TESNPPT GTGT GAGASGRA GAGA GASGRA GAGAGA GASGRA-- 
A7 62-623 TESNPPT GTGT GAGASGRA GAGA GASGRA GASGRA GASGRA-- 
Bi 62-14 ADTIABGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT ------ 
81 62-18 ADTIASGSQRSTNSASTSTTNNGBSQTTTPTA ADTPTAT ------ 
Dl 62-22 ADTIASG8QRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
Al 6 2 - 2 	------------------------------- GSG ----------- 
A2 62-14 -----------------------------------------GNG 
A3 62-18 -----------------------------------------GNG 
A4 62-22 -----------------------------------------GNG 
Al 62-262 -------------------------------- GSG ---------- 
A4 62-421 -----------------------------------------GNG 
A5 62-422 ------------- GASAGS GDGAVA SA GSG DGAVASAGNG 
A6 62-46 GASGRA GASGRA GAGAGS GDGAVA BA GSG DGAVVSAGNG 
A6 62-50 GASGRA GASGRA GASAGS GDGAVA BA GSG DGAVASAGNG 
A362-621 ------------------------------GNG ----------
A6 62-622 GASGRA GASGRA GASAGS GDGAVA BA GSG DGAVASAGNG 
A7 62-623 ------- ------ GASAGS GOGAVA SA GSG DGAVASAGNG 
81 62-14 ESNSP8PPTTTT ESSSSGNAPNRT 
81 62-18 ESNSPSPPITTT ESSSSGNAPNKT 
51 62-22 ESNSPSPPITPT ESSSSGNAPNT 
pJ 	DGNCADAEGSSST PAT ---- -------------- ----- .............. 
A2 62-14 ANPGADASRSPST PAT PAT PAT PAT PAT PAT PAT PAT 
A3 62-18 ANPGADAERSPST PAT PAT PAT PAT --------------- 
A4 62-22 ANPGAL)ABRSPST PAT PAT PAT PAT PAT PAT PAT PAT PAT 
i -,2-22 DGNGADAEGSSST PAT ----------. ----- -- ------- 
A4 62-421 ANPGADAERSPST PAT PAT PAT PAT PAT PAT PAT PAT PAT 
A5 62-422 ANPGADABGSSST PAT PAT --------------------- 
A6 62-46 ANPGADABGSSST PAT PAT --- --- --- --- --- --- ---  
AS 62-50 ANPGANP.EGSSST PAT PAT --------------------- 
A3 62-621 ANPSADAERSPST PAT PAT PAT PAT --------------- 
A6 62-622 ANPGADAGS8ST PAT PAT --------------------- 
A7 62-623 ANPGADAEGSSST PAT PAT --- --- --- --- --- --- ---  
A1 - ,rTTrKTPTTTT----'P''N 
A2 62-14 --- ---- - TTT TTT TPT - P N 
A3 62-18 --- ---- - --- TTT TTT - T N 
A4 62-22 PAT ---- - TTT PTT TTT - P N 
Al 62--262 --- TTTT K TTT TTT --- T T N 
A4 62-421 PAT ---- - TTT TTT TTT - P N 
AS 62-422 --- ---- - TTT TTT TI'T - T N 
A6 62-46 --- ---- - TTT TTT TTT - T N 
A6 62-50 --- ---- - TTT PTT TPT - T N 
A3 62-621 --- ---- - --- TTT TTT - T N 
A6 62-622 --- ---- - TTT TTT TTT - T N 
A7 62-623 --- ---- - TTT TTT TTT - P N 
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5.3.6.7 	Child 62 
Twelve A-type fragments and three B-type fragments were sequenced (Figure 36). 
The B-type fragments were all identical, indicating persistence of this parasite from 
week 14 to 22. Among the twelve A-type fragments, there were seven different 
sequences. Although these sequences are not identical there are significant areas of 
homology between them indicating the likelihood of immunological cross-reactivity. 
Sequence Al was present at week 2 and 26, A2 was present at week 14, A3 was present 
at week 18 and 62, A4 at week 22 and 42, A5 at week 42, A6 at week 46, 50 and 62 and 
A7 at week 62. Given the extensive diversity in MSP 2 sequences, it is highly unlikely 
that the child was independently infected with parasites carrying the same allele on two 
separate occasions. Thus, it is likely that the same parasite type had persisted from week 
18 to week 62 and from week 22 to 42 but was not detected by PCR (Chapter 4.3.2.9). 
From these data the infant seems to have been infected by 8 different parasite types over 
the period of study, with individual clones persisting for periods of up to 44 weeks. 
jEgL37 Child 65 
BI 65-54 ANEGSSTNSVGANAPK 
B2 65-58 ANKGSNTNSVG1U'1PN ADT I AsGsQRsTNsASrsTTNNGc2TTIPTA 
B2 65-62 ANKGSNTtqSVGANAPN ADT I SGSQRSTNSASTSTTNNGESQTTTiTh 
82 65-66 ANKGSNTNSVGANAPN ADTIASGSQRSTNSASTSTTNNGESQTTTPTA 
Al 65-38 AESKTPT GS GAGASGSA -------------------------  
Al 65-42 AESKTPT GS GAGASGSA ------------------------------ 
A2 65-58 TESNPP- AGAGAS GNPPAG AGAS GSAGAS GNPPAG AGAS----- 
Bi 65-54 ADTIASGSQSSTNSASTSTNNNGESQTTTPTA -----------------
B2 65-58 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ------------------- 
B2 65-62 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA -------------------- 
B2 65-66 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ---------- --
Al 65-38 ------------------- GSG ------ DGAVASARNGANPGADAEGSSST 
Al 65-42 ------------------ GSG -------- DGAVASARNGANPGADAEGSSST 
A2 65-58 GSAGAS GSAGAS--- GSA ------------ - -------- GAEGSSST 
Bi 65-54 ---------------- ---------------- ADTPTAT 
B2 65-58 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
B2 65-62 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
82 65-66 ADTIASGSQRSTNSASTSTTNNGESQTTTPTA ADTPTAT 
Al 65-38 PAT TTTT K TTT TTT T T N 
Al 65-42 PAT TTTT K TTT TTT T T N 
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ES S S SGNAP NKT 
ES8SSGNAPrTKT 
Fkgre 38 Child 71 
Bi 7 1-38 TESRTPT GAVASAGS GAGS GAVASAGS GAVASAGS GAVA 
Al 71-30 AVSNPST GAGGSGSA GGSGSA GAGGSGSA------------
Al 71-34 AVSNPST GAGGSGSA GGSGSA GAGGSGSA-------------- 
A2 71-38 EESNPPT VAGA GSGAGA VAGSGAGA VAGSGAGA VAGAGAGA 
A3 7 1-62 EESKPPT GASGSA GSGS GAVASA -------------------- 
B]. 71-38 SGSQSSTNSASTSTTNNGESQTTTPTA ADTPTAT KSNSPSPPITTT 
Al 71-30 GSG DGAVASARNGANPGADAEGSSST PAT --- --- ---  
Al 71-34 GSG DGAVASARNGANPGADAEGSSST PAT --------- 
A2 71-38 GSG ----------ANPGADAKKSPST PAT 
A3 71-62 GNG ----------ANPSADAKRSPST PAT PAT PAT PAT 
Bi 71-38 ESNSPSPPITTT ESSSSGNAPNKT 
Al 71-30 TTTT K TTT TTT T T N 
Al 7134TTTTLK TTT TT'r T T N 
A2 71-38 -----TTT TTT - T N 
A3 71-62 -----TTT TTT - T N 
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5.3.6.8 	Child 65 
Three A-type fragments and four B-type fragments were sequenced from this child 
(Figure 37). The A-type sequence from weeks 38 and 42 were identical. The sequence 
from week 58 was different in length and repeat structure, although a short region of 
homology towards the C terminus may confer immunological cross-reactivity. The B-
type fragments from weeks 58, 62, 66 were identical and consisted of three 32 amino 
acid unit repeat units followed by a single 12 amino acid unit. The B-type fragment from 
week 54 has a different repeat structure, having a single 32 amino acid unit repeat 
followed by four 12 amino acid unit repeats. The extensive homology between these 
sequences, however, makes immunological cross reactivity likely. These data suggest 
that the infant was infected with 2 different A-type parasites and 2 different B-type 
parasites. 
5.3.6.9 	Child 71 
Four A-type fragments were sequenced and two (from week 30 and 34) were 
identical (Figure 38). The fragment from week 38 had a different repeat structure and the 
fragment from week 62 was different again. The second A-type fragment from week 38 
was sequenced and seems to be a hybrid allele, possibly the product of a crossing over 
event between A-type and B-type alleles (See description in Chapter 5.3.4.4 and Figure 
19). These data suggest that the infant was infected with four different parasites over the 
period of study. 
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5.3.6.10 Child 120 
Four fragments from this infant have been sequenced (Figure 39). Three A-type 
fragments were sequenced from weeks 10, 14 and 18 and were found to be identical at 
the DNA sequence level, suggesting that the same parasite clone had persisted for at 
least eight weeks. A single B-type fragment was sequenced from week 10. 
No sequences were obtained from child 12 or child 81 and only a single sequence 
was obtained from child 45 
Figure 39 Child 120 
Bi 120-10 ANEGSNTNRVDANAPK ADTIASGSQSSTNSASTSTTNNGESQTTTPTA 
Al 120-10 TESKPPT GD GAGSGA GAVASA GNG 
Al 120-14 TESKPPT GD .GAGSGA GAVASA GNG 
Al 120-18 TESKPPT GD GAGSGA GAVASA GNG 
Bl 120-10 ADTPTAT ESNSRSPPITTT ESNSRSPPITTT ESNSRSPPITTT 
Al 120-10 ANTGADAKKSPST PAT TTT TTT T N 
Al 120-14 ANTGADAKKSPST PAT TTT TTT T N 
Al 120-18 ANTGADAKKSPST PAT TTT TTT T N 
Bi 120-10 ESNSRSPPITTT ESNSRSPPITTT ESSSSGNAPNKT 
Figure 40 Number of different sequences found in each child 
Child No of Sequences No of different A 
type sequences' 
No of different B 
type sequences' 
5 3 0 3 
15 6 5 1 
17 2 2 0 
29 2 2 0 
47 7 6 1 
52 2 2 0 
62 8 7 1 
65 4 2 2 
71 14 3 1 
120 12 1 1 
'This number was calculated after the presumed errors have been corrected 
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5.3.7 Combining the PCR and Sequencing data 
In order to make full use of all the available data generated in this chapter and that 
from Chapter 4, ables summarising the infection patterns were generated where the 
PCR data and sequencing data are combined to produce the best estimate of the 
number of different alleles (different parasites) 
In most cases the sequencing data re-enforced the PCR data and in a few cases the 
increased sensitivity of the sequencing techniques reveals additional alleles which 
were not detected by PCR alone. 
Key 
MSP 1 di MSP 1 dimorphic family 
MSP 1 poly MSP 1 polymorphic size (bp) 
MSP 2 di MSP 2 dimorphic family 
MSP 2poly MSP 2 polymorphic size (bp) 
MSP 2 seq MSP 2 sequence number given to a specific sequence 
(Section 5.3.6) 
NP No product 
M Maternal sample 
Gen. code - Genotype code is an arbitrary code assigning a number to each infection, 
which is different within a child 
5-122 
5-123 
Ilkn ire 41 Child 5 
Week No M 2 4 6 10 4 18 26 30 14 38 
PCF P'ositi'e - - 4 + + 4 
Slide Positive - - - 
N4i'Id - - __ 
MSP2d  B B B B 
WS-1;2  —pp ly 440 485 69C 690 
420 
SM -------------- -.-------.-------------------  
NS BI 82 B3 
Gencode 1 2 3 34 
IFulllre 42 Child :15 ------------- -_ .---- ---- -- ---- -,--,__ ----- 
Week No 	K4 	) 	2 	6 	10 	14 	18 	22 	30 	34 	3 	42 	50 	-561 	66 	70 	78 
S'inipk cat 14/5/94 21/5/94 	8i6/94 25/1/94 23/8/94 2'0/9/94 18/10/94 13/12/94 12/1 '95 	14/2/95 	1413/95 	2/5/95 13/695 22/05 	1. &,9/.95 14/11 '95 
PCR Positive 	+ 	 - 	 - 	+ + 4 4 	- 	+ + 
Slid Positive 	- 130 	260 	303 	 347 	1300 
MSP I di K1 	 El 	 MAD2O MAD20 MAD2O 	K I 	MAD2() 	NP 
N4SPIpply 	460 460 550 	0 	550 5iO 550 NF 
N4SP 21; di 	 A 	 A 	A 	A 	A 	 A 	A 
B 13 
N4SP2pply 	705 	 550 	 550 	550 	550 	640 	590 	675 
40 
MSP2Seq. 	NS 	 A. I 	 BP 	B 	14S 	A3 	 A 	AS 
AT A2 A2 A4 
Gen code 	1 	_____ 	1 2 	 2 	3 4 	3 4 	56 	 7 	8 
5.3.7.1 	Child 5 
The PCR products from the parasite detected at week 14 could not be sequenced 
(Figure 40. According to the PCR data, three different B-type alleles, with sizes 485, 
690,420 bp, were detected at weeks 26,30 and 38. Accordingly, three different MSP 2 
B-type alleles were sequenced, although the 69C' bp allele which was detected 'by PCR at 
weeks 34 and 38; could only be isolated' for sequencing at week 34. 
5.3.72 Chi Id I5 
The PCR products. from. the parasite. detected at week 0 could not be. sequenced 
(Figure 42). The k-type allele (k 550), detected by PCR. at weeks. 10,34,.38 ;. 42 could he 
resolved into two alleles by sequencing (A1 and A2). Both alleles may have been 
present from week 10 to 42 asPGR typing. of MP I alleles indicated the presence of a 
mixed 'infection at week 10. Combining the two sets Of data, the 'likely combined 
genotype of this mixed infection is MSP 1 '(K'1/MAD'20 460/550) MSP2'(A 550, Al and 
A2), although not all the alleles were detected -by PCR or sequencing in every sample. 
At weeks 34, 38 'and 42 'a'thiTd 'clone was 'detected, 'carrying 'a B-type 'allele which 
-sequenced from weeks 34-and 38. The results from 'the 'sequencing 'support 'the PCR data 




Week No. M .0 	. .2 4 6 . 	 1 26 31 .34 38 42 46 54 
Sanip1cJat  30/5/94 15/6,94 28/6/94 12P/94 1/ 0i94 29/11/94 3/1/95 '24!1/951 21,2/95 4/3/95 5/4/95 27/6/95 
PCFIositi'e + + - + + + + + + + 
Shdç Positive - - - - 44 516 
P I di NP W2() MAD20 MAD20M1020 MAD0MAD20MAD20 
MsP I pplv NP 570 NP 520 520 20 520 520 520 
Msi' 2 di A B A A A A A A 
'2PPTV 550 490 550 150 550 550 550 550 550 
senmijence 	I -j -- -- 
TTT 
-- -----------.---.-. 
Aj A2 ~4s Al 
Gth. cbde . . 1 . . 2 . 	 2.  
Child 29 
WeekNTa MO.. 2 4 6 18 2 31 34.38 . 42 • 4 054 58 . 4. 
Sample Date 6/7,94 21a7/94 5/8/94 19/994 10/11/94 1202/94 3/2,9' 313195 31/3195 28149' 16/595 0'6/95 '1,7/95 18/8/95 28/11 !95 
PCR PositiVe + + + + + + - + 
Slidp Pos itive - - - 86 258 - 
MSP I dit MAD' 2Q MAJ)20 MA])20 MAI)20 M4,D20 MAt)2() MAD2() MAD2C 
NISI' I poly  '520 520 520 610 540 '20 520 520 
N4SP2dt, A A A A A A A A 
MS]' 2 poly 64) 560 560 610 640 6 10 61() 610 
Al A2 A2 A2 Al Al AZ Al 
Gencode 1 2 =T 2 1 2 2 1 
53J3 Chikt17 
In child 17 there is good agreement between PCR and sequencing data with the same 
msp 2 allele (A 550. A2) being detected in all samples from weeks 18 to 46 (Figure 43). 
This msp 7 allele appears to be associated to a MA92O 520 msp 1 allele. However, a Ki 
msp I allele was transiently detected by PCR at week 18 but the msp 2 allele linked to this 
parasite was not detected. 
5.3.7A Chi(S29 
Although the, sequences. found. do not.direc.tly correspond. with. the. clones.found by PCR 
at any particular linie points, the s.eqileuee data, support the iclea, suggested, in. Chapt,et 4 
that two parasites types are present and fluctuate about the detection limit of the methods 
used (Figure 44). Discrepancies between the two tethniques may be due to the low 
sensitivity of PR product detection on agarose gels. 'This is a problem that may explain a 
lot of the discrepancies between the sequence data and the PCR data. The msp2 
polymorphic fragments were sized on three occasions and the same results were obtained 
on each occasion. 
5-126 
5-127 
Aj (:hild 47 
Wee kNo. M 2.4.6 10 141822 26 30 34 .38 42 46 .50. 58 
Sample Date 30/8194 3i9/94 27/9/94 251 lt)/94 22/11/94 20/ 12'94 17/1/95 14/2/Q5 14/1/95 1214V95 9'5/95 6//95 4/7/95 1/8/95 26/9/95 24' 10/95 21/11/05 19/1 2/  5 
PC1Fos1ti.e - - - + + - + 4 
Slid 	Positive - ' 430 4212 17' 223 43 
MSP1d -- p - MAD0AD"OMkD2OMAD20 D20 — MA0MAD20 
I poly 640 570 500 ±40 540 NP 570 





Mpply . . 	. - . . . 550 6.50 560 650 
7:15 
560 6-50 675 
. 	71.5  
675 . 535 50 
MSP 
Sequeiice 














Gen. cbde . I . 	. . . . 1,2,3,4 . 	1,2 t 5 
1F'kiuure 46 Child 52 
- r ° 14 .38b 46 50 54 58 62 
Sanipk Date 18/1 1/4 7'12/94 29/1/94 27//5 24/2/95 24,3/95 21/4/95 19/59'5 16/6/95 1 fl/95 10/9'9'5 7/9/05 6/10/95 3 11/95 30/11105 29/1215 26/1, 
96 
PCR Positive - . - - + + - 
Slide Positive 168345 .. 129 - 258 1'?200() 29 - 
-- LD2OMAD20 
I pplv NP 5"O 520 520  
MSI5 2d3  NP A A A 




MSP2suj N$ Al A2 A2 
Gen. cod6 ____ fl 
	
5.3.7.5 	Child 47 
A conservative interpretation of the PCR data indicates that two parasite clones 
belonging to different dimorphic families were present at week 26 of which only one 
MSP 2 allie could be sequenced (Figure 45). These two clones persisted at weeks 30 
and 34 when both M P2allks cou1 be sequenced. A third A-type parasite clone was 
detected by PCR at weeks 30 - and 34 although sequencing detected two novel A-type 
sequences rihoifiy three- different parasites- were detected by PCR between weeks 
26 and 34, at least four different genotypes were- detected- by sequencing. This suggests-
that this diversity was not detected- by PCR as the difference in size between two- of the 
alleles would- not be detected-on- agarose gei& in- addition, novel- MSP 2 alleles- detected-
by PCR at weeks. 50,66 and. 70-were-also-found-to-be-different by sequencing. 
5.3.7.6 	Child 52 
The infection- detected- at birth- could- not be- characterised. by molecular techniques 
PCR analysis- detected a single clone, infection- at week 1.0, which. was- sequenced. 
(Figure 46).. The PCR data. suggeata that. there were two MSP 2A-type cloiies- present at. 
weeks 38 and 42 but when PCR was used to generate cloning. fragments only a single 
product was generated. 
5-128 
5-129 
47 Child 62, 
0 477  3034 38 42550 542 66 70 
Samplb Date 0l10/94 4/111'94  18,11/94 2/ 694 29/12/94 27/1/95 412/95 '43/5 21/4/95 191/95 16/095 13/7/95 10/8/95 6/ 109 1/1 1I5 2I 2/95 26/11% 23,2/96 
P(F Positi,'e - + - + + + + + - 4. + + + - + 
Slid 	Positive - 6 - 86() 45 86 - - 1462 86 129 215 192  
N4S15 1 di MAD2() MA02() MAD20 MAD2() MAD20 MAD2() MAD '0 NP MAD2s) MA D20 NP 
Ki  
N4SI' I pplv S90 570 570 570 -570 590 490 520 520 520 NP 
• .555 555 .555 .55 . . I 
NSP.dj A B A A A A A A NP 
B. B, B. . . . 
ASPpp1y 530 510 .56 16 510 510 510 63050 610 570 670 NP 
• . . 	. . . 58() . 	58() . 	8Q . 580 . . 510  
Al. • 1 81 31 131 Al A4 A6 0 A3 
seqMerce 
.. . 




Gn.cbdè, .• I 2,3 ,:,3 . .2,3, .2,3,4 . 5,6 7 .'. 7 . 
Apufre  S Child 65 
Week No. JLJ  10 . JPL LLL 
S4impl Date 2/121 16112 3/1/ 
94/94.95.95,95,95,, 



















PC1Positi've - - - - - - + - - - + + .. + + + 
ShdPo,itive .. - .• - - - 344() 215() 86 1C6fl 688 731 215 
N4SP I d 	• 








--- -- -- 
MAD2O 
-0 
MAD20 MAD20 MAD2O MAD20 
--- --- 0 -- 
.500. 540 510 456 455 .4,55 510. 
____ 
di MSP2tdi 'A 
00 
A'A 































0 0 	. 0 0 	• 







_____L_L___ ___ Q 
53;7.7 Child'62 
A single clone infection, detected by PCR at week two was confirmed by 
sequencing (Figure 47). PCR analysis indicated that two clones (One M5P 2 ,K-type 
and one MSP2B-type) were present from IG to 26 weeks. The persistence Of the B-
allele was confrnnedby sequencing at weeks 14, 18 and 22. However the A•-type 
allele was foundto be subtly different at each time point (differences in the number 
-of PAT -repeats). Two -new MS!' 2 A-type- -alleles- were- detected-by PCR but only one-
of these- could - be-sequenced. 	clone-infection present- -at weeks 46,50- (and- 
.62) was confirmed by:.s.cqueneing. Sequencing also'cveaied the p--sistcnee of the 
A3- all ele at. week 62 (whichhad--notbeen-detected. by PCR)- and -alse- the presence of 
a- novel, allele--which--had also- not been--detected- by PCR. 
5.37.8 - 'Claild45 
PR data suggested that two different parasite types were present at week 3 and 
42 but sequencing found- that the same allele was present in these two samples 
(Figum'48) The-'di'screpancies'mayiYeelainid -by minsi-zing the- PCR 
-products , or more--likely sequencing- detected-different - alleles to- those- detected- by the-
••MSP 2pol-ymorphic PCR. The PGR-dataindcatc-thc pr'csenee-of two-alleles atweck 
54and-two alleles- at week 58-Althou-gk only---ne-allele could be sequenced-at- week 
54, both--week 58-al-leles.were sequenced- and it seems--that two- entirely- new parasites. 
were, present.  tthisime. The BZ.allele-probably represents-the B 665 allele (which. 
is probably associated with the MSP IMAD2O 445al.lele)...Only TheM2parasite   is 
detected (by PCR and sequencing) at week 62. Both the B2 allele and a new A-type 
allele (which could notbe sequenced) were present at week 66. Another A-type 
allele was present on wek70but could not'be sequenced. 
5-131 
Tkort 41 Child 71 
_M_jj0_j 
Sample Date 22/11 (5/12/ 20/12 3/1/ 1/11 28/2/ 27l3i 25/4/ 26/5/ 206/95 19/7/95 14/8/95 12/9195 10/10 74I1, 5i12'95 2/1/ 3/4/06 1131 26/3' 
194 94 ;I94 95 95. 95 .95 95 95 /95 95 96 i. 96 96 
PCR Positive 
Slide,Positiv 2752 86 86 - r - 
MS' I d - I MAW MAD2 MAD2 MA]2 NO MA D)0 -- 
.0 0 0 01 . 	 . . . 
MS I poly . . 570 570 475 NP NP 520 
435 . . . 
MSP2di A A A A A 
ms . p FOY ~70 600 
13 
470 NP NiT 545 
520 420 . . . 
MSp2 . . . Al Al • A2 NS NS 1 A.3 
----------------------- 
IPiiire l Child :120 
Weck No 2 1 .4 6 10 14 18 22 26 30 34 38 42 46 So 54 58 6' 66 70 
SAM pit Date 24//95 915r95 23 1,'5195 6/6/95 4/7195 1/8/95 4918195 26/9/95 24/10,95 2141 19/12 16/1/ 13/,'/ 1 -2/3/ 9/4/ 7/5/ 7/6/ 2/7/ 30/7/ 2718/ 
195 /95 96 96 96 96 96 90 96 96 96 
PC 	P'ositive - + + + + - - - 
Slid-,Po,itive  2322 5203 93998 $6 129 - 
N4SP I di MAI)20 r,-- 1 MAD20 14P MAD2O 
Ki . 1(1 
N4SPIpply : 445 NP 535 
__ 
-------------.------------------------ 
MS15 2d1 1: A AANPA 
B 
i'2pp1y . . 500 5) 500 NP 600 
.1 . , 600. • 600 
MSP 2 - B! Al. NS NS NS . 
seerice 4. AL .A1. 
Gcnode 12 1 134 5 
5.37.9 1 Child* 71 
A single clone was detected by PCR and sequencing at week 30 (Figure 49).  PCR 
data iüdicated the presence of 'two novel M5P 2 alleles at week 34 - (although the mp f 
allele was the same as at week 30), and- the week 30tnsp 2 allele was sequenced again at 
week 34. Two possibilities exist; either there was an error in sizing the week 30 or week 
34PCR products (i.e. one allele persisted from week 30 and. the other was a new allele) 
the rnsp 2A1 allele persisted until -week 34 but-two other parasite types-were present.... 
for. which .the:.insp. 2 alleles-could not be sequenced. As the.msp. 2 Al allele. was-detected 
by sequencing at w.cck-34 this -seems the- most .hkel-y interpretation-of the data. Tw,oncw, 
alleles were present at week 38. (detected by.PCR and confirmed by sequencing)and a. 
sixth genotype was. deteçte4at week 62, 
5317.10- Child 120- 
The msp 2PCR data suggests that this child Was infected by two parasite genotypes 
(A/B 500/600) -from weeks 10 - to 26 and - two alleles (one A-type and one B-type) were 
sequetced-(-Fi-gun..50) However-the-rn -p-i. 	 .... 
infection pattern, with- at least five. different genotypes being- present. This suggests either 
that thc same .msp. 2 allcicswerc associated:with diflcrcnt.msp.L alleles: or that some 
nisp. 2 aileles were not detected. 
ç-  1 32 
5.4. Discussion 
The sequence data suggest that sizing of PCR products can give errors of up to 50 bp 
i.e. size differences may be detected but when sequencing, is carried out the MSP 2 
polymorphic region is the same size. The variation In sizing of PR products has been 
seen before: when MSP 1 R033 alleles are run on the same gel, some alleles 
consistently show a'20 bp difference which is not present when the PCR products are 
sequenced '(Dr L. Ranford-Cartwright, pers comm.). 
A possible explanation could be that two different PCR reactions (the sizing P€R and 
the PCR generating fragmeuts'for sequencing) are amplifying different' alleles due to 
stochastic sampling of the initial DN-A sample; For exam, pie if afewcopiesof-a.'minor 
clone were amplified...PCR using.-AC primer pair and then-this PCR was used as am 
insert for, cloning, the minor clone may become detected when colonies are. picked. and 
sequence4. The; only occasions-,when multiple aile-ie-s.we.re- .detected.in . a. sample hy. 
q.tçt.cg  .gity wctt whcn the .mpJc had bca 	d- '[Ij w.y•.bc •hçaue th 
amplification implicit in cloning,,is necessary for these alleles to be detected or because 
the process of doting leads to mutations, as for example may have happened with both 
47-26 arid"62-'62;the .. diiferent'áll6les'in these samples varied otiy in number of repeat 
units.-Variation in the number Of repeats is seen, 'however, in sequential samples i.e. 
child -62 weeks 14, 18 and 22; inthese samples the variation is in the number of PAT 
"epeats. 
 
Also- there- were' many samples inwhkh'there'was'rnvariationin number of 
'.repeats'despite thesame'number of'coloniesbeiirg picked. ltseemsmost likely 'thatthe 
A 	ailtIcs wcrc not 'artefacts but wcrctictcctcd di 	amplification d'uringthc 
'cloning process. 
Where a single -genotype..wasdetected- by PCR only one sequence wag generated; 
multiple sequences. from. a. sample..showin.g a single genotype by PCR..  were . only 
detct,d, on tNyo 	 1h.sprep?pj.e. ,btwn PCR bad, aplysjs. and, s.qunig 
of,alleles.has-not heennoted hefore;,however.There does-not appear to-have.heen any 
work where the same samples have been typed using.both PCR and sequencing. 
In many cases there is .good correlation between the PCR data and the sequencing 
data, although this is not always the case (see previous section). in child' 52, there is full 
agreement between the sequencing data and -the PCR data. In child' 17, there is almost 
,31 
total agreement between the two techniques, except in one sample. In some cases the 
discrepancies are due to differences between the alleles which the PR techniques could 
not detect and those detected by sequencing, i.e. in child 62 weeks 14, 18 and 22. The 
differences were 21 imeleotides at most. The variation in the number of PAT repeats was 
taken as -a tiue representation -and not -a cloning 'or PC-R generate -artefact. 
Where a specific repeat structure is found a number of times within- each child, the 
nucleotide sequence is either identical- or variations could be explained- by sequencing 
artefacts-. This suggests that the same clone wa-s found- repeatedly in- the infant, rather 
than repeated- infection with- different clones- carrying the- same- amino- acid sequence. 
The revised- infection patterns. are shown in the previous. section.. 
Some of the point mutations in the A type sequences may be due to PCRlsequenc-ing 
errors, especially when the changes produce atypical amino acid residues e.g. 62-14 (D 
(GAT.) is found instead of N (AAT)). Where there are changes in a single repeat unit and 
the rest of the sequence is identical these may also dUe be PCRThequencing errors i.e. in 
17-34 type sequences. The differences in the dimorphic sequences found in 2922 type 
sequences from child 62 are detected in 3 consecutive samples, suggesting that they are 
true mutations carried by a specific parasite type rather than due to PCRisequencing 
errors. When' nucelotide differences-leading to amino acid- substitutions occurred in: the-
polymorphic region-, they were in posit-ion- one or two- of a codon-. 
	
Where difference -seen within a-group, -e.g. ,17-34 -type, 17-18 and 	 were single 
amino acid -changes -(which were -due to single nucleotide changes), -these differences 
may be due to PCR errors. New sequencing templates were generated but these 
imitations were -seen again. Therefore these -sequences may,either -be susceptible to 
pilita 	or the 	have been induced in the i ii-iai PC. step.. 
In the repeat regions,. serine is coded for by, either TCT or AGT, and the codon 
present seems to vary between repeat units. In some sequences only AGT was seen,, e.g. 
29-18, 15-66,71-34,62-50, while in other sequences onilyTCT was seen, e.g. 47-26 and 
71-38. in the other sequences, -both codons were seen in repeat units but only one codon 
was seen in each repeat unit. As a generalisation where both codons were presentTCT is 
seen in repeats preceding repeats containing AGT. 
ç — 	Li.. 
Although there is a great deal of variation found in the sequences, certain nucleotide 
patterns are evident. Prior to the central non-repetitive region there was always GXG 
(GGT XXT GOT) where X was either S (TCT) or N (AAT) residues with one exception 
(65-58) where GSA was seen (GGT AAT GOT). The codons here suggested that this 
motif was generated from a partial repeat as the S residue was coded by AAT rather than 
TT in other cases. 
In the A-type sequences there seems to be a conserved nucleotide sequence that codes 
for PAT repeats, as in all sequences it is coded for by CCC GCT ACT. The poly-T 
region also seems to have a nucleotide pattern underlying the primary amino acid 
sequence. Where a K residue is present it is always preceded by four T residues with 
common nucleotide pattern,. ACC ACA ACT ACC. Following the K residue is a 
different nucleotide pattern coding for T residues,. ACT ACC ACA this is repeated a 
number of times followed by ACT once or twice. Where PAT repeats are followed by 
only poly-T regions there is a third distinct nucleotide pattern coding, ACC ACA ACT, 
repeated two to four times followed by ACT. There were no synonymous sequencing 
errors detected in this region. 
When the number of clones was calculated using the sequencing data, the maximum 
number of clones detected was four different alleles: one B-type and three A-type alleles 
from child 47 on week 30. Three A type sequences were detected in child 62 on week 
62. The rest of the samples contained only a single sequence or a single A and a single B 
sequence. 
The use of sequencing in this study allowed the discrimination between persistent 
infection, and infection with novel alleles- As expected the number of novel alleles 
detected were greater than using simple PCR based techniques.. In addition the sequence 
data enable the analysis of antibody response to specific antigens. This approach has not 
been used with malaria antigens before. lJnfortunately the sample size was not large 
enough to Show investigation into the trends in allele frequency over time. 
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6.1 Introduction 
In order to investigate the differential recognition of different sequence variants of 
MSP 2, purified proteins representing the different MSP 2 alleles were produced. As 
production of native proteins by parasite culture was impossible because the parasites 
had not been preserved in a viable state, recombinant DNA technology was used. 
Two types of recombinant proteins were produced. The first were antigens 
representing the different polymorphic regions of MSP 2 which had beeen detected in 
the cohort by sequencing; these were based on the data described in chapter 5. The 
second were two antigens which represent the 5' and 3' dimorphic regions - but not the 
polymorphic regions - of the A-type and B-type allelic families respectively. These two 
types of antigens were produced in order to discriminate between the humoral responses 
to the dimorphic and polymorphic regions of MSP 2. 
All antigens were expressed in a prokaryotic expression vector, pGEX2-T [115]. 
pGEX was chosen as the vector for the production of the recombinant antigens for a 
number of reasons. Firstly, this vector is based on pGEX plasmid [116] which produces 
a fusion protein with the glutathione-S-transferase of Schistosomajaponicum (GST) at 
the N-terminus of the expressed protein with a thrombin cleavage site between the GST 
and the insert allowing removal of GST [115]. The GST fusion partner allows single 
step purification of the recombinant protein by affinity chromatography [1] or batch 
absorption to glutathione-agarose beads [116]. Secondly, pGEX plasmids have been 
used previously to produce specific malaria antigens for use in ELISA assays; for 
example, different domains of MSP 1 [16,65,100] and MSP 2 [58,66]. The vector had 
previously been used to produce MSP 2 recombinant proteins which were 
conformationally correct (using immunological techniques) and the purification process 
was straight forward and rapid [66]. One potential disadvantage of pGEX is that as the 
fusion partner is cloned from Schistosoma japonicum, there may be imunological cross 
reactivity with glutathione-S-transferase (GST) from S. mansoni or S. haematobium 
which are endemic in Africa. However, schistosomiaisis is not endemic in the study area 
in Ghana so this was not a major problem. Nevertheless, ELISA analysis was carried out 
in such a manner that any reactivity to GST could be subtracted from reactivity to the 
malaria antigen alone. 
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Recombinant pGEX proteins representing the EGF domains of the 19 kDa region of 
MSP 1 (MSP1 19) have been used to investigate the role of antibodies in protection 
against clinical malaria [65].  In this study, it was found that the prevalence of antibodies 
against the second EGF domain was higher in children who had asymptomatic malaria 
infection than in children who had clinical malaria, indicating a role for antibodies to 
specific epitopes in MSP1 19 in protection of children from clinical malaria. 
Antisera raised in mice against pGEX recombinant proteins representing different 
regions of MSP 2 recognised native MSP 2 proteins from cultured parasite strains [66]. 
Thus, the recombinant proteins appear to represent the structure of the native proteins. 
When these antigens were used in ELISAs to analyse sera from people living in endemic 
areas, it was found that antibodies to the two allelic forms of MSP 2 did not cross react 
[66] and that the dimorphic and polymorphic regions were recognised more frequently 
than the C-terminal conserved region. On the basis of these previous data, antigens 
produced for this study in Ghana represented the dimorphic and the polymorphic regions 
of MSP 2 but not the conserved region. A study also indicated that there was a change in 
the IgG subclass profile of the antibodies with increasing age of the study population; 
children less than 10 years old produced predominately IgGi while people older than 10 
years old produced predominately lgG3 [66]. This finding has since been confirmed in 
other studies [67]. A subsequent study [58] found that in children aged between 3 and 8 
years old, IgG3 antibodies to A-type alleles of MSP 2 were negatively associated with 
clinical malaria while IgGi antibodies to B-type alleles of MSP 2 were positively 
associated with clinical malaria, indicating that IgG3 antibodies to certain MSP 2 
antigens may confer resistance to clinical malaria. However, the antigens used in 
previous studies did not allow the discrimination of humoral responses to the dimorphic 
and polymorphic regions of the antigen as both dimorphic and polymorphic sequences 
were present in the same recombinant proteins. 
For the work presented here, antigens representing the 5' and 3' dimorphic regions of 
MSP 2 were expressed as a single protein. These antigens were produced using a 
technique called gene Splicing by Overlap Extension (SUE) [117] developed to produce 
hybrid genes. This technique has been used with MSP 2 previously [68], to clone the 
truncated antigen sequence into a hexaHis expression vector. The truncated A-type 
sequence produced a soluble protein but the truncated B type product was insoluble (Dr. 
R.A. Anders, pers. comm.). Although the dimorpic A construct was made available to us 
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(Dr. R.A. Anders), two new constructs were made in order to express the equivalent A 
and B sequences in soluble form using the pGEXIE. coli expression system. 
Primers were designed to amplify the dimorphic regions of MSP 2 from both 
dimorphic types. The sequences of HB3 and 3D7 MSP 2 were obtained from 
Dr L. Ranford-Cartwright and GenEMBL respectively. These were used to design 
primers to amplify the dimorphic regions of MSP 2 from these strains. The 3' primer of 
the 5' PCR product has a 5' extension which is homologous to primer 3 allowing the 
production of a single molecule in the final PCR (Figure 1). The two dimorphic regions 
were amplified in two separate PCR reactions and then the products from these initial 
PCRs were used as templates for a final PCR which produces a single fused product. 
The PCR product was cloned into pGEX as with the other antigens. 
6.2 Materials and Methods 
6.21 Producing polymorphic antigens 
Twenty three novel repetitive sequences identified in Chapter 5 were selected for 
expression in pGEX-2T. These sequences represented the most common ones found. 
6.2.2 Producing inserts for sub-cloning 
6.2.2.1 Large scale isolation of recombinant pBluescript phagenzids 
pBluescript DNA from each novel clone was diluted 1:100 and 10 141 of this dilution 
was used to transform competent XL-1 Blue E. coli as described before (Chapter 5.2.5). 
A single colony was picked and inoculated into 50 ml LB-AMP-TET and grown 
overnight at 37 °C in an orbital incubator. The cells were harvested by centrifugation at 
2500 x g for 10 min and the supernatant was discarded. The phagemid DNA was 
harvested using a scaled-up alkaline lysis method modified from Maniatis (1989). The 
cells were resuspended in 33 ml of solution I (Appendix 8.1.7.1), then 66 ml of 
solution 2 (Appendix 8.1.7.2) was added and the tube was inverted 4 times. 5 ml of 
solution 3 (Appendix 8.1.7.3) was added and the tube was inverted 4 times. The 
supernatant was recovered following centrifugation at 14 000 x g for 10 mm, added to 
05 x volume isopropanol and centrifuged for 10 min at 2500 x g. The pellet was 
resuspended in 1 ml of TE buffer, mixed with 1 ml of phenol/chloroform then 
centrifuged at 1600 x g for 5 mm. The top aqueous layer was removed and added to 1 x 
volume ice cold 100 % ethanol. This was centrifuged at 2500 x g for 10 min and the 
supernatant was removed and the pellet was washed in 1 x volume ice cold 75 % 
ethanol. DNA was removed from solution again by centrifugation at 2500 x g for 10 
mm, the supernatant was removed and then the pellet was dried at 65 °C in a heating 
block for 10 mm. The dried pellet was resuspended in 150 jsl of daH20. 
6.2.2.2 Restriction digests of recombinant pBluescript phagemids 
The DNA prepared above was then double digested to produce both the insert and a 
double digested plasmid, which were separated by agarose gel electrophoresis. The 
digestion reaction mix contained 20 units of Bam}I1 and EcoRl (Boehringer 
Mannheim), 20 p1 of 10 x Buffer B (Boebringer Mannheim), 20 pg ml-1 RNase lilA 
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and 150 p1 of DNA. The reaction was made up to 200 p1 with daH20, overlaid with 
mineral oil and incubated at 37°C overnight. The digest was then mixed with 20 141  of 
loading buffer and loaded onto 25 % agarose/05 x TBE gel. The insert was excised 
from the gel and eluted using Prep-A-Gene kit (BioRad) using 20 p1 of matrix. This 
resulted in the insert being eluted in 40 j.sl of daH20. Two microlitres of the eluate were 
run on an 1-5 % agarose/05 x TBE gel to estimate DNA concentration. 
6.2.3 Producing recombinant pGEX-2T plasmids 
pGEX-2T was the vector into which these inserts were cloned. Double digested 
plasmid was prepared using the same method as used for pBluescript as previously 
described (Chapter 5.2.3). In the ligation mix, 800 ng of double digested vector were 
mixed with 150 ng of insert. The ligation mix and conditions were as previously 
described (Chapter 5.2.4 and 5.2.5) except that E.coli DH5oc were used. Transformed 
cells were spread onto LB-AMP plates and incubated at 37 °C overnight. Single colonies 
were picked and grown overnight in 3 ml of LB-AMP at 37 °C in a shaking incubator. 
The colonies were screened by the same PCR method as used for the pBluescript clones 
(Chapter 5.2.6) but pGEXR primer was used instead of Ml 3F primer with 2C (See 
Appendix 8.2.5 for primer sequences). The product obtained was 70 bp larger than the 
insert. Each positive clone was inoculated into 100 ml of LB-AMP and grown overnight 
in a 37 °C shaking incubator. Plasmid DNA was isolated using Wizard Midi prep kits 
(Promega). 
6.2.4 Sequencing the recombinant pGEX-2T plasmids 
Direct sequencing of the recombinant pGEX2T failed for reasons unknown, as had 
the direct sequencing of pBluescript described earlier (Chapter 5.2.8). In an alternative 
approach, primers were designed to amplify a section of pGEX which contains the 
insert. These were used to produce a PCR product which was used as a sequencing 
template as described for recombinant pBluescript phagemids (Chapter 5.2.8).The 
primers (pGEXF and pGEXR) used in the sequencing reactions were same as the ones 
used to produce sequencing template (Chapter 5.2). 
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6.2.5 Expression of GST-2AC and GST-2BC recombinant proteins 
6.2.5.1 Test expression 
The plasmid DNA from positive clones was diluted 1:100 in daH20 and then 10 ptl 
was used to transform competent DH5cx E. coli (Chapter 5.2.5). 200p1  of transformed 
DH5cx E. coli were spread onto LB-AMP agar plates and grown at 37 °C overnight. A 
single colony was picked and inoculated into 3 ml of LB-AMP and grown for three 
hours in a 37°C shaking incubator. One ml of the culture was removed for SDS-PAGE 
analysis and then 2 y of 100 mM IPT G was added to the remaining culture in order to 
induce expression of the fusion protein. The incubation was continued for a further two 
hours, after which one ml of culture was removed again. The culture samples taken 
before and after induction were centrifuged at 12000 x g for one minute in a microfuge 
and the supernatant was removed. The pellet was resuspended in 100  Y of 1 x PBS 
(Sigma). iø pi of the resuspended pellet was removed for SDS-PAGE analysis. The 
remaining resuspended pellet was used to carry out a test extraction using agarose-
glutathione beads (Sigma). The resuspended pellet was lysed by three rounds of freeze 
(liquid nitrogen or -70 °C) thawing (37 °C heating block). The insoluble fraction was 
removed by centrifuging at 12000 x g for one minute in a microfuge. The supernatant 
was removed and incubated with 10 p1 of 50 % agarose-glutathione beads/PBS for 10 
min at room temperature. The beads were removed by centrifuging as described above 
and washed three times in 300141 of PBS before being resuspended in 10#1 of 1 x 
sample buffer. These samples were then run on SDS-PAGE gels as described before 
(Chapter 3.6). 
6.2.5.2 Large scale fusion protein extraction 
Large scale GST fusion protein extraction was carried out as described in the 
Pharmacia pGEX handbook. A single colony from a LB-AMP plate was inoculated into 
5 ml of LB-AMP and grown overnight in a 37°C orbital incubator. This overnight 
culture was added to 500 ml of LB-AMP and incubation was continued until 0D600 of 
08 to FO was reached. Expression of the fusion protein was induced by addition of 
500 p1 of 100 mM IPTG to the culture. After a further three hours incubation at 37°C, 
the cells were harvested by centrifugation at 5000 x g. The pellet was resuspended in 10 
ml of 1 x PBS (Sigma) and the bacteria were lysed by four rounds of freeze thawing as 
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described above. To remove the insoluble fraction the lysate was centrifuged at 14 000 x 
g for 10 mm. The supernatant was added to a 50 % agarose-glutathione bead slurry 
(Sigma) equilibrated in 1 x PBS in a ratio of 500 JAl of slurry to 10 ml of supernatant and 
incubated for one hour at 4°C with gentle mixing. The beads were separated from the 
supernatant by centrifugation at 1000 x g for five minutes and washed in 10 ml of 1 x 
PBS three times. To elute the fusion protein, the washed, pelleted beads were incubated 
with 250 p110 mM reduced glutathione in 50 mM Tris-HC1 (pH 80) for 10 min at room 
temperature. The beads were centrifuged at 500 x g for five minutes and the supernatant 
was removed. The elution was repeated twice and the eluate pooled. 
The lysate collected after the first binding to agarose-glutathione beads was rebound 
to the beads alter elution. The binding, washing and elution steps were repeated. The 
eluate from this second binding was collected separately. This additional binding 
increases the yield from the bacterial culture by approximately two fold. 
Samples were taken throughout the purification process for SDS-PAGE analysis 
(Chapter 3.6). 
Figure 1 Splicing by Overlap Extension (SOE) strategy used to produce dimorphic 
MSP 2 antigens lacking central polymorphic region 








I- 	 - 
	
1, // -/ _..___ f•/_ / X ,~ gg I I 
J 
\ Anneal two PCR products 
together  
Hybrid 




Bold number are the primers 
used 








6.2.6 Production of dimorphic MSF 2 (dIMSP 2) antigens by.Splicingby.overlap 
extension' (SOE) 
Primers were designed to amplify the'S' and 3"dimorphic regions Of'MSP2'from 
both dimorphic types. 
6.2.6.1- PCR- reactions used-to produce 'diMSP-2 fragment- 
Primer 2 had aS' extension which was homologous to primer '3 allowing the 
hybridization of-the two PC  products in the second PCR. Primer 4 had a5' extension 
containinga'stop'codonand BamHl'site - ãiid -primer 2C (as described in - Chapter -5.2)- has 
a -5" extension containing an -EcoRisite; (Appendix-8.-2:3) 
The-template -for-the 'first-amplification reactions-was- genomie DNA extractedfrom - 
in -vitro cul Wre of HB3 and 3D7 strains; isolated as- described before-(Chapter4.2:2).' 
S3D2 and D3 13 -primer pairs-were used to amplify-from- the 3D7 .(A-type) template 
while S3H2 and H313 were. used to amplify.. from. the HB3 (B-type) template. 20 p1 
PCRs were set up as described in chapter 2.3. The PCR conditions used were 95 °C for 
25 sec, then 42 °C for I mm, then 65 °C for 2 min for 30 cycles. Four microlitres of the 
PCR were run out on 1-5 % agarose/05 x TBE. Expected product sizes of c.200 bp for 
S3H2 (PCR product I in fig.4) and c. 300 bp for 1-1313 (PCR product 2 in fig.4) were 
seen. The PCR product was then purified and eluted from HPPPK in 15 tl of daH20. 
For the production of the 3D7 antigen, it was necessary to increase the MgC12 
concentration to 3 mM in all PCR reactions. 
The second PCR ( 50 p1) was set up with 2C and D4 (H4) primers. The template for 
this PCR was 5 p1 of S3D2 (or S3H2) and D313 (or H313), determined by titration. As 
the Tin of the overlap was 36 ° C, the following PCR conditions were used: 95 °C for 1 
mm, then 34 °C for 30 sec, then 50 °C for 90 sec for 2 cycles, then the annealing and 
extension temperatures were increased 2 °C per cycle until annealing temperature was 
46 °C, when a further 15 cycles were carried out. 4 p1 of the PCR was run out on 1-5 % 
agarose/05 x TBE. The expected product size of c. 180 bp for 2CH4 was seen. The PCR 
product was then cleaned up and eluted from HPPPK in 30 .tl of daH20. 
rri 
6.2.6.2 Cloning of diMSP 2-fragment 
The eluted PCR product was-digested with EcoRl and BamHl as described for 
polymorphic PCR fragments (Chapter 5.2.2). The double digested pGEX-2T was 
produced as described in Chapter 5.2.3. The ligation and screening was carried out as 
dribed forpolymorphic antigens (Chapter 6.2.2). 
62.-63 Sequencing diMSP2contaiiziizg vector 
Unlike the clones containing polymorphic regions it was possible to sequence this 
insert directly, from the plasmid. The plasmid DNA was prepared using- the modified 
mini-prep method (Chapter 5.2.7) except that before ethanol precipitation the lysate was 
added to an equal volume Of phenol/chloroform, vortexed and then centrifuged at 
12000 x g for one minute. The top(aqueous)' layer was recovered, and was added to 
another equal volume of phenol/chloroform and vortexedthen centrifuged as described 
above. The top layer was added to 2 .x volume. icecold. 100% ethanol, then,  
as described-above. The supernatant - was- removed, the'pel.let- washedwith one-mi 75 - % 
ethanol then centrifuged as described above The pellet was dried in a. 65 °C heating 
block for 10 mm, and finally resuspended in 50y1:ofdaH20 containing 20-14g. ml-I 
RNase 11 1A (Sigma, prepared as described in Maniatis). Four microlitres- of plasmid 
DNA were used as a scquencing template in 1.0.jl reaction as.. described before. (chapter 
3.5). The primers used were pGEXF and pGEXR (Appendix 8.2.5); used at.l6 pmol per 
reaction. 
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6.2.6.4 Expression of dIMSP 2 fusion proteins 
This .was-carriedout as described. for. polymorphic antigens (Chapter 62.5).. 
6.2.7 Testing ajfljgenicity of the expressed proteins and titrating the antigens to 
obtain theoptimal antigen concentration for ELISAs . ... 
6.2. 7.1 Sera used in titration ELISAs 
Four different sources of sera were used: a pool of sera collected from immune 
individuals in Brefët, The Gãmbià (Brefët) 111; a hyperiinmune iñdividüal from 
Farafenni, The Gambia (1599) [7]; serum from a nonimmune individual European child' 
(S3); and -an exposed but -not infected European adult -(SF). 
6.2.7.2 Enzyme-linkedimmunosorbentassay(ELiSA) 
See chapter 33.1 for the ELISA method. In order to determine the optimum 
concentration of -antigen for use in further experiments, a range of antigen concentrations 
were used from; 0-03125 to - 1 jsgml- 1 in -doubling dilutions 
6.3 Results 
6.11 Sequencing 
All cloned fragments were found to have the same sequence as that of the original 
PCR product. 
6.3.2 Expression of recombinant proteins 
The. recombinant proteins representing the polymorphic regions of MSP 2 were 
soluble, i.e. in the cell supernatant, so a standard purification protocol was used. 
Figure 2 
PAGE gel showing the purification of recombinant protein 15-70 
1 	2345 
40 43kDa 
 -•--- -. 30kDa 
Key 
5 jl of 1:1 ratio of sample to loading dye was loaded in each well 
Lane 
1 - Supernatant prior to incubation with glutathione beads 
2 - Supernatant after incubation with glutathione beads 
3 - Low molecular weight markers (Pharmacia) 
4 - First eluate from glutathione beads 
5 - Second eluate from glutathione beads 
Note lanes 4 and 5 show only a single band, therefore a single size product is present 
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Figure 3 
PAGE gel showing 3 purified recombinant proteins 
2345   6 7 
jy 5 l of 1:1 ratio of eluted protein loadingdye was loaded in each well 
Lane 
1 - First eluate of 71-34 
2- Second eluate of 71-34 
3 - Low molecular weight markers (Pharmacia) 
4 - First eluate of 52-42 
5- Second eluate of 52-42 
6 - First eluate of 5-34 
7 - Second eluate of 5-34 
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6.3.3 Production of diMSP 2 recombinant genes 
Products of the expected sizes were obtained and then purified for use as templates in 
the final SUE PCR. 
6.3.3.1 Initial SOE PCR for diB 
Figure 4 
Agarose gel showing the products from the initial PCR for producing diB hybrid gene 










M - 100 bp markers 
1- - ye control 
2 - PCR with 11133 DNA template 
3 - PCR with HB3 DNA template 
4 - - ye control 
5 - PCR with HB3 DNA template 
6- PCR with HB3 DNA template 
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6.3.3.2 Final SOE PCR for diB 
Figure 5 
Agarose gel showing the products from the final PCR for producing diB hybrid gene 
M 1 2 3 M 
500 bp 




M - 100 bp markers 
1 - - ye control 
2 - 10 d of product from 13H3 and S31-12 PCRs as template 
3 - 5 ul of product from 13H3 and S3H2 PCRs as template 
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6.3.4 Titralion of recombinant antigens 
An acceptable- antigen concentration for -coating EUSA plates was found toi be- 1 
gnil- L Example-results 'are-shown 'for-the-two-dimorphic antigens-and one A-type-and.. 
one 'Btype.antigen. Both immune, sera. showed specific recognition of the MS-P.,2 
protein, indicated by a positive OD 492 after subtractionof, the (3D 492 to OST alone. In 
contrast, neither- of the control non-immune sera showed significant recognition of MSP 
2.. 
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6.3.4.1 Titration of diA (2CD4) 
Figure 6 
The titration of diA against four sera (two immune sera; Brefet and 1599: two non-
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6.3.4.2 Titration of diB (2CH4) 
Figure 7 
The titration of diB against four sera (two immune sera; Brefet and 1599: two 
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Figure 8 
The titration of 15-66 (a polymorphic A -type antigen) against four sera (two immune 
sera; Brefet and 1599: two nonimmune sera; S3 and SF). 











1 	 0.5 	0.25 	0.125 	0.0625 	0.03125 
Protein concentration ug/m1 
The titration of 62-22 (a polymorphic B -type antigen) against four sera (two immune 
sera; Brefet and 1599: two nonimmune sera; S3 and SF). 
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6.4 Discussion 
All the polymorphic antigens produced were soluble and were easily purified using 
the standard technique. The antigens were recognised by immune sera but not by sera 
from the naive child and adult. The fact that the proteins were specifically recognised by 
malaria-immune serum suggests that the proteins faithfully represent at least some MSP 
2 epitopes from the native proteili. However, confirm ation of this would require 
production of monospecific antibody reagents (either by immunisation of mice or rabbits 
or by phage display methods) and demonstration that these reagents also recognise 
native MSP 2 antigen, by Western blotting or immunofluoresence on fixed blood stage 
parasites. Unfortunately, due to the lack of time, this could not be done. However work 
is underway in the laboratory to produce such monospecific reagents. 
The truncated proteins (diA and diB) produced for -this study were expressed as GST 
fusion proteins and both dimorphic forms were found to produce soluble protein. This 
was in contast to the findings of Anders et al (unpublished) who found that the truncated 
Btype protein was not soluble. Small differences in the sequence of the protein or the 
addition of the GST fusion partner may explain why the B-type protein produced for this 
study was soluble. It has been noted that the GST fusion partner keeps MSP 2 proteins in 
solution. For example, when proteins expressed in pGEXX, which incorporates a Factor 
X cleavage site between the GST and the protein of interest, are cleaved with factor X to 
remove the GST protein, the MSP 2 protein frequently becomes insoluble (D.R. 
Cavanagh, pers. comm.) 
DiB was found to be recognised by sera from a hyperimmune individual (1599) albeit 
with an OD 498 approximately half that obtained with the other antigens. There are a 
number of possibilities as to why this was observed. The structure of recombinant 
protein may not contain epitopes which occur in the native protein. The lack of epitopes 
may be due to the removal of the central repetitive region which may prevent correct 
folding of the recombinant protein or that some of the epitopes may be produced by the 
addition of lipids or sugars which would be lacking if a protein had been expressed in E. 
coll. The use of another expression system i.e. yeast based system may enable the 
correct lipids or sugars. Another approach would be to produce a construct which only 
represents the 5' diniorphicregion. Production of specific reagents to diB would enable 
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investigation of the antigenic differences between diB and a full length B-type MSP 2 
antigen. 
As described in the Material and Methods, it was found that direct plasmid 
sequencing of diMSP 2 inserts was possible. This strongly supports the idea that the AC 
or BC (polymorphic) fragments could not be sequenced due to secondary structure of the 
DNA of the repetitive region. The results obtained from attempts to sequence cloned 
polymorphic fragments often showed a short section of readable sequence followed by 
unreadable sequence, as if there were multiple plasmids transformed into a single 
bacteria (therefore in a single colony) but retransforming the purified plasmids and 
repeating colony selection but this did not improve the readability of the sequences. 
Other studies have -found -it is possible to sequence cloned MSP 2 fragments which 
include the 5 conserved sequence [113]. It is possible that inclusion of the conserved 
region changes the DNA secondary structure leading to successful sequencing. 
In summary, 23 different MS.P 2polymorphic.regions, and two dimorphic antigens 
were cloned.. and expressed-for- use in serological stud ies. 
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Z 1 Introduction 
The development of the infants' humoral response to the infections described in 
chapters 4 and 5 was investigated using an ELISA method. 
Antibody responses to defined malaria antigens have been correlated with protection 
from clinical illness. This protection has been found to be associated with antibodies to a 
specific MSP 2 dimorphic type [68]; in this study it was found that antibodies to an MSP 
2 A—type dimorphic antigen were positively associated with protection against clinical 
illness. Antibodies to the C-terminus of MSP 1 (MSP 119) have also be found to be 
protective against clinical illness [88]. 
A recent paper reporting a modelling exercise of epidemiological data, has suggested 
that immunity against severe malaria may develop after as few as one or two malaria 
infection [120]. In this paper, it is suggested that the lower levels of clinical illness in 
high tranmission areas are due to the cross over of maternal antibody mediated 
protection and the development of the child's own immune response. 
Previous work [58,62,66] has shown that the dimorphic and polymorphic regions of 
MSP 2 are immunogenic in malaria exposed individuals, but that the conserved regions 
are not. However, the antigens used in these studies did not allow the discrimination of 
humoral response to the dimorphic and polymorphic regions. One reason why responses 
to polymorphic antigens have been difficult to look at in previous studies is that matched 
sera and parasites from the same person were not available. Non-reactivity of a serum 
with a particular polymorphic antigen could be due to a failure to respond to that antigen 
or could be due to the fact that the person has never been infected with a parasite 
carrying that sequence. The particular advantage of this study is that matched parasites 
and plasma are available from the same children, and multiple serum samples are 
available so that the development of the antibodies response can be monitored over time. 
VA 
The antigens used in this study represent the exact MSP 2 polymorphic region to 
which the infants are known to have been exposed (Chapter 4 and 5), and two antigens 
which represent the 2 dimorphic forms of MSP 2 (Chapter 6). This enabled the 
specificity of the novel humoral response to the different regions of MSP 2 to be 
investigated. Using these antigens, the following questions were investigated: 
Do the infants produce an antibody response to all of the different malaria antigens 
with which they are infected or is there selection of certain immunodominant 
antigens? 
Is the humoral response directed against the dimorphic or polymorphic regions of 
MSP 2 or are both regions recognised? 
If there was differential recognition of the regions, is it constant through the study 
period or does it change with time? 
Is there any correlation between the titre of specific antibodies and appearance or 
disappearance of specific parasite types, which might indicate that strain-specific 
immunity is operating at the level of MSP 2? 
Are different polymorphic sequences of MSP 2 recognised as distinct antigens, or is 
there cross-reactivity of antibody recognition of different sequences, which might 
indicate the MSP 2 can be classified into a number of serotypes, with each serotype 
composed of multiple allelic sequences? 
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7.2 Materials and Methods 
7.2.1 Sample Collection 
Plasma samples were collected as described before (Chapter 3.1.2). Briefly, blood 
was taken from the study infants by heel prick or venous puncture and collected in 
heparin treated tubes. The blood was then separated into packed red cells and plasma by 
centrifugation, and stored at -20 °C. in order to avoid repeated thawing and freezing, 
aliquots of plasma were diluted 1:10 in PBS containing 0.02 % NaN3 and these diluted 
samples were stored at 4 °C. 
7.2.2 Control Plasma 
A set of plasmas from non-immune European children was used to determine non-
specific IgG binding to the antigens used. 
7.2.3 Antigens 
7.2.3.1 MSP 2 antigens 
Recombinant MSP 2 antigens were produced, as GST fusion proteins, as described in 
Chapter 6. 
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7.2.3.2 Non MSP 2 antigens 
In order to look more broadly at the child's antibody response to malaria, a range of 
other malaria antigens were also used. Crude antigen was prepared as described in 
Wagner [1021. 
Antigen Description Expression System Provided by 
PfMSP1 Full length 19 kDa E. coil / GST fusion DR A. Holder, NIMR, 
19 fragment of MSP 1 Mill Hill, UK [1181 
protein from 
Wellcome strain of 
P. flilciparum  
AMA-1 Full ectodomain of E. coli hexahis tagged Dr. R. Anders, WEHI, 
3D7 form  Australia [119] 
RESA C-terminal 70% of E. coil hexahis tagged Dr. R. Anders, WEHI, 
Pf155/RESA  Australia [69] 
3D7 Ssp I fragment of E. coil hexahis tagged Dr. R. Anders, WEHI, 
MSP 2 3D7 MSP 2 cDNA Australia [68] 
(near full length 
MSP 2 transcript)  
FC27 Ssp I fragment of E. coii hexahis tagged Dr. R. Anders, WEHI, 
MSP 2 FC27 MSP 2 cDNA Australia [68] 
(near full length 
MSP 2 transcript)  
CS Full length P. E. coil hexahis tagged Sanjai Kumar, US Navy 
falciparum CS gene Medical Research 
Institute 
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7.2.4 Enzyme-linked mimunosorbent assay (ELISA) 
The assays were carried out as described in chapter 3.7.1. MSP 2 antigens were used 
at 1 pg mi1 , the optimum antigen concentration being determined by titration (Chapter 
6.3.4). Each experiment was earned out with a known positive plasma (1599) and a 
known negative plasma (S3) on each plate to minimise interassay variation. Plasmas 
were tested at a final dilution of 1:1000 in 1 x PBS. 
7.2.5 Competition ELISA 
Plasma samples, which showed a high OD value to two or more antigens in the 
longitudinal ELISAs, were selected. These plasma (diluted 1:1000) were preincubated 
with one of the antigens (X) at a range of concentrations from 0 to 0.5 mg m11 overnight 
at 4 T. The incubated serum was then tested for reactivity to the other antigen (Y) by 




The antibody responses of individual infants were tested against antigens representing 
the precise genotypes of the parasite that the infant had been infected with. In addition, 
each plasma sample was tested for antibodies to antigens representing the N—terminal 
and C—terminal dimorphic regions of the two alleles of A'ISP 2 (Chapter 6.2.5). Data on 
antibody responses to non-MSP 2 antigens was available from the main study and is 
presented here in order to put the MSP 2 responses in context. The antigens used were 
MSP 1 9, AMA 1, RESA and CSP. These data were generated by M. Kaviratne 
(University of Edinburgh), S. Mohamud (LSTHM) and M. Ofori (NMIMR). Sera were 
tested in duplicate against both the fusion protein and, where appropriate, a GST protein 
control. Only the MSP 2 and MSP I proteins were linked to GST; all the other antigens 
were produced as hexa-his -linked proteins where no control protein was used. Results 
are expressed as specific OD 4 values: the 013 4 values of the plasma were adjusted for 
GST reactivity by subtracting the OD,,,  values to GST from the OD, for the MSP 2 
GST fusion protein. 
Figure 1 Cut-offs for all MSP 2 antigens 
The cut-off for a positive result was calculated by testing a panel of non-immune sera 
(n=30) against the antigens used. Mean ODs were calculated for each antigen, and the 
cut off was set as the mean OD 4 + 2 SD. 
Antigen Cut off OD4 
mean ± 2 SD 
Antigen Cut off OD4 
mean ± 2 SD 
0.178  0.514 
H 0.134  0.159 
0.5 14  0.050 
0.146  0.066 
0.138  0.166 
0.266  0.323 
0.178  0.171 
0.145  0.533 
0.081  0.176 
0.490 1 	10 1 	0.178 
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A number of antigens showed relativity high reactivity with non immune sera. These 
antigens were re-extracted to ensure there was no contamination. These antigens may 
possess epitopes which cross react with antigens to which non immune individuals may 
have been exposed. There are no obvious primary sequence similarities between the 
antigens showing high reactivity with non immune sera. 
The following information applies to all the graphs shown in this chapter 
diA refers to the A-type dimorphic antigen and diB refers to the B-type dimorphic 
antigen. The numbering of each MSP 2 antigen is specific for each child i.e. Al in child 
15 indicates the first A type allele with which child 15 was infected, while Al in child 
17 indicates the first A type allele with which child 17 was infected. The number in 
brackets indicates which DNA sample was used to produce the antigen. For example, in 
child 15 the antigen Al was the first A type allele detected in child 15 on week 10, the 
sequence found in this sample was identical to one found in child 17 at week 34(17-34) 
and as an antigen representing the sequence found in sample 15-10 had already been 
expressed from sample 17-34, this antigen was used. 
—2 weeks represents the maternal sample taken by venous blood sampling at the time 
the mother was enrolled into the study. 
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Figure 2a Graph showing the antibody profiles of Child 5 to MSP 2 antigens 
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73.1 Child 5 
Three different MSP 2 alleles were sequenced and expressed from this child, from 
infections occurring at 26,34 and 38 weeks. All alleles were from the B-type dimorphic 
type family. The mother's plasma contained antibodies, which recognised all three of 
these MSP2 alleles as well as the dimorphic regions of both MSP2 families (diA and 
diB). Levels of antibody to 'Ri, B2 and diA were noticeably higher than antibodies to 
diB and B3. It would appear that all antibodies were transferred from the mother to the 
child, who becomes sero-negative to all antigens-by -14-weeks-of-age. infection B  was 
first -detected at week 26, but antibodies to this antigen began to increase from wek 1-8, 
-suggesting that the infection -had been present at very low levels for some weeks before 
it- was-detectable-by .PCR. -li fact,..a -B-type parasite was present-at week 14 -but could -not 
be sequenced. The -sudden- drop in antibody- levels- at 30-weeks-may be an artefact (due to 
deterioration of the--plasma sample) or-may be -a -real- event--Antibp4ies to .B2 rose 
between week 18 and week 26 although the B2 parasite was not detected until week 34. 
B2 may have been present but not detected or the antibody response to B2 may have be 
due to cross—reactiOn of - the antibody response to BI - and B2;-which although clearly 
different sequences do have regions of homology. No competition analysis was carried 
with these two antigens because the plasma sgive only low 013 4 readings. It was not 
possible to-use more- concentrated--plasma-due to-the-small volume of-sample-available. 
Infection 133, which was detected at week 38, was not accompanied by a detectable 
antibody. response, at week 38.No sampksWere avãiláble' beyond 38 weeks. 
Interestingly, despitebeing infected- with .3 -different - parasites i all :Carryin-g BLtypeMSP -2 
alleles, this child made no antibody response to diB representing the dimorphic regions 
of the protein. A weak transient response was made to -diA although no A type parasites 
were detected. 
Antibodies to crude antigen were present in the maternal sample and the initial 
child's sample. The levels in the child then, gradually declined until week 38 when there 
was an increase in antibody response. There was no response to the other antigens 
(Figure 2b) 
-Overall, despite being infected with three MSP - 2 B-type parasites this child made 
only a transient response - to MSP 2 and no response to the other 'P.falciparum antigens. 
The child reththned asympton aticovet the study period. 
VA 
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Figure 3b Graph showing the antibody profiles of Child 15 to other antigens 















7.3.2 Child 15 
This child received extremely high levels of antibodies to diA from her mother, 
which did not decay completely until the child was 26 weeks of age. In contrast, the 
mother - and hence the child - was seronegative for antibodies to diB. Interestingly, 
despite being infected by a B-type parasite and making a strong response to the B type 
polymorphic antigen, the child also remained seronegative for diB. 
The mother's plasma recognised all the polymorphic antigens tested; but antibody 
levels-were relatively low and-the child-became serongativetoall 
week 14. The-child became PCRpdsitivcfOr iñfectiön Al atwëëkl0 âñdthisparásitë 
appeared topersist at vëtlOwleiiels until at least week 34 1  but thervãs no antibody 
response to this infection. However,, infection with Bi. at week 34 led to an immediate 
and very strongB 1-specific respofise (but thedimorphic regions of this allele were not 
recognised),. 
At the-time-of the BI infe .ction. thç child was. cQflcupentJy infected with Al adA2 
but neither of these A-type infections induced antibodies. It was not until the B 1-specific 
antibodies had significantly declined, by week 66, that antibodies to A-type parasites 
became detectable. At this time antibodies were detected to the dimorphic A antigen and 
to polymorphic antigens Al, A3 and A5 but not to A2'or A4; This suggests that the 
antibodies to Al, A3andA5 may be cross-reactive but that they do not cross react with 
AZ or A4. A moderate antibody -response toA2' was observed at 78 weeks many months 
after the original -A2 parasite was- detected. 
The're' was a respoñe'to MSP 1 9 On. Week 22 although' no infection - was detected. At 
W 66 38 there- as a Eapid rise in antibodies to cru'dahtigeii. Which declined -slowly over 
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Figure 4b Graph showing antibody profile of Child 17 to other antigens 
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733 Child 17 
This child presents a relatively straightforward picture. The mother possessed high 
levels of antibody to the diA antigen and also to one of the two A-type polymorphic 
sequences tested (A2). These antibodies were transferred to the child, who became 
seronegative by week 18. At exactly this time, the A2 infection became detectable by 
PCR. The child made a response to both diA and A2 but remained subclinically infected 
with A2 until at least 46 weeks of age. 
An-infection (At) detectediicthe niãtèrñãi säñIie was nót ogiiiéd b tli 
mother's plasma-and did- not induce antibodies-in -the child. A- B-type infection -presentin 
the child at ,.2 weeks. of age could not- be- sequencedbut did. not induce any, detectable 
responsetothe diB antigen. 
This child also generated antibody response to most of the other antigens from week 
18 onward, although no response was made to AMA-1. 
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Figure 5a Graph showing antibody profiles of Child 29 to MSP 2 antigens 
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7;3.4 Child 29 
This child was persistently infected by two A-type parasites from week 18 to 58. The 
mother's plasma contained antibodies to diA and to both the A-type polymorphic 
sequences but not to diB. Maternally delived antibodies to A-type alleles were lost by 
the age of 18 weeks. 
Again, as in child 17, an A-type infection became detectable by PCR at exactly the 
time at which the antibodies disappeared, possibly suggesting that maternal antibodies 
had sUppfessed the iiIfectiOñ up to that point. Immediately upon infection antibody 
responses to both Al and A2 were made and persisted until at least week 58. 
Despite being-chronically and asymptomaticallyinfected With A-tyje parásites the 
child did. not, make a- detectable, antibody response.to dimorphic .A sequences until 58 
weeks.. 
There were low-responses to the other antigens from week 18 onward. On -week 46 




Figure 6a Graph showing antibody profiles of Child 47 to MSP 2 antigens 
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7.3.5 Child 47 
The mother's plasma contained very high titre antibodies to diA, to a number of 
different polymorphic A-type sequences and at least one B-type polymorphic sequence. 
The mother was seronegative to the dimorphic B sequence. The child lost antibodies to 
MSP 2 antigens, which were transferred from the mother by week 14. Antibodies to the 
MSP 2 of parasite B I - which could not be sequenced until week 30, although a B-type 
allele was detected by PCR on week 26 - began to increase from week 18, suggesting 
that the parasite was present for some weeks before it became detectable by PCR. The 
child was infected with parasite Al at week 26 and immediately made a strong and 
persistent antibody response to Al. Antibodies to A4 were detected from week 46 but 
the parasite was not detected by PCR until week 50. Parasite A6 was not detected until 
week 70, but antibodies to A6 increased from week 46, peaked at week 50 and had 
declined to negligible levels by week 70. This may, again, indicate that the presence of 
antibodies suppresses parasitaemia below the level of PCR detection but once antibodies 
levels fall below a critical concentration, parasitaemia may incease. No detectable 
antibody response was made to the AS antigen following infection with AS at week 66. 
Antigens A2 and A3 were not expressed as recombinant proteins. 
Despite being infected with both A-type and B-type parasites, and making strong 
responses to polymorphic sequences, this child did not make antibodies to either of the 
dimorphic sequences (although a slight response to diA was seen at 70 weeks and 
increased thereafter). 
On week 26 there was a large short lived response to MSP1 . The responses to the 
other antigens fluctuated about the detection limit. The child remained essentialy 
seronegative to these antigens. 
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Serum from week 50 showed some cross-reaction between A6 and A4, possibly due to a 
number of common motifs, GX.G or AXA. 
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A4(47-50) blocked with 
29-18 
29-22 EESKPPT GAS GSA 	GSGS 
47-50 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
29-22 GAVASA GNG 
47-50 GAGGSGSA GAGGSGSA GAGA SGSGSAGAS GSGSAGAGA 
29-22 	 ANPSADAKRSPST PAT PAT PAT PAT TTT TTT T N 
47-50 GAGASGSA GSG ADAKRSPST PAT 	 TTT TTT TTT T N 
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Figure 7a Graph showing antibody profiles of Child 52 to MSP 2 antigens 
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7.3.6 Child 52 
The mother's plasma contained antibodies which recognised two polymorphic A-type 
proteins,, but neither of the dimorphic proteins of MSP 2 were recognised. The child 
became sero—negative by week 10- 14. A transient infection with Al at week 10 did not 
induce any detectable antibody response 'but an infection with parasite A2 led to a high titre 
response to A2 and to the dimorphic antigen diA. Interestingly high titre antibodies to Al 
appeared at exactly the same time as antibodies against A2. One possible explanation for 
this finding is the antibodies to Al and A2 are -cross-reactive. 
Antibodies to3D7 MSP2 andMSP1 19 rose during the detectedinfectionsatweek 10 
and- weeks-34-and 38 There.was, an inçreasern the,titre of antibodies to thesetwo antigens 
andtoA.MAi on-week 58, which continued until week 70, but no infection, was detected 
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- Al (52-10) blocked with A 1(52-10) 
A 1(52-10) blocked with A2(5238) 
A2(52-38) blocked with A2(52-38) 
—9*—A2(52-38) blocked with A 1(52-10) 
Serum 52-34 showed cross reaction between the two antigens that were found in this 
child 
52-10 AESNLPT GAGARS GDGARS GDGARS GDGARS GDGAVA 
52-38 AVSNPST GAGGSGSA GAGGSGSA GAGGSGSA GAGGSGSA 
52-10 	 SA GSG 	 ADAEGSSST 
52-38 GAGGSGSA GSG DGAVASARNGANPGADAEGSSST 
52-10 PAT PAT TTT TTT TTT TTT T N 
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Figure 8a Graph showing antibody profiles of Child 62 to MSP 2 antigens 
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Figure 8b Graph showing antibody profiles of Child 62 to other antigens 
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7.3.7 Child 62 
There are a number of interesting features about the antibody responses of this child. 
The child became infected with parasite BI at week 14, when maternal antibodies to BI 
had declined considerably. Infections with A3 and A4 coincided with the loss of 
maternal antibodies to the dimorphic A antigen. Antibodies to A4 rose rapidly from 
week 14, although infection with A4 was not detectable by PCR until week 22. 
Antibodies to A3 showed a quite different profile to A4 suggesting that these two 
proteins are not immunologically cross-reactive. However, the antibody profiles suggest 
that antibodies to A3 may be cross—reactive with Al, A6 and A7, as the levels of 
antibodies to these antigens, all increased at the same time, even though only parasites 
with the A3 allele were detectable by PCR. 
Following infection with 4 different MSP 2 alleles between weeks 2 and 24, 
antibodies to polymorphic regions declined to very low levels by week 42. At this time, 
the child again became infected with A-type parasites. This suggests that the antibody 
response may have suppressed parasitaemia to very low levels, but was not able to 
eradicate the infection. At week 42, parasite A4 was still present and antibodies to A4 
were boosted only transiently and then continued to decline. Although no other parasite 
genotypes were detected at this time, the antibody response to Bi, A3 and Al were 
boosted, suggesting that parasites B  and either A3 or A4 were still present. In fact, A3 
was detected again at week 62. At week 46, parasite A6 was detected and at the same 
time the antibody response to A6 and A7 were boosted - again, these responses appear to 
be cross-reactive. Antigens A6 and A7 differ only in the number of repeats present, so 
the cross reaction would be expected. A7 itself was not detected by PCR until week 62. 
From the first peak of antibodies to Al. A3, A6 and A7, it appears that all four 
sequences may be cross reactive but the second peak at week 46 resolves these four 
sequences into two pairs of cross—reactive sequences, A1/A3 and A6/A7. 
Finally, although the polymorphic antigens are well recognised, the diA antigen is not 
recognised until very late (week 42) and the diB antigen is not recognised at all. 
The responses to the other antigens rise and fall with the presence and absence of 
parasites (Figure 8b). The greatest response was seen against MSPI and 3D7 MSP 2 
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with an early peak at week 14 against RESA and a later peak at week 62 against AMA-
1. 
The cross reactivity of A 1/A3 had already been investigated using plasma from week 
18. This antigen pair were able to fully compete out response to each other. 
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7.3.8 Child 120 
The mother's plasma contained antibodies to the diA antigen and to polymorphic A-
type and B—type antigens but not to the diB antigen. The child was seronegative to MSP 
2 by week 10 and at exactly this time a mixed (A/B) infection became detectable by 
PCR. This mixed infection was accompanied by an immediate, high litre response to the 
dimorphic A antigen but there was no response to the dimorphic B antigen. Responses to 
the polymorphic sequences were delayed and of lower titre. The polymorphic responses 
were transient and disappeared by week 28. Interestingly, as the response to diA waned 
at week 38, the response to the polymorphic A 1 rose again, suggesting that the A 1 
parasite was still present, although it was not detectable by PCR. 
7-185 
7.4 Discussion 
The responses in native European plasmas (which were used to determine the cut-offs 
for a positive response in the Ghanian children) were generally low, suggesting that, 
antibody responses seen in the Ghanian children were directed specifically against 
malarial antigens rather than against contaminating antigen, although there were some 
exceptions. Some antigens gave cutt-off OD's which were much higher than others. The 
antigens which gave a high cut—off were re-analysed using SDS-PAGE to ensure there 
was no contamination with bacterial protein (data not shown) and there was no 
indication of bacterial contamination of these antigens. There was no obvious sequence 
similarity between these antigens which would explain the higher level of cross-
reactivity seen for non-immune sera. 
The initial finding is that in the cohort as a whole, the children were capable of 
producing a humoral response to at least one or more of the antigens which represent the 
infecting parasite. Whether that response is directed against the dimorphic or 
polymorphic region varies with each individual. In child 120, the predominant response 
was seen to the dimorphic A-type antigen. In children 17 and 52 there was a humoral 
response to dimorphic A-type antigen as well as to the polymorphic antigen. In the other 
children (15, 29, 47, 62), responses were directed against the polymorphic antigens 
rather than against the dimorphic antigen. Within this group, children 29 and 62 showed 
a response to dimorphic A-type antigen alter 54 weeks as well as responses to 
polymorphic antigens, but the responses to the dimorphic antigens were short lived. In 
summary the polymorphic regions of MSP 2 appear to be more immunogenic in very 
young children than dimorphic epitopes with responses to dimorphic proteins 
developing later infancy. In the first year of life the antibody responses against the 
dimorphic antigens seem shorter lived than those against polymorphic antigens. Analysis 
of samples taken tip to 2 years of age would shed light on whether this pattern is 
continued in later life. 
Over the whole cohort there seems to be more detection of antibodies against diA 
than against diB but as discussed previously (chapter 6) the recognition of diB was at a 
lower titre than diA with control sera. The differentiation recognition of the two MSP 2 
dimorphic regions by control sera confounds the interpretation of the ELISA results. 
Also, as well as the recognition of diB, the frequency of B—type alleles in the cohort was 
much lower than the frequency of A-type alleles so the lack of response may also be due 
to the reduced level of exposure. 
In two individuals (children 29 and 62) there are example of high titres to diA protein 
but these occur after week 54 and following the production of antibodies to polymorphic 
antigens in the first year. These two individuals seemed to recognise both the diA 
protein and the polymorphic antigen, rather than a switch from one to the other. A 
follow-up study would be able to investigate whether these children were in the process 
of switching their immune response from a polymorphic to dimorphic response or 
whether they would continue to recognise both antigens. When dimorphic antigens were 
recognised the antibody response was short lived i.e. only seen in one or two samples. 
Child 17 is an exception to this rule; the diA protein response persisted for the same 
length of time (28 weeks) as the response to A2. PCR detectable parasites were found 
during this period suggesting that the antibodies response may have been boasted by 
persistent antigen. 
In a number of children, a specific parasite type is detected when the titre of the 
corresponding antibodies disappears e.g. children 17, 29 and 120. Antibodies to MSP 119 
in child 29 declined to zero in a sample which was PCR positive. This suggests that 
antibodies to MSP 1, 9 may be involved in protection. In child 17, antibodies to A2 
declined to zero at week 18 and the child became infected with parasites carrying A2 at 
exactly the same time. However antibodies to Al also declined to zero at the same time, 
with no concurrent detectable infection with Al type parasites. 
In child 29, antibodies to Al and A2 declined to zero at week 18. The child was 
infected with parasites carrying Al at week 18 followed by A2 type parasite at week 22. 
The reasons for the delay in detection of A2 type parasites has been discussed previously 
(chapter 5). 
In some children, there was a response to only one parasite type despite there being a 
number of types detectable, e.g. in child 15, despite 6 different parasite types being 
detected between weeks 34 to 50, the only detected humoral response was to the B-type 
parasite detected on week 34 and 38 and there was no response detected to any of the A-
type parasites. After this period the child did produce a specific humoral response to the 
subsequent A-type parasites which were detected on week 66 and 70. This raises the 
question as to whether A-type specific 1gM antibodies may have been produced at the 
time of A-type infection but that the switch to IgG production may have been delayed. 
The humoral responses were predominantly directed against the polymorphic regions 
in most individuals, with the exception of child 120. In this child the predominant 
response was to diA. This individual is a dizygotic twin and the other twin is not in the 
cohort described in this work (i.e. was not repeatedly infected). This suggests that 
infection and antibody production have elements of stochastism. There are examples 
where antibody titres remained high after the specific parasite type was no longer 
detected, e.g. in child 47, titres to Al remained high for 28 weeks after parasites carrying 
Al was last detected. This could be explained by either the persistence of the parasite 
which was not detected by PCR or sequencing or that the child maintained the antibody 
titre due to antigen depots. Antibody titres to A4 in child 47 were also seen to increase in 
the sample prior to the detection of that specific parasite type. This suggests that child 
was infected with A4 type parasite at a level below that which could be detected by 
PCR, but that this was sufficient to lead to the initiation of an immune response. In child 
52, there was an increase in antibody titres to A2 at week 34 while A2 type parasites 
were not detected until week 38. The analysis of the antibodies present suggests that 
some parasite infections stimulated an antibody response before the infection could be 
detected by PCR. 
Loss of antibodies seemed to be associated with infection with a specific parasite type 
but the development of specific antibodies was not associated with the clearance of the 
specific parasite type. Antibodies to blood stage antigens in general and MSP 2 in 
particular seem to be able supress but not eliminate parasitaemia. This suggests that 
parasite killing may be operating by some form of density-dependent mechanism. One 
potential mechanism for this is antibody dependent cell mediated cytotoxity [129]. Other 
work from our group (E. Riley et al submitted for publication) has found that additional 
factors, which may be involved in the protection of infant i.e. the decline of foetal 
haemoglobin, also decline at a similar rate to maternal antibodies. Therefore it is 
difficult to separate the role of these two factors in control of early infections in life. 
The competition ELISAs showed that some of the different MSP 2 antigens were not 
recognised as different by sera from exposed individuals, antigens 29-18 and 29-22 form 
a serogroup, and antigens 15-66 and 52-10 form another. The lack of sera limited this 
analysis but work is continuing in our lab to produce specific reagents (by phage 
display) which would allow further investigation of the role of MSP 2 serogroups. 
The role of 1gM in this cohort was not investigated, so where there were no IgG 
responses detected in response to an infection, there may have been an 1gM response e.g. 
child 52 week 10. A study which investigated 1gM responses in children found that the 
1gM seropositivity rate was higher than that for IgG but the OD values were lower [12]. 
This study did not look at children under 3 years old. Future work with these plasma will 
include analyis of 1gM antibodies. nevertheless, switching of antibody production to IgG 
subclass clearly happens very rapidly as lgG antibodies were frequently detected some 
weeks beforewe could detect parasite against which they were directed. 
In summary, the children in this study produced specific antibody responses when 
infected with malaria parasites. The antibody response to dimorphic regions did not 
cross-react with the antibody responses to polymorphic antigens. 
There were examples seen in this cohort where the decline in a specific MSP 2 
antibody titre was associated with infection with a parasite which carried the same MSP 
2 polymorphic antigen. This suggests that there may be strain-specific immunity 
operating at the level of MSP 2, but futher work is required to confirm this. 
The results presented here show that the responses to specific antigens vary between 
individuals and individuals can produce different responses to the same antigen at 
different time points depending on the presence of other antigens and the time of 
infection. The number of individuals investigated here are not sufficient to enable 
generalisations to be made regarding antibody responses to specific antigens but do 
show that there is variation within a population in their response to specific antigens. 
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8 Discussion 
The work described here was carried out to shed light on the dynamics of malaria 
infection, within the first year of life, of individuals living in areas of endemic malaria 
transmission. The effect of early infection on subsequent humoral immune responses was 
also examined. The work presented in chapters 4 and 5 showed that infants became infected 
with parasites which carried different alleles of msp 1 and msp 2. Some infants were found 
to have persistent infections (defined as infections with the same allele of msp 1 and/or msp 
2 for up to 10 months), while others were infected with genetically distinct parasites in each 
subsequent positive sample. 
A general pattern of infection becomes clear. The first infection in these children 
occurred within the first six months of life (in 9/13 infants), and the infants generally 
continued to be infected. There is one exception to this general pattern. In child 120, all the 
infections were seen to occur before six months of age and then there were no further 
infections after this age. 
Children with very long-term infections were likely to be infected with msp-2 sequences 
that were also found in other children (data not shown), suggesting that they are a reservoir 
for infection in the community. The PCR method used here does not differentiate between 
asexual stages of the parasite and gametocytes; it is quite possible that the intermittent 
detection of P. falciparum in these samples is due to the presence of circulating mature 
gametocytes rather than asexual stages. However, as the maximum life span of an 
individual gametocyte in the periphery is believed to be only 2 days, [131] long-term 
parasite carriage is likely to require persistence of replicating asexual parasites as well as 
gametocytes. 
In this cohort, many of the children were clearly super-infected with novel parasite 
genotypes without developing clinical symptoms, indicating that although novel infections 
may lead to clinical disease [29] , they frequently do not [135]. These data throw doubt on 
the notion that acquisition of clinical immunity to malaria is simply a matter of building up 
a repertoire of responses to variant antigens. Even very young children can cope quite well 
with the majority of parasite infections they acquire —in this age group clinical disease 
appears to be a relatively uncommon consequence of malaria infection. This raises the very 
important question - what causes some infections to become symptomatic when so many 
infections appear to be rather innocuous? Is it a function of immunity or of the child's age 
or some other variable? Is it primarily determined by the parasite or the host? 
When the individuals in this cohort became infected early in life (before 5 months of 
age), the infections which occurred generally did not develop into chronic infections. There 
are a number of potential immunological and physiological explanations for this including 
the presence of foetal haemoglobin, immaturity of infant red cells, and lack of essential 
parasite growth factors in the blood [130]. By contrast, children older than 5 months tend 
to develop persistent infections which are asymptomatic and have low parasitaemia, if 
detectable at all, by blood films. Presumably these children possess effective immune 
mechanisms for limiting (but not eliminating) parasite growth. One mechanism by which 
such density-dependent control of malaria infections may be controlled is by antibody-
dependent cell-mediated cytotoxicity [129] which appears to be mediated by antigens 
expressed on the merozoite surface. 
Child 120 was one of a dizygotic twin pair; the other twin was not in the study group 
because he was not multiply infected. It is possible, though unlikely, that the twins had 
different sleeping places and may therefore have had different levels of exposure. Because 
the twins were non-identical it is also possible that the other child had a higher level of 
genetic resistance. There was no clustering of infected individuals in the cohort in the study 
village and no evidence of any specific area having a higher transmission pressure than any 
other. 
The use of both PCR-based typing and sequence-based typing of infecting parasites 
identifed a larger number of parasite types than if a single technique had been used. The 
process of cloning fragments prior to sequencing added a further amplification step. This 
additional step enabled additional parasite types to be identified which were not detected by 
PCR alone e.g. child 62 week 62: PCR only detected one parasite type, while sequencing 
from the same sample detected three different rnsp 2 alleles. As well as the amplification 
step, sequencing also enables a more precise measurement of the size of the fragments to be 
obtained. In child 62 weeks 14 to 22, by PCR there appeared to be a single parasite type 
present. However, when the msp 2 alleles from these samples were sequenced, 3 different 
sequences were obtained from 3 samples. The variation between these alleles was only in 
the number of PAT repeats. 
The rest of the sequences from these alleles were very similar, suggesting that these 
alleles may be very closely related. It is possible that these alleles could have been created 
by changes in the number of repeats during a blood stage infection. The DNA sequence 
underlying the PAT repeats could be susceptible to replication slippage during mitotic 
replication, leading to deletion or insertion of repeat units. Alleles generated in this way 
would need to have an advantage in the host or they would not reach detectable levels. If 
replication slippage is responsible for this pattern of alleles, this suggests that the number of 
repeat units may affect parasite success, perhaps through differential immune recognition 
[114]. An alternative mechanism for the generation of these alleles could be uneven 
crossing over events at meiosis. Meiosis occurs in the mosquito vector stages preceding 
infection of the human. It is possible that the sporozoites inoculated into child 62 were the 
meiotic products from a single clone mosquito infection where uneven crossing over has 
generated new alleles. 
In addition, certain alleles seem to be found together in different children, suggesting 
that the parasite population may be transmitted as serogroups rather than as single variants. 
Similar alleles (by sequencing) were found in a single child e.g. child 29 all samples, child 
47 week 30, child 62 weeks 42 to 62. In addition to sequence similarity, when proteins 
representing these alleles were expressed and used in competition ELISAs, it was found 
that antibodies to the proteins cross-reacted. 
By designing recombinant antigens, which represent the dimorphic and polymorphic 
regions in separate proteins, it has been possible to discriminate the immunogenicity of 
these two regions. In previous studies [66-69], the antigens used either represented the 
whole MSP 2 protein or the dimorphic and polymorphic regions together in a single 
protein. The data presented in chapter 7 showed that, generally, the polymorphic regions 
were recognised more frequently than the dimorphic regions in the first year of life. The 
exception, child 120, was discussed earlier in this chapter. In the rest of the cohort, IgG 
recognising a dimorphic antigen was, generally, not detected until after one year of life. 
The delay in detection of a dimorphic immune response may explain the susceptibility to 
infection between 5 and 12 months. During this time the child has lost protection derived 
from the mother and has not yet developed their own protection. The protection of the child 
from infection for the first 5 months may be due to constituents of the innate immune 
system which are present in children after birth, or there may be soluble factors other than 
antibodies which were transferred to the child while in utero. This switch in recognition 
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may be due the maturation of child's immune system or the development of a specific 
immune response though repeated infection leading to the development of T cell helper 
responses. If this delay is due to immaturity of the immune system then a vaccine would 
not be effective. If, however, it was due to repeated infection then a vaccine may provide 
stimulation to the immune system, and so reduce the number of infections required to 
generate a protective immune response. These possibilities could be investigated by 
studying a naive adult population, which then becomes exposed to endemic malaria, and 
monitoring the changes that occur in that population's immune response. 
The mechanism by which people become immune to malaria is not clear. It has been 
proposed that antigenic diversity leads to variant-specific immunity, and that clinical 
immunity to malaria is dependent on the acquisition of immune responses which recognise 
the different variants in the parasite population, after exposure to all antigenic variants in 
the parasite population [132]. Another possibility is that clinical immunity is the result of 
the development of specific immune responses which can recognise a number of variant 
antigens (serogroups), i.e. not all differences between alleles lead to a difference in 
recognition of the protein by the immune response. This would have important 
implications, as it would mean that not all variants would have to be seen, and only 
antigens representing each serogroup would have to be included in a vaccine. As well as 
immune responses to protein constituents of P. falciparum, it has been shown that 
antibodies that bind the lipid, phosphatidylinositol, are able to prevent the release of TNF 
from macrophages incubated with schizont lysates [127]. This mechanism would operate as 
anti-disease immunity because raised levels of TNF have been found to be associated with 
fevers in malaria patients [133] and control of TNF levels by Mabs reduced fever [134]. In 
sera from malaria patients such antibodies have been found to be of the 1gM isotype [128]. 
The production of TNF is thought to have evolved to control bacterial infections, but in 
malaria infections the levels of triggering toxins can be much larger leading to uncontrolled 
TNF release; a mechanism that neutralizes the effect of malaria toxins would be needed to 
survive clinical malaria. The work presented in this thesis did not address the role of 1gM in 
the cohort due to the small volume of plasma available. In any future studies the role of 
1gM in the infants' protection to malarial disease and infection should be investigated. 1gM 
is the first subclass of antibody to be produced in response to exposure to a novel antigen 
but, in most cases, this is followed by an IgG response. Where IgG antibodies to a 
particular antigen are present, there is only limited benefit in also looking for 1gM. 
E:I!] 
However, when IgG antibodies are not present, the 1gM response should be looked at. 
Persistent production of 1gM in the absence of IgG may reflect a lack of T-cell help for 
class switching to occur. 
As well as having an unusual infection pattern, Child 120 also has unusual antibody 
responses, such as an early antibody response against diA antigen. The normal observation 
is that a response to diA antigen, which represents the dimorphic region of A-type MSP 2, 
occurs alter 54 weeks from birth. In child 120 the diA response occurs in the first 30 weeks 
of life. A high diA response and very low response to the polymorphic antigens is unusual 
in the cohort described here. This finding suggests that diA responses may be protective 
against infection. Two previous studies have also found that response to the A-type MSP 2 
is negatively associated with clinical illness in The Gambia [58] and Papua New Guinea 
[122]. One explanation for the slow development of immunity in some children may 
therefore be that their initial antibody reponse is directed against less protective epitopes. 
In three children (15,47 and 62) where both A-type and B-type MSP 2 types are present 
in the same samples, the associated antibody response could be to either antigen type. In 
child 62 the dominant antibody response was against the A-type polymorphic antigens, 
while in the other two children, 15 and 47, the dominant antibody response was against the 
B-type polymorphic antigens. There was a difference in the way that these two groups 
experienced their infections: child 62 experienced an A-type infection at 2 weeks before 
infection with a mixed A-B infection; whereas child 15 and child 47 experienced both A-
type and B-type infections at the same time. This might suggest that child 62 became fixed 
to make a response to A-type sequences due to her early exposure to A-type polymorphic 
antigens. A study carried in The Gambia found that individuals consistently either 
responded or did not responded to specific antigens when tested over a number of seasons 
[62]. The authors suggested that this might be due to clonal imprinting. A similar situation 
may be occurring in child 62 leading to only A-type antigens being recognised despite the 
child subsequently being infected with parasites carrying both A-type and B-type MSP 2 
antigens. One explanation for this clonal imprinting may be that T cell help for antibody 
production by B cells may be provided by a T cell that recognises a consvered or cross-
reactive epitope present in both A-type and B-type parasites. Conserved T cell epitopes 
have been described in MSP 2 [136]. 
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There loss of specific antibodies seems to be associated with the detection of parasites 
which carry those specific antigens. This is seen in a number of children e.g. child 17, 29 
and 120. These specific antibodies were transferred from the mother when the child was in 
utero. There is a natural decline in these antibodies following the birth of the child, which 
may be accelerated by the presence of the antigen to which the antibodies bind. The 
mechanism by which this occurs may be antibody-dependent-cell-mediated inhibition 
(ADC). ADCI is induced when monocytes and merozoites are cross-linked by cytophilic 
antibodies. ADCI appears to be mediated by soluble factors released from activated 
monocytes [129] and these soluble factors are thought to act to inhibit intra-erythrocytic 
development of parasites. A result of this proposed mechanism is that the antibodies would 
not remove all parasites but allow a low level of parasitaemia to remain. This situation is 
seen in immune adults with parasites being detected by PCR but not by blood film [95]. For 
this mechanism to be operating the isotype of the antibodies must be IgGi or IgG3 because 
these are the only isotypes whose Fc region contain domains which can bind to monocyte 
surface.The IgG response is mainly IgG3 [66,67], and this has now been confirmed in sera 
from this study [K. Tetteh, personal communication]. Another merozoite antigen, MSP 3, 
has been found to be the target of antibodies which are involved in ADd!. 
A technique which enables critical amino acids required for antibody binding to be 
identified suggests that a small number specific amino acids are required in an oligopeptide 
for binding of a specific antibody. These critical amino acid sequences have been called 
mimotopes. Mimotopes are peptides that mimic the 3D structure of the epitope but do not 
necessarily contain the same amino acid sequence. They may share critical amino acids but 
this is not always the case. The identification of mimotopes for MSP 2 polymorphic regions 
would reduce the number of peptides required to represent epitopes in different variants of 
MSP 2. Such mimotopes would be good candidates for inclusion in a vaccine as it would 
only be necessary to develop a vaccine which contains these minotopes rather than all 
variants found in the population. 
The data from this work may provide evidence in support of the strain theory of malaria 
transmission [123, 1241. This theory suggests that rather than each variant in the population 
being transmitted individually they are transmitted as a smaller number of groups or 
"strains". It has been suggested that the immune system may act to "structure" the 
population in this way. Parasites which are immunologically similar to one another are able 
to survive in hosts which do not make a response to that variant. These parasites will 
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therefore contain closely related (but not identical) antigens, although they differ from one 
another at other loci. Strain theory has important implications for vaccine-based methods of 
malaria control because the effective basic rate of reproduction of infection (Ro) is reduced. 
This in turn would reduce the necessary immunization rate to control or eliminate the 
parasite from the human population from 99% which would be necessary if all variants 
were transmitted independently, to about 80% [123]. 
The data collected in this study may support this theory; the sequencing of longitudinal 
samples from infected children showed that similar antigen sequences were found to co-
exist in an individual child. The investigation of the reactivity of that child's sera against 
the antigens found together in a child showed that these similar antigen sequences were also 
immunologically cross-reactive i.e. immune sera could not discriminate between the 
different sequences. 
In summary the work presented here has shown that there is a large degree of variation 
in infection patterns even within a small cohort. It is not clear why children vary in their 
infection patterns - exposure levels are not believed to be sufficiently different to explain 
these differences. It is striking that very young children (<5 months) have repeated 
asymptomatic infections; the infecting parasites are not always the same genotype as the 
early parasites, and so the severity of infection does not seem to be correlated either with 
parasite type or complexity. The only factor shown here to be different between younger 
and older children is their recognition of different parts of the MSP 2 molecule. However, 
given the small size of this cohort, it is not clear if this is a chance finding, or if it does 
represent a causal relationship between infection and disease maturation. This study now 
needs to be expanded to investigate the frequencies of the different patterns of infection and 
antibody responses seen in this cohort and any associated pathology. Further work is 
ongoing; this includes ELISAs with polymorphic antigens against sera from children as 
they get older. The data also suggest that MSP 2 variant specific antibodies may be 
involved in the control of malaria parasites. If further work supports this, then MSP 2 
would be an important component of a malaria vaccine especially if the key cross-reactive 
epitopes between the variants could be identified. 
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tO.i. Reagents 
10 1.1- TFiSEDTA Butler (p1174) 
10mM TrisCi (pH.-74) 
1 mM EDTA -(pH'&0) 
10d.2. Sx-TrsBorateEDTABuffer 
54 gTiis base 
275 g boric acid 
20'ml05MEDTA(pH80) 
• Diluted 1:10 for working dilution 
1-0;1.3 DNA loading Buffer 
025% Bromophenoi Blue 
25%:Ficoll 
10 mMTfis HCI 
1. mM EDTA (pH 80). 
1&14LuriaBtahiMdhnn 
Bactotryptone(Difco) 	 10 g. 
Yeast extract (BetaLab) 5 g 
NaCl: lOg 
Adjust H to 77.2 with .1 OM. NaOH 
Makeup toone litre 
10.1.5 Luria-BrtaniAgar 
as above 
Agar No 3 (Oxoid 	 15.g 
Make up to one litre 
10. L6 S ,ti,ns. used for prQduh1g Qmp.etei1tEschenchla coli 
10.1.6.1 Transforming.Buffer 1 (TFB 1) 
30 mM CH.COOK 
10 mM CaCl2 
100 mM KC1. 
50 mM MnCI1 
IS % glycerol 
lOJ.6.2 Transforming Buffer2 (TFB 2) 
75 mlvi CaCl2 
10 mM KC1 
10 mM NaMOPS (pH 70) 
15 % glycerol 
10-210 
10. 1.7 Solution for alkaline lyis miniprep method of DNA extraction 
10.1.7.1- Solution 1' 
50mM glucose. 
25 mM Tris Cl(pH:&0) 
010 thMEDTA (pH 80 
(Autoclaved before use).. 
103.7.2'Sóluti6n 2 
0-.2 .M NaOH 
1%SDS 
10.L 73.. Solution3. 
5. M Potassium : acetate, 





10.1.8 PAGE gel.reagents 




0.2 % bromophenol blue 
20 % glycerol 
101.8.2 Five •x Tris glycine Bufjer(PAGE gel r.unningbuffer) 
151 g Trig base 
94 g glycine(clçç.(ophpresi grade). (p1-I. 8,3). 
50 ml 10 % SDS (electophoresis grade) 
10.1 .8.3 10 % resolving-gel solution (10 ,nl -volume) 
120 • 	4.8.mJ 
40% acrylamide (Sigmapremix.). 	 2:.5.:ml. 
1. 5 mMTris (pH 8'8) 	 38 ml 
10%SDS 	 01 ml. 
10 %ammoiüum,persulphate 	 01 ml. 
TEMED 	 . QØO4 ml 
:10-211 
•10.1;8.4Five stacking gel (4 ml :vólume) 
H,() 
40% acrylamide (Sigma premix) 
1-5 mM Tris (pH 68) 
10%SDS 
10 % ammoni urn persuiphate-
TEMED 



















.10.1.9 Reagents used in ELISAs 
1.0.1.91 Carbonate coating buffer (ph .9.4-9.6) 
i .59g NajCo. 
2.93g .NaHCO3 
IL dH2O. 
10;192 PBSITween solution 
489 PBS (Duibccco) 
2.5 ml Tween (Sigma) (0.05%). 
51 .dH2O 
103 93 OPD 
1:tablet (10Mg) OPD (Sigma) 
6m1buffèrA(0:1 M citric acid- 96 gin 500 ml ofdH 2O) 
6.4.ml büffer.B.(0.2 M .phosphate-14.2.g Na,HP0 4Th 500 ml of dH20). 
12.5 mi dH20 
i02i 2 
10.2 POR -prlhiers -USed 
AU primçr equenes arc written 5"'W 3' 
10.2;1 .7H8/6 diagnostic PCR 
Primer 	'Description 	Sequence 
Name 
P17 	 ACATTATCATAATGAC( T) CCAGAACT 
.3' ..GTTTCCAATAATTCT-TTTTCTA-TC 
10.2.2 Genotyping primers 
I0123- MSP4 Polymorphic-- 
Primer.. Description- 	. 
;Name  
-01 5' outer -CACATGAAAGT-TATCAAGAACTTGTC 
02 .3'.oiitcr 	. GTcGTCTAATTCTTGCCG 
Ni 5inner GAGTATTGACAGGTTATGG 
N2 1 3 -Inner GATTGAAAGGTATTTGAC. 
10.2.2.2MSPI Dimorphic 
Primer 'Description Sequence 
Name  
IG 5' outer A'GtCGATATTtCTTAAATTCACG 
1 H. 	' 3 outer ATTATTTTCGTTACAAGTAGG 
1A 5' MAD2O GAGAAGTTCCCATCATCACCAC 
-inner  
1 B 5' Ki specific GAATTGCTGATTTATCAACAG 
inner  
IC 3' conserved CATCTAAATGTCTGAAACATCC 
inner  
10-213 




13 5' outer AATGAPAGTAAATATAGCAAQACATTC 
10. 3 quteii GAAGAGAATTAT4TGAATATGGC 
Si 	:I-5:' -inner . ' GAGTATAAGGAGAAGTATG 
J :S4 . 3 .i.nner ICTAGAACCATGCATATG?C C 
1O2.2.4 MSP.2 Dimorphic. 
:Primer . Description. Sequence 
Name  
2D ii — c 	AQ(..TMAAGAAGAGG  
inner  
2E 5' A:specific ACTGCACAACCTGAACMGC 
inner  
2F .3 conserved . GTGTTGCTGAAATTAAAACAAC 
inner 
10.2.3 MSP2  ci loning ,primers 
Primer Description Sequence 
Name  
.2A .3' 	s.pecific 	. GG3AATTCTTAGGTACTGGTAGATGCTTCTGCAT 
C... 
2B 3'FC27 GGGAATTCTTATTCACTCTCTTCTCCTTTACCGT 
specific  
2C 5' conserved 	. CGCGGATCCAATATGAGTATAAGGAGAAGATG 
EcoiRl target sequence 
BamH I target sequence 
Stop codon 
1.0-214 
10.2.4 Primers used to generate dimorphic MSP 2 antigens 







Complementary to D3 
EcoRl target sequence 
Stop codon 
10.2.4.2 B type MSP2 dimorphic primers 
Complementary to H3 
EcoRl target sequence 
Stop codon 
S2 GAAGGTAATFAAAACAT1'GTC 
10.2.5 pGEX primers (PCR and sequencing), 
Primer Description Sequence 
Name  
pGEXF pGEX plasmid- GCATGECCTTTGCAGGG 
forward  
pGEXR pGEX plasmid OCGGGAGCPGCATGTGTGTCAAGAGG 
reverse 	- 
10-215 
